JP4970682B2 - Vitamin D precursors, methods and intermediates - Google Patents
Vitamin D precursors, methods and intermediates Download PDFInfo
- Publication number
- JP4970682B2 JP4970682B2 JP2001543549A JP2001543549A JP4970682B2 JP 4970682 B2 JP4970682 B2 JP 4970682B2 JP 2001543549 A JP2001543549 A JP 2001543549A JP 2001543549 A JP2001543549 A JP 2001543549A JP 4970682 B2 JP4970682 B2 JP 4970682B2
- Authority
- JP
- Japan
- Prior art keywords
- cooch
- alkyl
- tbdps
- group
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 28
- 239000002243 precursor Substances 0.000 title description 10
- 239000000543 intermediate Substances 0.000 title description 9
- 229930003316 Vitamin D Natural products 0.000 title description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title description 5
- 235000019166 vitamin D Nutrition 0.000 title description 5
- 239000011710 vitamin D Substances 0.000 title description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 title description 5
- 229940046008 vitamin d Drugs 0.000 title description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 121
- 150000001875 compounds Chemical class 0.000 claims description 44
- 239000001257 hydrogen Substances 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 239000004367 Lipase Substances 0.000 claims description 12
- 102000004882 Lipase Human genes 0.000 claims description 12
- 108090001060 Lipase Proteins 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 235000019421 lipase Nutrition 0.000 claims description 12
- -1 vinyl fatty acid Chemical class 0.000 claims description 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 5
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 150000008065 acid anhydrides Chemical class 0.000 claims description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 3
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 claims description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 2
- 125000005862 (C1-C6)alkanoyl group Chemical group 0.000 claims description 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 2
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 claims description 2
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 150000008366 benzophenones Chemical group 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 238000000844 transformation Methods 0.000 claims 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 118
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 110
- 229910052698 phosphorus Inorganic materials 0.000 description 102
- 238000005160 1H NMR spectroscopy Methods 0.000 description 94
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 83
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 65
- 238000006243 chemical reaction Methods 0.000 description 63
- 239000000243 solution Substances 0.000 description 51
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 49
- 235000019439 ethyl acetate Nutrition 0.000 description 47
- 239000000203 mixture Substances 0.000 description 42
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene chloride Substances ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 30
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 24
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 23
- 239000012230 colorless oil Substances 0.000 description 23
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 23
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 22
- 239000003921 oil Substances 0.000 description 22
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 21
- 239000000741 silica gel Substances 0.000 description 21
- 229910002027 silica gel Inorganic materials 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 238000003818 flash chromatography Methods 0.000 description 20
- 239000012044 organic layer Substances 0.000 description 19
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 239000010410 layer Substances 0.000 description 15
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- RNVFYQUEEMZKLR-UHFFFAOYSA-N 1-carbomethoxy-3,5-dihydroxybenzene Natural products COC(=O)C1=CC(O)=CC(O)=C1 RNVFYQUEEMZKLR-UHFFFAOYSA-N 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 6
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 0 *[C@](C(C1)(C(*)C(C2)C12N)O)N Chemical compound *[C@](C(C1)(C(*)C(C2)C12N)O)N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- JWVUIKXKNJEOID-YIZRAAEISA-N methyl (1s,3s,5r)-3-acetyloxy-5-hydroxycyclohexane-1-carboxylate Chemical compound COC(=O)[C@H]1C[C@@H](O)C[C@@H](OC(C)=O)C1 JWVUIKXKNJEOID-YIZRAAEISA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- CPVSOZCCFCMWGD-ILXRZTDVSA-N [(1s,3s,5r)-3-acetyloxy-5-methoxycarbonylcyclohexyl] benzoate Chemical compound C1[C@H](C(=O)OC)C[C@H](OC(C)=O)C[C@H]1OC(=O)C1=CC=CC=C1 CPVSOZCCFCMWGD-ILXRZTDVSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 3
- JAPMJSVZDUYFKL-UHFFFAOYSA-N bicyclo[3.1.0]hexane Chemical class C1CCC2CC21 JAPMJSVZDUYFKL-UHFFFAOYSA-N 0.000 description 3
- 150000005690 diesters Chemical class 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000006197 hydroboration reaction Methods 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 3
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 3
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 2
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- FNTHQRXVZDCWSP-UHFFFAOYSA-N cyclohexane-1,1,2-triol Chemical compound OC1CCCCC1(O)O FNTHQRXVZDCWSP-UHFFFAOYSA-N 0.000 description 2
- WEIMJSIRDZDHAH-UHFFFAOYSA-N cyclopent-3-en-1-ol Chemical compound OC1CC=CC1 WEIMJSIRDZDHAH-UHFFFAOYSA-N 0.000 description 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FUQRMLNQPPTPTF-VPOLOUISSA-N methyl (1r,3r,4s,5s)-3-acetyloxy-4-ethyl-5-hydroxycyclohexane-1-carboxylate Chemical compound CC[C@H]1[C@@H](O)C[C@@H](C(=O)OC)C[C@H]1OC(C)=O FUQRMLNQPPTPTF-VPOLOUISSA-N 0.000 description 2
- PSNPOBHKAGJGKV-QRYDPKPESA-N methyl (1r,3r,4s,5s)-3-acetyloxy-5-hydroxy-4-methylcyclohexane-1-carboxylate Chemical compound COC(=O)[C@@H]1C[C@H](O)[C@H](C)[C@H](OC(C)=O)C1 PSNPOBHKAGJGKV-QRYDPKPESA-N 0.000 description 2
- JITHOIDNPRRFQI-FRRDWIJNSA-N methyl (1r,3s,5r)-3-hydroxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](O)C[C@@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JITHOIDNPRRFQI-FRRDWIJNSA-N 0.000 description 2
- JITHOIDNPRRFQI-AVGNSLFASA-N methyl (1s,3s,5s)-3-hydroxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)C[C@H](O)C[C@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JITHOIDNPRRFQI-AVGNSLFASA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 150000003509 tertiary alcohols Chemical group 0.000 description 2
- PKFBWEUIKKCWEW-WEZTXPJVSA-N (1r,3r)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1C[C@@H](O)C[C@H](O)C1 PKFBWEUIKKCWEW-WEZTXPJVSA-N 0.000 description 1
- DDCPKNYKNWXULB-RXMQYKEDSA-N (2r)-2-azaniumyl-3-[(2-methylpropan-2-yl)oxy]propanoate Chemical compound CC(C)(C)OC[C@@H]([NH3+])C([O-])=O DDCPKNYKNWXULB-RXMQYKEDSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- BPOVRAAUERBWFK-UHFFFAOYSA-N 1-hydroxycyclohexane-1-carboxylic acid Chemical compound OC(=O)C1(O)CCCCC1 BPOVRAAUERBWFK-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 1
- SHHIMUFCXCXSMK-UHFFFAOYSA-N 3,5-dihydroxy-2-methylbenzoic acid Chemical compound CC1=C(O)C=C(O)C=C1C(O)=O SHHIMUFCXCXSMK-UHFFFAOYSA-N 0.000 description 1
- KMMHZIBWCXYAAH-UHFFFAOYSA-N 4-bromobenzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C(Br)C=C1 KMMHZIBWCXYAAH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- RBYVTPIIZPRYPA-UHFFFAOYSA-N C(=O)=C1CC(CC(C1)O)O Chemical compound C(=O)=C1CC(CC(C1)O)O RBYVTPIIZPRYPA-UHFFFAOYSA-N 0.000 description 1
- ULNBMNBGCAIRGQ-MQBGSOHWSA-N CC1CC[C@@H](C[C@@H]1O[Si](C2=CC=CC=C2)(C3=CC=CC=C3)C(C)(C)C)C(=O)OC Chemical compound CC1CC[C@@H](C[C@@H]1O[Si](C2=CC=CC=C2)(C3=CC=CC=C3)C(C)(C)C)C(=O)OC ULNBMNBGCAIRGQ-MQBGSOHWSA-N 0.000 description 1
- XYXMEIVHXXARLE-OSZJIOELSA-N C[C@@H]1[C@@H](C[C@@H](C[C@@H]1O[Si](C2=CC=CC=C2)(C3=CC=CC=C3)C(C)(C)C)C(=O)O)O Chemical compound C[C@@H]1[C@@H](C[C@@H](C[C@@H]1O[Si](C2=CC=CC=C2)(C3=CC=CC=C3)C(C)(C)C)C(=O)O)O XYXMEIVHXXARLE-OSZJIOELSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- ZYZBAAMICXPFBE-QDPPLXMDSA-N [(1r,2r,3s,5s)-3-[tert-butyl(diphenyl)silyl]oxy-2,5-dimethylcyclohexyl] acetate Chemical compound C1[C@@H](C)C[C@@H](OC(C)=O)[C@@H](C)[C@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 ZYZBAAMICXPFBE-QDPPLXMDSA-N 0.000 description 1
- WIKBZEASMKHYBJ-CCOBIDFTSA-N [(1r,2r,3s,5s)-3-[tert-butyl(diphenyl)silyl]oxy-2-ethyl-5-methylcyclohexyl] acetate Chemical compound CC[C@@H]1[C@H](OC(C)=O)C[C@H](C)C[C@@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 WIKBZEASMKHYBJ-CCOBIDFTSA-N 0.000 description 1
- XQQIZHXFVZUURQ-KBAYOESNSA-N [(1r,3r,5r)-3-(4-bromophenyl)sulfonyloxy-5-methoxycarbonylcyclohexyl] benzoate Chemical compound O([C@H]1C[C@@H](C[C@H](C1)C(=O)OC)OC(=O)C=1C=CC=CC=1)S(=O)(=O)C1=CC=C(Br)C=C1 XQQIZHXFVZUURQ-KBAYOESNSA-N 0.000 description 1
- JRTVOYWRDKDNBV-GUDVDZBRSA-N [(1r,3r,5r)-3-methoxycarbonyl-5-(4-methylphenyl)sulfonyloxycyclohexyl] benzoate Chemical compound O([C@H]1C[C@@H](C[C@H](C1)C(=O)OC)OC(=O)C=1C=CC=CC=1)S(=O)(=O)C1=CC=C(C)C=C1 JRTVOYWRDKDNBV-GUDVDZBRSA-N 0.000 description 1
- GIYSFXIBRXHGHW-AGIUHOORSA-N [(1s,3s,5r)-3-hydroxy-5-methoxycarbonylcyclohexyl] benzoate Chemical compound C1[C@H](C(=O)OC)C[C@H](O)C[C@H]1OC(=O)C1=CC=CC=C1 GIYSFXIBRXHGHW-AGIUHOORSA-N 0.000 description 1
- JRTVOYWRDKDNBV-FHWLQOOXSA-N [(1s,3s,5s)-3-methoxycarbonyl-5-(4-methylphenyl)sulfonyloxycyclohexyl] benzoate Chemical compound O([C@@H]1C[C@H](C[C@@H](C1)C(=O)OC)OC(=O)C=1C=CC=CC=1)S(=O)(=O)C1=CC=C(C)C=C1 JRTVOYWRDKDNBV-FHWLQOOXSA-N 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 125000003865 brosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)S(*)(=O)=O 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005888 cyclopropanation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- AIJOUPQRPWQTLR-ICDZXHCJSA-N methyl (1r,3r,5r)-3-(4-bromophenyl)sulfonyloxy-5-[tert-butyl(diphenyl)silyl]oxycyclohexane-1-carboxylate Chemical compound O([C@H]1C[C@@H](C[C@H](C1)C(=O)OC)O[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C(C)(C)C)S(=O)(=O)C1=CC=C(Br)C=C1 AIJOUPQRPWQTLR-ICDZXHCJSA-N 0.000 description 1
- JQBJQIBEXIJBCB-RCCFBDPRSA-N methyl (1r,3r,5r)-3-[tert-butyl(dimethyl)silyl]oxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JQBJQIBEXIJBCB-RCCFBDPRSA-N 0.000 description 1
- JITHOIDNPRRFQI-JHJVBQTASA-N methyl (1r,3r,5r)-3-hydroxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@@H](O)C[C@@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JITHOIDNPRRFQI-JHJVBQTASA-N 0.000 description 1
- VPKBHSIOHKNSIW-ADEWGFFLSA-N methyl (1r,3r,5s)-3-(4-bromophenyl)sulfonyloxy-5-hydroxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](O)C[C@@H]1OS(=O)(=O)C1=CC=C(Br)C=C1 VPKBHSIOHKNSIW-ADEWGFFLSA-N 0.000 description 1
- YGVKGHFNFXVQEK-GRYCIOLGSA-N methyl (1r,3r,5s)-3-[tert-butyl(dimethyl)silyl]oxy-5-hydroxycyclohexane-1-carboxylate Chemical compound COC(=O)[C@@H]1C[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)C1 YGVKGHFNFXVQEK-GRYCIOLGSA-N 0.000 description 1
- OGWJMWJOXWTOJI-HSALFYBXSA-N methyl (1r,3r,5s)-3-[tert-butyl(diphenyl)silyl]oxy-5-hydroxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](O)C[C@@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 OGWJMWJOXWTOJI-HSALFYBXSA-N 0.000 description 1
- JQBJQIBEXIJBCB-KSZLIROESA-N methyl (1r,3s,5r)-3-[tert-butyl(dimethyl)silyl]oxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JQBJQIBEXIJBCB-KSZLIROESA-N 0.000 description 1
- FENXFVOOMDLVOP-NXCFDTQHSA-N methyl (1r,3s,5r)-3-[tert-butyl(diphenyl)silyl]oxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound O([C@H]1C[C@H](C[C@H](C1)C(=O)OC)O[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C(C)(C)C)S(=O)(=O)C1=CC=C(C)C=C1 FENXFVOOMDLVOP-NXCFDTQHSA-N 0.000 description 1
- AVFDPXOAVOGRBT-KWCYVHTRSA-N methyl (1r,3s,5r)-3-acetyloxy-5-(4-bromophenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](OC(C)=O)C[C@@H]1OS(=O)(=O)C1=CC=C(Br)C=C1 AVFDPXOAVOGRBT-KWCYVHTRSA-N 0.000 description 1
- IFCCNIGKFKRSOM-QLFBSQMISA-N methyl (1r,3s,5r)-3-acetyloxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](OC(C)=O)C[C@@H]1OS(=O)(=O)C1=CC=C(C)C=C1 IFCCNIGKFKRSOM-QLFBSQMISA-N 0.000 description 1
- WFDWFBDXGZTMRB-HZSPNIEDSA-N methyl (1r,3s,5r)-3-acetyloxy-5-[tert-butyl(dimethyl)silyl]oxycyclohexane-1-carboxylate Chemical compound COC(=O)[C@@H]1C[C@H](OC(C)=O)C[C@H](O[Si](C)(C)C(C)(C)C)C1 WFDWFBDXGZTMRB-HZSPNIEDSA-N 0.000 description 1
- CLBZGIBELCKMSP-AKAGGGOCSA-N methyl (1s,3r,4r,5s)-3-[tert-butyl(diphenyl)silyl]oxy-4-ethyl-5-methylsulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@H](C(=O)OC)C[C@H](OS(C)(=O)=O)[C@H](CC)[C@@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 CLBZGIBELCKMSP-AKAGGGOCSA-N 0.000 description 1
- IZDXAQGFJLTQHF-XLHSGLJYSA-N methyl (1s,3r,4r,5s)-3-[tert-butyl(diphenyl)silyl]oxy-4-methyl-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound O([C@@H]1C[C@@H](C[C@@H]([C@@H]1C)OS(=O)(=O)C=1C=CC(C)=CC=1)C(=O)OC)[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 IZDXAQGFJLTQHF-XLHSGLJYSA-N 0.000 description 1
- IXBUTIWYBDFSLS-QCNOEVLYSA-N methyl (1s,3r,4r,5s)-3-acetyloxy-4-ethyl-5-methylsulfonyloxycyclohexane-1-carboxylate Chemical compound CC[C@@H]1[C@H](OC(C)=O)C[C@H](C(=O)OC)C[C@@H]1OS(C)(=O)=O IXBUTIWYBDFSLS-QCNOEVLYSA-N 0.000 description 1
- KFHSKVMLHRDVSD-UOJCXKCYSA-N methyl (1s,3r,4r,5s)-3-acetyloxy-4-methyl-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)C[C@@H](OC(C)=O)[C@@H](C)[C@H]1OS(=O)(=O)C1=CC=C(C)C=C1 KFHSKVMLHRDVSD-UOJCXKCYSA-N 0.000 description 1
- PSNPOBHKAGJGKV-DOWZNPNQSA-N methyl (1s,3r,4r,5s)-3-acetyloxy-5-hydroxy-4-methylcyclohexane-1-carboxylate Chemical compound COC(=O)[C@H]1C[C@H](O)[C@@H](C)[C@H](OC(C)=O)C1 PSNPOBHKAGJGKV-DOWZNPNQSA-N 0.000 description 1
- BKWNGFOVJXORIK-VPOLOUISSA-N methyl (1s,3r,4r,5s)-3-butanoyloxy-5-hydroxy-4-methylcyclohexane-1-carboxylate Chemical compound CCCC(=O)O[C@@H]1C[C@@H](C(=O)OC)C[C@H](O)[C@H]1C BKWNGFOVJXORIK-VPOLOUISSA-N 0.000 description 1
- QLRSRLOAACDRDY-OSRDXIQISA-N methyl (1s,3r,4r,5s)-3-hydroxy-4-methyl-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)C[C@@H](O)[C@@H](C)[C@H]1OS(=O)(=O)C1=CC=C(C)C=C1 QLRSRLOAACDRDY-OSRDXIQISA-N 0.000 description 1
- KZHCUJVOHIWXPS-JLIMGVALSA-N methyl (1s,3r,4r,5s)-4-ethyl-3-hydroxy-5-methylsulfonyloxycyclohexane-1-carboxylate Chemical compound CC[C@@H]1[C@H](O)C[C@H](C(=O)OC)C[C@@H]1OS(C)(=O)=O KZHCUJVOHIWXPS-JLIMGVALSA-N 0.000 description 1
- JQBJQIBEXIJBCB-FGTMMUONSA-N methyl (1s,3r,5s)-3-[tert-butyl(dimethyl)silyl]oxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JQBJQIBEXIJBCB-FGTMMUONSA-N 0.000 description 1
- FENXFVOOMDLVOP-UODIDJSMSA-N methyl (1s,3r,5s)-3-[tert-butyl(diphenyl)silyl]oxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound O([C@@H]1C[C@@H](C[C@@H](C1)C(=O)OC)O[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C(C)(C)C)S(=O)(=O)C1=CC=C(C)C=C1 FENXFVOOMDLVOP-UODIDJSMSA-N 0.000 description 1
- CWZKXDNNFUDMGH-YXQCUUTOSA-N methyl (1s,3s,4r,5r)-3-[tert-butyl(diphenyl)silyl]oxy-4-ethyl-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound O([C@@H]1C[C@H](C[C@@H]([C@H]1CC)O[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C(C)(C)C)C(=O)OC)S(=O)(=O)C1=CC=C(C)C=C1 CWZKXDNNFUDMGH-YXQCUUTOSA-N 0.000 description 1
- PIQLTTPJNRLKFH-QVGHQYEOSA-N methyl (1s,3s,4r,5r)-3-[tert-butyl(diphenyl)silyl]oxy-4-ethyl-5-hydroxycyclohexane-1-carboxylate Chemical compound CC[C@@H]1[C@H](O)C[C@H](C(=O)OC)C[C@@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 PIQLTTPJNRLKFH-QVGHQYEOSA-N 0.000 description 1
- IZDXAQGFJLTQHF-CYZBZIJESA-N methyl (1s,3s,4r,5r)-3-[tert-butyl(diphenyl)silyl]oxy-4-methyl-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound O([C@H]1C[C@@H](C[C@H]([C@@H]1C)OS(=O)(=O)C=1C=CC(C)=CC=1)C(=O)OC)[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 IZDXAQGFJLTQHF-CYZBZIJESA-N 0.000 description 1
- HXPOPFFUGWXAIM-KZTDQWPFSA-N methyl (1s,3s,4r,5s)-3-[tert-butyl(diphenyl)silyl]oxy-4-methyl-5-methylsulfonyloxycyclohexane-1-carboxylate Chemical compound C[C@H]1[C@@H](OS(C)(=O)=O)C[C@@H](C(=O)OC)C[C@@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 HXPOPFFUGWXAIM-KZTDQWPFSA-N 0.000 description 1
- IEBSMUFUWBYYTB-FUKQBSRTSA-N methyl (1s,3s,4r,5s)-3-[tert-butyl(diphenyl)silyl]oxy-5-hydroxy-4-methylcyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)C[C@H](O)[C@@H](C)[C@H]1O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 IEBSMUFUWBYYTB-FUKQBSRTSA-N 0.000 description 1
- JQBJQIBEXIJBCB-SQNIBIBYSA-N methyl (1s,3s,5s)-3-[tert-butyl(dimethyl)silyl]oxy-5-(4-methylphenyl)sulfonyloxycyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1OS(=O)(=O)C1=CC=C(C)C=C1 JQBJQIBEXIJBCB-SQNIBIBYSA-N 0.000 description 1
- CUBFNXKMEASJGN-NLPUTRAISA-N methyl (1s,3s,5s)-3-tert-butyl-5-(4-methylphenyl)sulfonyloxy-1,2-diphenylcyclohexane-1-carboxylate Chemical compound C1([C@H](C[C@@H](C[C@@]1(C(=O)OC)C=1C=CC=CC=1)OS(=O)(=O)C=1C=CC(C)=CC=1)C(C)(C)C)C1=CC=CC=C1 CUBFNXKMEASJGN-NLPUTRAISA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 description 1
- 229940081066 picolinic acid Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- KJTULOVPMGUBJS-UHFFFAOYSA-N tert-butyl-[tert-butyl(diphenyl)silyl]oxy-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 KJTULOVPMGUBJS-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/40—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【0001】
本発明は19−ノール−ビタミンD類似化合物の合成に有効に用いられる前駆物質、更にそれを調製するための方法及び中間体に関する。より具体的には、本発明は上記ビタミンD類似化合物のA−環の前駆物質に関する。このA環は下記の構造で表される(例えば、Mazur et al., Tetrahedron Letters 1995, 2987参照)。
【0002】
【化8】
【0003】
(−)−キナ酸又はシクロヘキサン−トリオールから、19−ノール−A−環前駆物質としてのビシクロ[3.1.0]ヘキサン誘導体を合成する技術は、M. Vandewalleらによって(Tetrahedron Letters, 1995, 36 (45), 8299−8302)発展してきた、また、それはシクロプロピリックアルコ−ルからホモアリリックアルコールへの公知のシグマトロピー再配列に基づいている。天然ビタミンDにおけるこの再配列の可能性は、Mazurら(op. cit.)によって初めて立証された。他に2,4−ペンタン−ジオンからの合成技術も報告された(S.Z. Zhou, S. Anne, M. Vandewalle, Tetrahedron Letters, 1996, 37 (42), 7637−7640)。3−シクロペンテノールもまた、上記調製のための前駆物質として使用された(W. Yong, M. Vandewalle; Synlett, 1996, 9, 911−912)。
【0004】
これらの方法は、しかしながら、以下の不都合がある:
−(−)−キナ酸からの調製には、大量生産での制御が難しいラジカル脱酸素反応が含まれ、さらに有毒なトリブチルスズ水素化物を使用している;
−シクロヘキサントリオールからの工程は多くのステップ(12)を通して行なわれ、2つの酵素反応を必要とする;
−開始物質である3−シクロペンテノールは市販されていない。シクロペンタジエンから収率の低いヒドロホウ素化ステップを用いて調製しなければいけない。さらに、ホルミル基のシクロプロパネーション及び導入は扱いにくい;
−2,4−ペンタンジオンから開始する合成(10ステップ)は中間体ビスエポキシドを調製する第一ステップにおいて低収率になる。さらに、それらが低分子量であるために、中間体の中には揮発しやすくて、大量スケール工程では精製しにくいものもある。
【0005】
広範囲の19−ノール−A−環前駆物質は3,5−ジヒドロキシ安息香酸誘導体又はその4−アルキル置換同族体から開始することで調製されることが分かっている。これらの前駆物質はこれまでに開示された方法より効果的な方法によって大量スケールで得ることができる。
【0006】
従って第一の特徴において、本発明は式(I):
【0007】
【化9】
【0008】
式中、
−Aは−CH2OH基, −CH2−OCOR’基, −COR’’基, −CSR’’基又はエチニル基であり;
−Rは水素又は (C1−C6)アルキルであり;
−R1は水素、(C1−C6)アルキル又は−(CH2)n−OP基であり;
−R2は水素又は−OP基であり;
−R’は(C1−C6)アルキル又はフェニルであり;
−R’’は水素、ヒドロキシル、(C1−C6)アルキル、(C1−C6)アルコキシ、(C1−C6)アルキルチオ、又は、ジ(C1−C3)アルキルアミノであり;
−Pは水素;(C1−C6)アルカノイル;(C1−C4)アルキル、ハロゲン若しくはニトロによってフェニルが任意に置換されたベンゾイル;(C1−C6)アルコキシカルボニル;各R3が独立に(C1−C6)アルキル若しくはフェニルを表す−Si(R3)3基;モノ若しくはジ(C1−C6)アルコキシ(C1−C6)アルキル;テトラヒドロフラニル;又は、テトラヒドロピラニルであり;
−nは0、1、2、3、又は、4である:
の化合物の調製方法であって、
(i)式1
【0009】
【化10】
【0010】
式中、Aは(C1−C6)アルコキシカルボニル、好ましくはメトキシカルボニル、又は、ジ(C1−C3)アルキルアミノカルボニルであり、Rは上記に定義したものと同様である;
の化合物とリパーゼを、ビニル脂肪酸又は酸無水物中で反応させるステップ、
(ii)得られた式2又は2’
【0011】
【化11】
【0012】
式中、Zは(C1−C6)アルキルなどのアルキル、好ましくは(C1−C3)アルキルである;
の化合物を対応する式(I)の化合物に変換させるステップ、
からなる調製方法に関する。
【0013】
一般スキーム1に示したように、A−環前駆物質の調製に用いられる開始物質はメチル3,5−ジヒドロキシ−安息香酸又はそのエステル、若しくは、その4−アルキル置換同族体のエステルに水素添加し、P. WangとJ. AdamsによってJ Am Chem Soc 1994, 116, 3296−3305に記載された方法から少し変更した方法を行なって得られる。
【0014】
最初のステップは、1−アルコキシ(又はジアルキルアミノ)カルボニル−3,5−ジヒドロキシ−シクロヘキサン又はその4−アルキル置換同族体を、例えば、ビニルアセテート、ビニルプロピオネート若しくはビニルブチレート等のビニルアルカノエート、又は、無水酢酸、無水プロピオン酸若しくは無水酪酸などの酸無水物の溶媒中で、SAM II(Pseudomonas fluorescens由来のリパーゼ),CCL(Candida cylindracea由来のリパーゼ),PPL(porcine pancreas由来のリパーゼ),PSL(Pseudomonas cepacia由来のリパーゼ),GCL(Gotrichum candidum由来のリパーゼ)などのリパーゼを用いて、10℃〜40℃で好ましくは20℃で6〜72時間かけて、酵素により触媒作用を持たせて不斉化することからなる。このステップによって対応するアルキル(又はジアルキル)(1S,3S,5R)−3−アルキルカルボニルオキシ−5−ヒドロキシ若しくは(1S,3S,4R,5R)−4−アルキル−3−アルキルカルボニルオキシ−5−ヒドロキシ−シクロヘキサンカルボキシレート(又はカルボキシアミド)2、又は、対応するアルキル(又はジアルキル)(1S,3S,5R)−5−アルキルカルボニルオキシ−3−ヒドロキシ若しくは(1S,3S,4R,5R)−4−アルキル−5−アルキルカルボニルオキシ−3−ヒドロキシ−シクロヘキサンカルボキシレート(又はカルボキシアミド)2’が得られる。
【0015】
また、ジエステル3を、適当な酵素を用いて、enantiotoposelective酵素により触媒作用を持たせて加水分解することによる不斉化は、同一ファミリーの化合物につながるために起こりうる。
【0016】
スキーム2及び3にはスキーム1に記載した化合物2又は2’から、R=H、R2=OPの一般式(I)のすべてのジアステレオ異性体を合成する方法について記載されている。
【0017】
これらのスキームに示された通り、化合物(I)への化合物2又は2’の変換は、結果として得られるジアステレオ異性体に依存して様々な順序で部分的に又は全体的に行なわれ得る以下のステップの1つ又は複数を用いて行なわれる:(1)ヒドロキシ基の保護(例えば、P=TBDMS、TBDPS)、(2)エステル加水分解、(3)3又は5−ヒドロキシ基の反転、(4)脱離基の形成(例えば、L = OTos、 OBros、OMs)、(5)所望のビシクロ[3.1.0]ヘキサンへの塩基含有閉環反応、(6)カルボアルコキシ又はカルバモイル官能基(A)から所望の置換基Aへの変換。
【0018】
ステップ(2)及び(4)は従来から当業者によく知られた公知の反応である。ステップ(1)はJ. Am. Chem. Soc.(1972, 94, 6190)又はProtective groups in Organic Synthesis, T.W. Greene, John Wiley Sons(New York)に従って行なわれ得る。ステップ(3)はSynthesis(1981, 1)に従って、又は、2段階の工程によって行なわ得る(脱離反応、ヒドロホウ素化反応)。ステップ(5)はTetrahedron Letters, 1995, 36 (45), 8299−8302に従って行なわれ得る。ステップ(6)はJ. Gen. Chem. USSR 1964, 34, 1021に従って行なわれ得る。
【0019】
スキーム2は、具体的には、3aSコンフィグレーション(α配向シクロプロピル環)を持ったすべてのジアステレオ異性体の合成法について記載されている。
【0020】
スキーム3は、具体的には、3aRコンフィグレーション(β配向シクロプロピル環)を持ったすべてのジアステレオ異性体の合成法について記載されている。
【0021】
一般的なスキーム4に示されているように、R=H及びA=CH2OHの3aヒドロキシメチル置換ビシクロ[3.1.0]ヘキサン化合物(I)はC−1で変成するビタミンD類似化合物に対するA−環前駆物質の合成に役に立つことができる。その可能性は、重要な中間体としてケトン4.2を用いるI.a(R=H,P=TBDPS,A=CH2OH)から例示される。グリニャール反応(例えばR1=Me又はEt)によってジアステレオ選択的に三級アルコールI.iが得られ、同時に保護エステル官能基の除去が起こる。一方、4.2のメチレン化によって4.3が得られる。最も良い結果(収率68%)はLombardo法(Tetrahedron Lett., 1982, 23, 4293)により得られる。また、Wittig又はTebbe反応(J. Org. Chem.,1985, 50, 1212)によってそれぞれ39%、54%の収率が得られる。
【0022】
4.3の二ヒドロキシル化によって、エピマー4.4の次に主要な生成物として所望のジオールI.m.が得られる(比率85:15:ここには示さない)。一方、4.3のヒドロホウ素化によって2R及び2Sヒドロキシメチル化合物が75:25の比率で得られる(73%)。これらのエピマーアルコールが分けられて、TBDPSエーテル形成後I.jが得られ(81%)、次にエステル加水分解後I.kが得られる(81%)。4.3において酢酸水銀が介在する水の添加によって、三級アルコールI.l、次にI.iが75:25の比率で得られる。
【0023】
3,5−ジヒドロキシ安息香酸誘導体から19−ノールA環前駆物質を調製する新規の方法は、これまでに述べられた方法よりも短い。上記経路の実際的な重要性は、主に、中間体の大部分は結晶性で、シリカゲルクロマトグラフィーによる昔からの精製法より大量スケールにおいてより簡易である結晶化によって精製出来るという事実にあり、異性体の純度を高いレベルで保証する。
【0024】
【化12】
【0025】
【化13】
【0026】
【化14】
【0027】
【化15】
【0028】
このように調製されたすべての化合物(I)はコンフィグレーション2S、3aS、4aS(Aはホルミル基、ヒドロキシメチル基、エチニル基又はメトキシカルボニル基であり、R及びR2は共に水素であり、R1は−OSi(R3)3基である)の化合物を除いて新規である。
【0029】
従って、これらの新規の化合物は本発明の他の特徴を表す。
好ましい化合物(I)としては
−Aは−CH2OH基, −CH2−OCOR’基, −COR’’基又はエチニル基であり;
−R1は(C1−C6)アルキル又は−(CH2)n−OP基であり;
−R’はフェニルであり;
−R’’は水素であり;
−Pは水素又は−Si(R3)3基であり;
−nは0、又は、1である
化合物が挙げられる。
【0030】
化合物(I)は、例えば、Tetrahedron Letters, 1996 ; 37 (42) : 7637−7640に記載されている以下のスキームに従ってビタミンD(19−ノール、1α、25(OH)2−D3)の合成に使用することが出来る。
【0031】
【化16】
【0032】
本発明は更に、化合物(I)を調製するための中間体に関する。特に、本発明は式(II):
【0033】
【化17】
【0034】
式中:
−A及びRは上記に定義したものと同様であり、
−R4及びR5はそれぞれ独立に上記に定義したP基、メシル基、トシル基、ブロシル基、又は、トリフルオロメシル基を表す、
ただし、Aがメトキシカルボニルで、Rが水素である時、化合物(II)のコンフィグレーションは1R、3R、5Rではない:
のジアステレオ異性体化合物に関する。
【0035】
また、式2又は2’:
【0036】
【化18】
式中、
−A及びRは上記に定義したものと同様であり、
−Zはアルキルである:
の化合物、さらに式1:
【0037】
【化19】
【0038】
式中、Aは上記に定義したものと同様であり、Rは(C1−C6)アルキルである:
の化合物も本発明の範囲である。
【0039】
本明細書、及び、添付した請求項において、「(C1−C3)アルキル」、「(C1−C4)アルキル」又は「(C1−C6)アルキル」という用語は、例えばメチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、t−ブチル基、ペンチル基、イソペンチル基又はヘキシル基などの1〜3個(それぞれ4個又は6個)の炭素原子を含有する直鎖又は分枝の炭化水素鎖を意図していると理解されたい。
【0040】
「(C1−C6)アルコキシ」又は「(C1−C6)アルキルチオ」という用語は、上記に定義したようにRが(C1−C6)アルキルであるOR基、SR基をそれぞれ意図していると理解されたい。
次に本発明を以下の調製法及び実施例によって説明する。
【0041】
式Iの中間体の調製
a)シス,シス−3,5−ジヒドロキシ−1−(メトキシカルボニル)シクロヘキサン:1.A(R=H,A=COOCH3)
Peng Wang及びJulian Adamsが3,5−ジヒドロキシ安息香酸の水素化に関してJ. Am. Chem. Soc.(1994, 116, 3296−3305)で記載したものと同様の条件で、メチル3,5−ジヒドロキシベンゾエートをMeOH中で水素化した。
メチル3,5−ジヒドロキシベンゾエート(57.6g,0.629mol,97%)、0.1%のAcOHを含有する5%のRh/Al2O3(5.76 g)のMeOH(400ml)溶液をオートクレーブ(1L)に加えた。オートクレーブに水素を用いてスチームを2回あてた(130atmから40atm)。水素圧は130atmに達し、温度は80〜85℃まで上昇した。温度が上がる過程で水素圧は低下する。圧が90atmまで低下したとき、水素圧は再び130atmまで上昇した。水素化は80〜85℃、130atmで12時間かけて行なわれ、次に、150℃まで加熱して、対応して圧は約155atmに達した。反応は36時間継続した。触媒をろ過して、ろ液を濃縮し、残留物をEtOAC/イソオクタンから結晶化して1.Aを得た(31.1g、収率50%)。
mp : 135.9 °C ;
UV (EtOH) : 211.4 nm (ε= 90.9) ;
IR (KBr) : 3284, 1734, 1259, 1015 cm-1 ;
1H-NMR (DMSO-d6) : δ1.13 (3H,m) ; 2.06 (3H,m) ; 2.30 (1H,m) ; 3.47 (2H,m) ; 3.61 (3H,s) ; 4.70 (2H,d) ppm.
【0042】
メチル3,5−ジヒドロキシベンゾエートを以下の化合物に置き換えた以外は、上述と同様の反応を行い:
−メチル3,5−ジヒドロキシ−4−メチルベンゾエート、又は、
−メチル3,5−ジヒドロキシ−4−エチルベンゾエート:
以下の化合物を得た:
−メチルオール−シス−3,5−ジヒドロキシ−4−メチル−シクロヘキサンカルボキシレート:1.B(R=Me, A=COOCH3)
mp : 123 °C ;
1H-NMR (500 MHz, CD3OD) : δ3.698 (2H,dt,J=4.0,12.0 Hz) ; 3.666 (3H,s) ; 2.40 (2H,tt,J=4.0,13.0 Hz) ; 2.23 (1H,m) ; (2H,dt,J=4.0,13.0 Hz) ; 1.54 (2H,q,J=13.0 Hz) ; 0.88 (3H,d,J=7.08 Hz) ppm.
−メチルオール−シス−4−エチル−3,5−ジヒドロキシ−シクロヘキサンカルボキシレート:1.C(R = Et,A=COOCH3)
mp : 94-96 °C;
1H-NMR (500 MHz, MeOD) : δ3.72 (2H, dt, J=10.9, 4.1 Hz), 3.66 (3H, s), 2.42 (1H, m), 1.86 (1H, bs), 1.79 (2H, dt, J=12.8, 4.1 Hz), 1.59 (2H, d, J=9.0 Hz), 1.46 (2H, m), 1.02 (3H, t, J=7.5 Hz) ppm.
【0043】
式2及び2’の中間体の調製(スキーム1)
I)一般式(I)とジオールの酵素エステル化
Ia)メチル(1S,3S,5R)−3−アセトキシ−5−ヒドロキシ−シクロヘキサンカルボキシレート:2.A(R=H,Z=Me,A=COOCH3)
メチルシス,シス−3,5−ジヒドロキシ−シクロヘキサンカルボキシレート1.A(R=H,A=COOCH3)(15.2 g, 87 mmol)と豚膵臓由来のリパーゼ(PPL −16.8 U/mg, 9.12 g)を円底フラスコに取り、続いてビニルアセテート(450 ml)を室温で加えた。フラスコを窒素で置換し、懸濁液を22時間、暗い中で攪拌した。次にセライトのパッドを通してろ過し、リパーゼを除去した。ろ液を蒸発させて濃縮した。残留物をシリカゲルのパッド(70〜200メッシュ、45g)を通してろ過することにより分離した。トルエン(210mL)で溶出し、次にトルエン/エチルアセテート=75/25(V/V,210mL)の混合液、続いてトルエン/エチルアセテート=50/50(V/V,210mL)の混合液で溶出し、最後に酢酸エチル(240mL)で溶出して濃縮後に2.A(R=H, Z=Me, A=COOCH3) (22.3 g,収量)を 黄色油状物として得た。
IR (film) : 3447, 1734, 1243 cm-1 ;
1H-NMR (CDCl3) : δ1.4 (3H,m), 2.1 (3H,s), 2.3 (5H,m), 3.7 (3H,s), 3.75 (1H,m), 4.7 (1H,m) ppm ;
[α]D 25 : +22.4 (c=1.25, CHCl3).
【0044】
Ib)メチル(1R,3S,4S,5R)−5−アセトキシ−3−ヒドロキシ−4−メチルシクロヘキサンカルボキシレート:2’.B(R=Me, Z=Me, A=COOCH3)及びメチル(1R,3S,4S,5R)−5−アセトキシ−3−ヒドロキシ−4−エチルシクロヘキサンカルボキシレート:2’.C(R=Et, Z=Me, A=COOCH3)
PPLをSAM II、PSL又はCCLに置き換える以外はIaに記載と同様の手順によって以下の化合物それぞれから:
−メチルオールシス−3,5−ジヒドロキシ−4−メチル−シクロヘキサンカルボキシレート:1.B(R=Me, A=COOCH3)
−メチルオールシスジヒドロキシ−4−エチル−3,5−シクロヘキサンカルボキシレート:1.C(R = Et, A=COOCH3)
以下の化合物を得た:
−メチル(1R,3S,4S,5R)−5−アセトキシ−3−ヒドロキシ−4−メチル−シクロヘキサンカルボキシレート:2’.B(R=Me, Z=Me, A=COOCH3):
IR (film) : 3434, 1731, 1439, 1243, 1027 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ4.84(1H, dt, J=4.3, 4.3 Hz) ; 3.82 (1H,m) ; 3.69 (3H,s) ; 2.45 (1H,m) ; 2.32 (1H,d, J=6.4 Hz) ; 2.05 (3H,s) ; 1.92 (2H,dt, J=4.0,
4.0 Hz) ; 1.77 (3H,m) ; 0.96 (3H,d, J=7.0 Hz) ppm ;
MS (m/z) : 231 (M+, 1) ; 213 ; 199 ; 186 ; 170 ; 152 ; 127 ; 111 ; 83 ; 87 ; 67 ; 43 (base peak) ;
[α]D 25 : -22.7 (c=0.38, CHCl3).
メチル(1R,3S,4S,5R)−5−アセトキシ−4−エチル−3−ヒドロキシ−シクロヘキサンカルボキシレート:2’.C(R=Et, Z=Me, A=COOCH3):
IR (film) : 3421, 2958, 2360, 1733, 1437, 1239, 1027, 739 cm-1
1H-NMR (500 MHz, CDCl3) : δ4.98 (1H, t, J=4.1 Hz), 3.87 (1H, m), 3.69 (3H, s), 2.60 (1H, bs), 2.16 (2H, m), 2.02 (3H, s), 1.84 (2H, m), 1.72 (1H, bs), 1.59 (2H, m), 1.47 (1H, m), 0.97 (3H, t, J=7.5 Hz) ppm ;
MS (m/z) : 245 (M++1), 233, 206, 184, 166, 141, 125, 111, 95, 87, 57, 43 (base peak).
[α]D 25: -50.2 (c=1.08, CHCl3).
【0045】
II)式3のジエステル類の酵素的加水分解
IIa)メチル(1S,3S,5R)−3−アセトキシ−5−ヒドロキシ−シクロヘキサン−カルボキシレート:2.A (R=H, Z=Me, A=COOCH3)
メソ−ジアセテート3.A (R=H, Z=Me, A=COOCH3) (92.1mg, 0.36mmol)の3.0mlCH3CN溶液に27.0mlの緩衝液(pH=7.0)を加え、次にSAM II(13.8 mg, 46.8 U/mg)を加えた。得られた混合液を室温で攪拌し、正確に計った1.0M NaOH溶液を加えてpHを7.0に保った。反応物は薄層クロトグラフィー分析によって測定した。NaClを加えて反応を終了させ、反応溶液を飽和させた。反応混合液をAcOEt(3 × 50 ml)で抽出した。ひとまとめの有機抽出物を飽和食塩水(3 × 10 ml)で洗浄し、MgSO4で乾燥し、濃縮した。残留物をイソオクタン/EtOAc(6:4)を溶離液としたHPLCで精製し、モノアセテート2.A(R=H, Z=Me, A=COOCH3)(30.1mg, 38.9 %)を無色油状物として得た。
【0046】
IIb)メチル(1S,3R,4R,5S)−3−ブタノイルオキシ−5−ヒドロキシ−4−メチル−シクロヘキサン−カルボキシレート:2B (R=Me, Z=n−C3H7, A=COOCH3)
1.B(R=Me, A=COOCH3)(0.2g, 1.10 mmol)のCH2Cl2(2ml)溶液に、室温で無水酪酸(538 μl, 3.29 mmol)を加え、次にTMSoTf(トリメチルシリルトリフレート)(25μl,1M)の溶液を加えた。この混合液を室温で30分間攪拌し、2.5mlのMeOHを加え、さらに2時間攪拌し、5% NaHCO3で反応を終了させた。反応溶液を飽和食塩水(3 × 20 ml)で洗浄し、で洗浄し、MgSO4で乾燥し、濃縮して残留物を得た。この残留物をイソオクタン:AcOEt(9:1)を溶離液としたシリカゲルクロマトグラフィーで精製し、ジブチレート3.B(R=Me, Z=n−C3H7, A=COOCH3)(3.9 g, 98.8%)を無色油状物として得た。このメソ−ジエステル(110mg,0.34mmol)のCH3CN(2.0ml)溶液に22.0mlの緩衝液(pH=7.0)を加え、次にSAM II(37 mg, 46.8 U/mg)を加えた。得られた混合液を室温で攪拌し、正確に計った1.0M NaOH溶液を加えてpHを7.0に保った。反応物は薄層クロトグラフィー分析によって測定した。NaClを反応溶液に加えて反応を終了させた。反応混合液をEtOAc(3 × 50 ml)で抽出し、MgSO4で乾燥し、濃縮して残留物を得た。残留物をイソオクタン/EtOAc(7:3)を溶離液としたHPLCで精製し、モノブチレート2.B(R=Me, Z=n−C3H7, A=COOCH3)(78 mg, 90 %)を無色油状物として得た。
IR (film) : 3495, 2964, 2878, 1731, 1438, 1281, 1183, 990 cm-1,
1H-NMR (CDCl3) : 4.83 (1H, dt), 3.83 (1H, m), 3.68 (3H, s), 2.45 (1H, m), 2.32 (1H, m), 2.28 (2H, t, J=7.9 Hz), 1.91 (2H, m), 1.82-1.62 (5H, m), 0.95 (6H, m).
[α]D 25 : +16.2 (c=2.09, CHCl3)
MS : 259 (M++1), 227, 214, 187, 170, 152, 127, 111, 93, 71, 43
【0047】
IIc)メチル(1S,3R,4R,5S)−3−アセトキシ−5−ヒドロキシ−4−メチル−シクロヘキサンカルボキシレート:2.C(R=Me, Z=Me, A=COOCH3)
メソ−ジアセテート3.C(R=Me, Z=Me, A=COOCH3)からIIa)記載と同様に反応を行なう。
[α]D 25 : +20 (c=2.9, CHCl3)
【0048】
IId)メチル(1R,3S,4S,5R)−5−アセトキシ−3−ヒドロキシ−4−メチル−シクロヘキサンカルボキシレート:2’.B(R=Me, Z=Me, A=COOCH3)
リパーゼとしてPPLを用いた以外は、メソ−ジアセテート3.C(R=Me, Z=Me, A=COOCH3)からIIa)記載と同様に反応を行なう。
[α]D 25 : -19.5 (c=2.88, CHCl3)
【0049】
実施例1:(2S, 3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン : I.b.1 (A=COOCH3, R=H, P=TBDMS)
a)メチル(1R,3S,5R)−3−アセトキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:2.4.a(R=H, L=OTos, A=COOCH3)
トリエチルアミン(50 ml)とメチレンクロライド(10 ml)混合液中のメチル(1S,3S,5R)−3−アセトキシ−5−ヒドロキシ−シクロヘキサンカルボキシレート2.A(R=H, Z=Me, A=COOCH3)(10.1 g, 43.7 mmol)及びジメチルアミノ−ピリジン(0.1g)溶液に、p−トルエンスルホニルクロライド(13.3 g, 70 mmol)を0°Cで加えた。得られた溶液を0℃で1時間攪拌した後、室温で22時間攪拌した。反応を水(300ml)で終了させ、メチレンクロライドで抽出した。有機層を水で洗浄し、MgSO4で乾燥させ、ろ過した後濃縮した。粗生成物をEtOHから結晶化し、2.4.a(R=H, L=OTos, A=COOCH3)(13.2 g, 81.6 %)を得た。
mp : 83.1 °C ;
IR (KBr) : 1734, 1175 cm-1 ;
1H-NMR (CDCl3) : δ 1.5 (3H,m), 2.0 (3H,s), 2.28 (4H,m), 2.47 (3H,s), 3.68 (3H,s), 4.4 (1H,m), 4.68 (1H,m), 7.35 (1H,d, J=8.5Hz), 7.8 (2H,d, J=8.5 Hz) ppm.
【0050】
b)メチル(1R,3S,5R)−3−ヒドロキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:2.5.a(R=H, L=OTos, A=COOCH3)
2.4.a(R=H, L=OTos, A=COOCH3)(23.35 g, 63 mmol)のMeOH懸濁液中に炭酸カリウム(4.36 g, 31 mmol)を加えた。得られた懸濁液を30分間攪拌し、水(1.5 L)に注いだ。析出物をろ過し、乾燥して2.5.aを得た(R=H, L=OTos, A=COOCH3)(18.5 g, 89 %)。
mp : 98.4 °C ;
UV (EtOH) : 225 nm (ε= 11935) ;
IR (KBr) : 3447, 1719, 1176 cm-1 ;
1H-NMR (CDCl3) : δ1.52 (4H,m), 2.25 (4H,m), 2.45 (3H,s), 3.6 (1H,m), 3.68 (3H,s), 4.42 (1H,m), 7.35 (2H,d, J=8.5Hz), 7.8 (2H,d, J=8.5 Hz) ppm ;[α]D 25 : -19 (c=1.00, EtOH)
【0051】
c)メチル(1R,3R,5R)−3−ベンゾイルオキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:2.6.a(R=H, L=OTos, A=COOCH3)
0℃の、2.5.a(R=H, L=OTos, A=COOCH3)(18.35 g, 56 mmol)、トリフェニルホスフィン(18.4 g, 70 mmol)、及び、安息香酸(8.53 g, 70 mmol)のトルエン(180 ml)とTHF(70 ml)溶液に、ジエチルアゾジカルボキシレート(11 ml, 70 mmol)を加えた。得られた混合液を室温で30分間攪拌し、ヘプタン(735 ml)を加えた後、ろ過してろ液を濃縮した。トルエンを粗生成物に加えて、得られた溶液をシリカゲルパッド(30〜70メッシュ)を用いてろ過した。トルエンで溶出し、次にトルエン/メチレンクロライドの混合液で溶出し、濃縮した後残留物を得た。この残留物をEtOHから結晶化して2.6.a(R=H, L=OTos, A=COOCH3)(19.77 g, 82 %)を得た。
mp : 76.2 °C ;
UV (EtOH) : 227 nm (ε= 20840) ;
IR (KBr) : 1709, 1177 cm-1 ;
1H-NMR (CDCl3) : δ1.7 (3H,m), 2.14 (2H,m), 2.35 (3H,s), 2.48 (1H,m), 2.83 (1H,m), 3.18 (3H,s), 4.75 (1H,m), 5.43 (1H,m), 7.2 (2H,d, J=11.4Hz), 7.5 (2H,d, J=8.5Hz), 7.6 (1H,m), 7.75 (2H,d, J=11.4 Hz), 7.94 (2H,d, J=8.5Hz) ppm ;
[α]D 25 : -65.8 (c=0.98, EtOH).
【0052】
d)メチル(1R,3R,5R)−3−ヒドロキシ−5−トシルオキシ−シクロヘキサンカルボキシレート: 2.7.a (R=H, L=OTos, A=COOCH3 )
2.6.a(R=H, L=OTos, A=COOCH3)(19.77 g, 46 mmol)のMeOH懸濁液中に炭酸カリウム(3.16 g, 22.9 mmol)を加えた。得られた混合液を室温で6時間攪拌し、水(1L)に注いだ。水層をジイソプロピルオキサイドで抽出し、MgSO4で乾燥し、ろ過した後濃縮して2.7.a(R=H, L=OTos, A=COOCH3)(17.45 g, 定量分析)を油状物として得た。
UV (EtOH) : 224 nm (ε= 12262) ;
IR (KBr) : 3525, 1731, 1174 cm-1 ;
1H-NMR (CDCl3) : δ1.67 (3H,m), 2.1 (3H,m), 2.45 (3H,s), 2.85 (1H,m), 3.7 (3H,s), 4.3 (1H,s), 4.82 (1H,m), 7.35 (2H,d, J=8.5Hz), 7.8 (2H,d, J=8.5Hz) ppm ;
[α]D 25 : -36.7 (c=1.06, CHCl3)
【0053】
e)メチル(1R,3R,5R)−3−t−ブチルジメチルシリルオキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)
2.7.a(R=H, L=OTos, A=COOCH3)(17.45 g, 46 mmol)及びイミダゾール(3.9 g, 57 mmol)の無水ジメチルホルムアミド(80 ml)溶液中に、t−ブチルジメチルシリルクロライド(8.6 g, 57 mmol)を加えた。得られた混合液を室温で1.5時間攪拌し、水上に注いで、トルエンで抽出した。有機層を水で洗浄した後濃縮した。粗生成物をヘプタンから結晶化し、2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(13.94 g, 69 %)を得た。
mp : 68.2 °C ;
UV (EtOH) : 225 nm (ε= 12390) ;
IR (KBr) : 2853, 1726, 1436, 1359, 1173, 831 cm-1 ;
1H-NMR (CDCl3) : δ0.02 (3H,s), 0.05 (3H,s), 0.82 (9H,s), 1.55 (4H,m), 1.85 (2H,m), 2.45 (3H,s), 2.8 (1H,m), 3.67 (3H,s), 4.2 (1H,bs), 4.7 (1H,m), 7.33 (2H,d, J=8.5Hz), 7.8 (2H,d, J=8.5Hz) ppm ;
[α]D 25 : -41.6 (c=1.00, EtOH).
【0054】
f) (2S,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.b.1(R=H, P=TBDMS, A=COOCH3)
攪拌した、64°Cの2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(378.5 g, 856 mmol)のt−ブタノール溶液に、ゆっくり1時間かけてt−ブチル酸カリウムのt−ブタノール溶液(1.02L)を加えた。添加終了5分後に、得られた懸濁液を30℃まで冷却し、アンモニウムクロライドの飽和溶液(3L)を加えた。10分後、水層をジイソプロピルオキサイドで抽出した。有機層を水で洗浄し、MgSO4で乾燥し、ろ過した後濃縮した。残留物を、ヘプタン/酢酸エチルの混合溶液を溶離液としてシリカゲル上でフラッシュクロマトグラフィーにより精製し、I.b.1 (R=H, P=TBDMS, A=COOCH3)(211.3 g, 91.3 %)を黄色油状物として得た。
Eb760 : 135 °C ;
UV (EtOH) : 201 nm (ε= 742) ;
IR (film) 1726 cm-1, 1458 cm-1, 1437 cm-1, 1254 cm-1, 837 cm-1 ;
1H-NMR (CDCl3) : δ0.01 (6H,s), 0.83 (9H,s), 1.28 (2H,m), 1.8 (2H,m), 2.11 (3H,m), 3.65 (3H,s), 3.9 (1H,m) ppm ;
[α]D 25 : -43 (c=1.04, EtOH).
【0055】
実施例2:(2S,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.b.2(R=H, P=TBDMS, A=CH2OH)
(2S,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサンI.b.1 (R=H, P=TBDMS, A=COOCH3)(207.5 g, 768 mmol)のトルエン(2.1L)溶液(−70℃)に、1.5Mのジイソブチルアンモニウムヒドライドのトルエン溶液(1.25L)を1.5時間かけて添加した。添加終了後、酒石酸カリウムナトリウムの飽和溶液をゆっくり加え、0℃まで加熱した。2時間攪拌した後、反応混合液をトルエンで抽出し、有機層をMgSO4で乾燥し、濃縮して標題化合物I.b.2を黄色油状物として142.9 g(88 %)得た。
IR (KBr) : 3355, 1471, 1255, 835, 774 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.32 (1H,m), 0.5 (1H,m), 0.83 (9H,s), 1.16 (1H,m), 1.87 (5H,m), 3.54 (2H,m), 4.0 (1H,m) ppm
【0056】
実施例3:(2S,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.b.3(R=H, P=TBDMS, A=CHO)
I.b.2(R=H, P=TBDMS, A=CH2OH)(69.6 g, 287 mmol)のメチレンクロライド(700 ml)溶液にピリジニウムクロロクロメート(68 g, 315 mmol)を室温で添加した。得られた混合液を1時間力強く攪拌した。35℃まで加熱し、次に25℃まで冷却した。懸濁液をセライトのパッドを用いてろ過し、メチレンクロライド及びジイソプロピルオキサイドで洗浄した。有機層を順に、水、炭酸水素ナトリウムの飽和溶液、pH6〜7の水で洗浄した。結合した有機層をMgSO4で乾燥し、ろ過した後濃縮した。残留物(66.8g)をヘプタン/酢酸エチル=95/5(V/V)を溶離液としてフロリジル上でフラッシュクロマトグラフィーにより精製し、I.b.3(R=H, P=TBDMS, A=CHO)を黄色油状物(50.33g, 73%)として得た。
UV (EtOH) : 204 nm (ε= 6292) ;
IR (KBr) : 1726, 1253, 1119, 838 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.87 (9H,s), 1.3 (2H,m), 1.85 (2H,m), 2.1 (3H,m), 4 (1H,m), 8.9 (1H,s) ppm ;
[α]D 25 : -49.4 (c=1.06, EtOH).
【0057】
実施例4:(2R,3aR,4aR)2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.h.1(R=H, A=COOCH3, P=TBDMS)
a)メチル(1R,3S,5S)−3−アセトキシ−5−ベンゾイルオキシ−シクロヘキサンカルボキシレート:3.9.a (R=H, A=COOCH3)2.6.a(R=H, L=OTos, A=COOCH3)で述べたように、メチル(1S,3S,5R)−3−アセトキシ−5−ヒドロキシ−シクロヘキサンカルボキシレート2.A(R=H,Z=Me,A=COOCH3)(25 g, 111.3 mmol)をメチル(1R,3S,5S)3−アセトキシ−5−ベンゾイルオキシ−シクロヘキサンカルボキシレート3.9.a(R=H, A=COOCH3)(32.4 g, 91 %)に変換した。
1H-NMR (CDCl3) : δ1.68 (3H,m), 2.05 (3H,s), 2.34 (3H,m), 2.92 (1H,m), 3.70 (3H,s), 5.18 (1H,m), 5.55 (1H,m), 7.50 (3H,m), 8.05 (2H,m) ppm ;
[α]D 25: +42.3 (c=0.82, CHCl3)
【0058】
b)メチル(1R,3S,5S)−5−ベンゾイルオキシ−3−ヒドロキシ−シクロヘキサンカルボキシレート:3.10.a(R=H, A=COOCH3)メチル(1R,3S,5S)−3−アセトキシ−5−ベンゾイルオキシ−シクロヘキサンカルボキシレート:3.9.a(R=H, A=COOCH3)(32.4 g, 151,9 mmol)を2.5.a(R=H, L=OTos, A=COOCH3)と同様に加水分解した。粗精製物をシリカゲル上でフラッシュクロマトグラフィーにより精製し、3.10.a(R=H, A=COOCH3)(22.38 g, 79.5 %)を得た。
1H-NMR (CDCl3) : δ 1.63 (4H,m), 1.92 (1H,s), 2.3 (2H,m), 2.86 (1H,m), 3.7 (3H,s), 4.1 (1H,m), 5.53 (1H,m), 7.5 (3H,m), 8.0 (2H,m) ppm ;
[α]D 25 : -13.5 (c=1.43, CHCl3)
【0059】
c)メチル(1S,3S,5S)− 5−ベンゾイルオキシ−3−トシルオキシ−シクロヘキサンカルボキシレート:3.11.a(R=H, L=OTos, A=COOCH3)
アルコール3.10.a(R=H, A=COOCH3)(25.2 g, 90.88 mmol)を2.4.a(R=H, L=OTos, A=COOCH3)と同様にトシラート化した。フラッシュクロマトグラフィー(ヘプタン/酢酸エチル=7/3)により精製し、及びヘプタン/EtOHから結晶化することにより標題化合物3.11.a(R=H, L=OTos, A=COOCH3)(39.75 g)を計量可能な収量で得た。
mp : 128.4 °C ;
IR (KBr) : 2950, 1715, 1175, 939 cm-1 ;
1H-NMR (CDCl3) : δ1.7 (3H,m), 2.18 (2H,m), 2.38 (3H,s), 2.5 (1H,m), 2.85 (1H,m), 3.68 (3H,s), 4.76 (1H,m), 5.43 (1H,m), 7.19 (2H,d), 7.5 (2H,d), 7.58 (1H,m), 7.77 (2H,d), 7.96 (2H,d) ppm ;
[α]D 25 : +69 (c=1.014, CHCl3).
【0060】
d)メチル(1S,3S,5S)−5−ヒドロキシ−3−トシルオキシ−シクロヘキサンカルボキシレート:3.12.a(R=H, L=OTos, A=COOCH3)
3.11.a(R=H, L=OTos, A=COOCH3)(38.25 g, 88.4 mmol)から2.7.a(R=H, L=OTos, A=COOCH3 )と同様にして、メチル(1S,3S,5S)−5−ヒドロキシ−3−トシルオキシ−シクロヘキサンカルボキシレート3.12.a(R=H, L=OTos, A=COOCH3)(29.25 g)を黄色油状物として計量可能な収量で得た。
1H-NMR (CDCl3) : δ1.6 (4H,m), 2.08 (3H,m), 2.47 (3H,s), 2.83 (1H,m), 3.68 (3H,s), 4.3 (1H,m), 4.82 (1H,m), 7.36 (2H,d), 7.8 (2H,d) ppm.
【0061】
e)メチル(1S,3S,5S)−5−t−ブチルジメチルシリルオキシ−3−トシルオキシ−シクロヘキサンカルボキシレート:3.13.a(R=H, L=OTos, P=TBDMS, A=COOCH3)
3.12.a(R=H, L=OTos, A=COOCH3)(29.2 g, 89.07 mmol)から2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)と同様にして反応を行なった。シリカゲル上のフラッシュクロマトグラフィー(ヘプタン/酢酸エチル=8/2)により精製し、3.13.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(34.8 g, 88 %)を黄色油状物として得た。
IR (film) : 2953, 2855, 1725, 1278, 1177, 949 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,d), 0.85 (9H,s), 1.55 (3H,m), 1.88 (2H,m), 2.38 (1H,s), 2.48 (3H,s), 2.82 (1H,m), 3.7 (3H, s), 4.2 (1H, m), 4.7 (1H,m), 7.8 (2H, d), 8.09 (2H,d) ppm ;
[α]D 25 : +29.5 (c=1.06, EtOH)
【0062】
f)(2R,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.h.1(R=H, P=TBDMS, A=COOCH3)
3.13.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(33.2 g, 75 mmol)からI.b.1(A=COOCH3, R=H, P=TBDMS)と同様に反応を行なった。シリカゲル上のフラッシュクロマトグラフィー(ヘプタン/酢酸エチル=95/5)により精製し、(2R,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサンI.h.1(R=H, P=TBDMS, A=COOCH3)(15.5 g, 78 %)を黄色油状物として得た。
IR (film) : 2952, 2856, 1724, 1113, 837 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.85 (9H,s), 1.11 (1H,d), 1.27 (2H,m), 1.6 (3H,s), 1.8 (1H,m), 2.11 (3H,m), 3.65 (3H, s), 3.9 (1H, m) ppm ;
[α]D 25 : +38.3 (c=1.122, EtOH)
【0063】
実施例5:(2R,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.h.2 (R=H, P=TBDMS, A=CH2OH)
(2R,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサンI.h.1(R=H, P=TBDMS, A=COOCH3)(15.15 g, 56 mmol)をI.b.2(R=H, P=TBDMS, A=CH2OH)と同様の条件を用いてI.h.2(R=H, P=TBDMS, A=CH2OH)(11.85 g, 87%)に変換した。
IR (film) : 3354, 2928, 2856, 1255, 835 cm-1 ;
1H-NMR (CDCl3) : δ 0.1 (6H,s), 0.35 (1H,t), 0.5 (1H,t), 0.86 (9H,s), 1.17 (1H,s), 1.85 (5H,m), 3.52 (2H,m), 4.0 (1H, m) ppm ;
[α]D 25 : +17.4 (c=1.15, EtOH)
【0064】
実施例6:(2R,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.h.3 (R=H, P=TBDMS, A=CHO)
I.h.2(R=H, P=TBDMS, A=CH2OH)(11.3 g, 46.6 mmol)からI.b.3(R=H, P=TBDMS, A=CHO)の方法に従って、I.h.3(R=H, P=TBDMS, A=CHO)(6.2 g, 55 %)を黄色油状物として得た。
UV (EtOH) : 204.5 mm (ε= 6600) ;
IR (film) : 2930, 2880, 2856, 1705, 1119, 1097, 836 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.83 (9H,s), 0.95 (1H,t), 1.22 (2H,m), 1.85 (2H,m), 2.1 (3H,m), 4.0 (1H,quintuplet), 8.87 (1H, s) ppm ;
[α]D 25 : +53.6 (c=1.008, EtOH)
【0065】
実施例7:(2R,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.a.1(R=H, P=TBDMS, A=COOCH3)
a.メチル(1R,3S,5R)−3−t−ブチルジメチルシリルオキシ−5−トシルオキシ−シクロヘキサンカルボキシレート: 2.3.a (R=H, L=OTos, P=TBDMS, A=COOCH3)
メチル(1R,3S,5R)−3−ヒドロキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:2.5.a(R=H, L=OTos, A=COOCH3)(29.3 g, 89.2 mmol)のヒドロキシ官能基は2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)と同様に保護され、2.3.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(36,75 g, 93%)を得た。
mp : 70.9 °C ;
IR (KBr) : 2957, 2855, 1734, 1174, 923 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.82 (9H,s), 1.41 (3H,m), 2.16 (4H,m), 2.46 (3H,s), 3.54 (1H,m), 3.69 (3H,s), 4.41 (1H,m), 7.34 (2H,d), 7.8 (2H,d) ppm ;
[α]D 25 : -8.2 (c=1.2, EtOH)
【0066】
b)(2R,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.a.1(R=H, P=TBDMS, A=COOCH3)
2.3.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(34.81 g, 78.6 mmol)から、I.b.1(A=COOCH3, R=H, P=TBDMS)と同様に反応を行なった。シリカゲル上のフラッシュクロマトグラフィー(ヘプタン/酢酸エチル=5/5)により精製し、I.a.1(R=H, P=TBDMS, A=COOCH3)(16.6 g, 78 %)を黄色油状物として得た。
IR (film) : 2953, 2855, 1726, 1148, 836 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.86 (9H,s), 1.5 (5H,m), 2.1 (1H,m), 2.48 (1H,m), 3.68 (3H,s), 4.33 (1H,t) ppm ;
[α]D 25 : -60.1 (c=0.998, EtOH)
【0067】
実施例8 : (2R,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.a.2(R=H, P=TBDMS, A=CH2OH).
I.a.1(R=H, P=TBDMS, A=CH2OH)(15.6 g, 57.7 mmol)からI.b.2(R=H, P=TBDMS, A=CH2OH)と同様に反応を行なった。I.a.2(R=H, P=TBDMS, A=CH2OH)(11.7 g, 83.7 %)を黄色油状物として得た。
IR (film) : 3331, 2927, 2855, 1254, 1094, 1006, 835 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.5 (1H,m), 0.88 (9H,s), 1.19 (3H,m), 1.72 (2H,m), 2.1 (2H,m), 3.6 (2H,s), 4.34 (1H,t) ppm ;
[α]D 25 : -23.5 (c=1.062, EtOH)
【0068】
実施例 9:(2R,3aS,4aS)−2−t−ブチルジメチルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.a.3(R=H, P=TBDMS, CHO).
I.a.2(R=H, P=TBDMS, A=CH2OH)(11.1 g, 45.5 mmol)から、I.b.3(R=H, P=TBDMS, A=CHO)と同様にして、I.a.3(R=H, P=TBDMS, A=CHO)(8.8 g, 80%)を黄色油状物として得た。
UV (EtOH) : 204.7 nm (ε= 6991) ;
IR (film) : 2928, 2855, 1702, 1255, 1072, 837 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.85 (9H,s), 1.45 (1H,m), 1.78 (3H,m), 2.02 (2H,m), 2.5 (1H,m), 4.35 (1H,m), 8.81 (1H,s) ppm ;
[α]D 25 : -71.8 (c=1.406, EtOH)
【0069】
実施例 10 : (2S,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン: I.f.1 (R=H, P=TBDMS, A=COOCH3).
a)メチル(1R,3S,5R)−3−アセトキシ−5−t−ブチルジメチルシリルオキシ−シクロヘキサンカルボキシレート: 3.7.a (R=H, P=TBDMS, A=COOCH3)
メチル(1S,3S,5R)−3−アセトキシ−5−ヒドロキシ−シクロヘキサンカルボキシレート2.A(R=H, A=COOCH3)(45.5 g, 0.210 mmol)のヒドロキシ官能基を2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)と同様にシリレート化した。ヘプタン/酢酸エチル(9/1)混合液を溶離液としてシリカゲル上のフラッシュクロマトグラフィーにより精製し、3.7.a(R=H, P=TBDMS, A=COOCH3)(69.97 g, 92 %)を黄色油状物として得た。
IR (film) : 2953, 2856, 1736, 1240 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.8 (9H,s), 1.33 (4H,m), 2 (3H,s), 2.1 (2H,m), 2.32 (1H,m), 3.55 (1H,m), 3.62 (3H,s), 4.66 (1H,m) ppm
【0070】
b)メチル(1R,3S,5R)−5−t−ブチルジメチルシリルオキシ−3−ヒドロキシ−シクロヘキサンカルボキシレート:3.8.a(R=H, P=TBDMS, A=COOCH3)
3.7.a(R=H, P=TBDMS, A=COOCH3)(63.67 g, 0.1926 mmol)から2.5.a(R=H, L=OTos, A=COOCH3)と同様にして反応を行なった。ヘプタン/酢酸エチル(7/3)を溶離液としてシリカゲル上のフラッシュクロマトグラフィーにより精製し、3.8.a(R=H, P=TBDMS, A=COOCH3)(46,24 g, 83 %) を黄色油状物として得た。
IR (film) : 3404, 2952, 2856, 1736, 837 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.81 (9H,s), 1.3 (3H,m), 1.67 (1H,m), 2.13 (4H,m), 3.56 (2H,m), 3.63 (3H,s) ppm ;
[α]D 25 : +6.8 (c=1.036, CHCl3).
【0071】
c)メチル(1S,3S,5R)−5−t−ブチルジメチルシリルオキシ−3−トシルオキシ−シクロヘキサンカルボキシレート:3.6.a(R=H, L=OTos, P=TBDMS, A=COOCH3)
3.8.a(R=H, P=TBDMS, A=COOCH3)(45.99 g, 0.159 mmol)から2.4.a(R=H, L=OTos, A=COOCH3) と同様にして反応を行なった。ヘプタン/酢酸エチル(8/2)を溶離液としてシリカゲル上のフラッシュクロマトグラフィーにより精製し、次にEtOHから結晶化し3.6.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(53.7 g, 76%)を得た。
mp : 71 °C ;
IR (KBr) : 2957, 2855, 1734, 1174, 923 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.82 (9H,s), 1.41 (3H,m), 2.16 (4H,m), 2.46 (3H,s), 3.54 (1H,m), 3.69 (3H,s), 4.41 (1H,m), 7.34 (2H,d), 7.8 (2H,d) ppm ;
[α]D 25 : +6.8 (c=1.032, EtOH).
【0072】
d) (2S,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.f.1(R=H, P=TBDMS, A=COOCH3).
3.6.a(R=H, L=OTos, P=TBDMS, A=COOCH3)(53.7 g, 0.121 mmol)からI.b.1(R=H, P=TBDMS, A=COOCH3)と同様にして反応を行なった。I.f.1 (R=H, P=TBDMS, A=COOCH3)(24.48 g, 74.6%)を淡黄色油状物として得た。
IR (film) : 2953, 2856, 1726, 1148, 836 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.86 (9H,s), 1.5 (5H,m), 2.1 (1H,m), 2.48 (1H,m), 3.68 (3H,s), 4.33 (1H,t) ppm ;
[α]D 25 : +62.9 (c 1.066, EtOH).
【0073】
実施例11 : (2S,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.f.2(R=H, P=TBDMS, A=CH2OH)
I.f.1(R=H, P=TBDMS, A=COOCH3)(10 g, 0.037 mmol)からI.b.2(R=H, P=TBDMS, A=CH2OH)と同様にして反応を行なった。I.f.2(R=H, P=TBDMS, A=CH2OH)を油状物として計量可能な収量(10 g)で得た。
IR (film) : 3331, 2927, 2855, 1254, 1094, 1006, 835 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.5 (1H,m), 0.88 (9H,s), 1.19 (3H,m), 1.72 (2H,m), 2.1 (2H,m), 3.6 (2H,s), 4.34 (1H,t) ppm ;
[α]D 25 : +23.2 (c=0.99, EtOH)
【0074】
実施例12:(2S,3aR,4aR)−2−t−ブチルジメチルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.f.3(R=H, P=TBDMS, A=CHO).
I.b.3(R=H, P=TBDMS, A=CHO)に関して、I.f.2(R=H, P=TBDMS, A=CH2OH)(10 g, 0.037 mmol)を淡黄色油状物として得られるI.f.3(R=H, P=TBDMS, A=CHO)(5.3g, 59.7%)に変換した。
IR (film) : 2928, 2855, 1702, 1255, 1072, 837 cm-1 ;
1H-NMR (CDCl3) : δ0 (6H,s), 0.85 (9H,s), 1.45 (1H,m), 1.78 (3H,m), 2.02 (2H,m), 2.5 (1H,m), 4.35 (1H,m), 8.81 (1H,s) ppm ;
UV (EtOH) : 205 nm ;
[α]D 25 : +70.4 (c=1.1 , EtOH).
【0075】
実施例 13 : (2S,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−cカルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.b.4(R=H, P=TBDPS, A=COOCH3).
a)メチル(1R, 3S, 5R)−3−アセトキシ−5−(4−ブロモベンゼンスルホニルオキシ)−シクロヘキサンカルボキシレート:2.4.b (R=H, L=OBros, A=COOCH3).
2.A(R=H)(1.4 g, 6.47 mmol)及び4−ブロモベンゼンスルホニルクロライド(4.22 g, 16.19 mmol)から2.4.a(R=H, L=OTos)と同様にして反応を行なった。2.4.b(R=H, L=OBros, A=COOCH3)(2.6 g, 96%)を白色結晶として得た。
mp : 110-111 °C ;
IR (film) : 2956, 1734, 1363, 1246, 1188, 822, 742 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.76 (2H, d, J=8.6Hz), 7.70 (2H, d, J=8.6Hz), 4.68 (1H, dddd, J=11.6, 11.6, 4.37, 4.37Hz), 4.46 (1H, dddd, 11.6, 11.6, 4.6, 4.6Hz), 3.69 (3H, s), 2.37 (1H, m), 2.28 (2H, m), 2.02 (3H, s), 1.58 (2H, m), 1.39 (1H, dd, J=24.0, 12.4Hz) ppm ;
MS (m/z) : 419 (M+, 1), 405 (1), 363 (3), 221 (10), 157 (34), 138 (70), 107 (15), 79 (68) ;
[α]D 25 : -10.65 (c=1.50, CHCl3).
【0076】
b)メチル(1R, 3S, 5R)−5−(4−ブロモベンゼンスルホニルオキシ)−3−ヒドロキシ−シクロヘキサンカルボキシレート:2.5.b(R=H, L=OBros, A=COOCH3).
2.4.b(R=H, L=OBros, A=COOCH3)(2.55 g, 6.08 mmolから、2.5.a(R=H, L=OTos)と同様にして反応を行なった。2.5.b(R=H, L=OBros, A=COOCH3)(2.25 g, 98%)を白色結晶として得た。
mp : 95-98 °C ;
IR (film): 3397, 2954, 1734, 1396, 1186, 815, 740 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.76 (2H, d, J=8.6Hz), 7.70 (2H, d, J=8.6Hz), 4.46 (1H, dddd, J=11.5, 11.5, 4.5, 4.5Hz), 3.68 (3H, s), 3.64 (1H, m), 2.25 (4H, m), 1.60 (1H, dd, J=24.2, 12.5Hz), 1.48 (1H, dd, J=23.0, 11.5Hz), 1.35 (1H, dd, J=23.8, 12.5Hz) ppm ;
MS (m/z) : 377 (M+,1), 328 (3), 235 (10), 221 (13), 156 (85), 113 (100), 97 (52), 79 (53) ;
[α]D 25 : -17.13 (c=1.48, CHCl3).
【0077】
c)メチル(1R,3R,5R)−3−ベンゾイルオキシ−5−(4−ブロモベンゼンスルホニルオキシ)−シクロヘキサンカルボキシレート:2.6.b(R=H, L=OBros, A=COOCH3)
2.5.b(R=H, L=OBros, A=COOCH3)(1.15 g, 3.05 mmol)から、2.6.a(R=H, L=OTos, A=COOCH3)と同様にして反応を行なった。収率は1.13 g(73%)であった。
mp : 131-133 °C ;
IR (film) : 3420, 2948, 1717, 1362, 1186, 817, 707 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.95 (2H, d, J=7.4Hz), 7.72 (2H, d, J= 8.5Hz), 7.60 (1H, t, J=7.4Hz), 7.58 (2H, d, J=8.5Hz), 7.49 (2H, t, 7.7Hz), 5.46 (1H, m), 4.81 (1H, dddd, J=11.3, 11.3, 4.4, 4.4Hz), 2.85 (1H, dddd, J=12.5, 12.5, 3.7, 3.7Hz), 2.47 (1H, m), 2.20 (2H, m), 1.73 (3H, m) ppm ;
MS (m/z) : 497 (M+,1), 391 (4), 377 (10), 260 (100), 237 (8), 221 (25) ;
[α]D 25 : -59.32 (c=1.79, CHCl3).
【0078】
d)メチル(1R,3R,5R−5−(4−ブロモベンゼンスルホニルオキシ)−3−ヒドロキシ−シクロヘキサンカルボキシレート:2.7.b(R=H, L=OBros, A=COOCH3).
2.6.b(R=H, L=OBros, A=COOCH3)(240 mg, 0.483 mmol)から、2.7.a(R=H, L=OTos, A=COOCH3)と同様にして反応を行なった。収率は167mg(88 %)であった。
mp : 107-108 °C.
IR (film) : 3527, 2954, 1732, 1577, 1365, 1187, 940, 818 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.78 (2H, d, J=8.6Hz), 7.70 (2H, d, J= 8.6Hz), 4.87 (1H, dddd, J=10.9, 10.9, 4.5, 4.5 Hz), 4.31 (1H, m), 3.69 (3H, s), 2.86 (1H, dddd, J=12.1, 12.1, 3.7, 3.7Hz), 2.24 (1H, d, J=12.7Hz), 2.04 (1H, d, J=11.7Hz),1.94 (1H, d, J=14.0Hz), 1.65 (3H, m) ppm ;
MS (m/z) : 394 (M++1, 1), 295 (2), 221 (4), 157 (11), 97 (10) ;
[α]D 25 : -38.75 (c=0.80, CHCl3).
【0079】
e)メチル(1R,3R,5R)−5−(4−ブロモベンゼンスルホニルオキシ)−3−t−ブチルジフェニルシリルオキシ−シクロヘキサンカルボキシレート:2.8.b(R=H, L=OBros, P=TBDPS, A=COOCH3).
2.7.b(R=H, L=OBros, A=COOCH3)(299 mg, 0.760 mmol)から、2.8.a(R=H, L=OTos, P=TBDPS, A=COOCH3)と同様にして反応を行なった。2.8.b(R=H, L=OBros, P=TBDPS, A=COOCH3)(198 mg, 93 %)を粘性油状物として得た。
IR (film) : 2955, 1738, 1577, 1472, 1370, 1180, 947, 821, 703 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.71 (2H, d, J=8.8Hz), 7.34-7.60 (12H, m), 4.87 (1H, m), 4.17 (1H, bs), 3.78 (3H, m), 2.98 (1H, dddd, J=9.1, 9.1, 3.5, 3.5 Hz), 2.39 (1H, d, J=11.9Hz), 1.89 (1H, d, J=13.9Hz), 1.79 (1H, d, J=12.3Hz), 1.63 (1H, m), 1.34 (2H, m), 1.02 (9H, s), 0.91 (3H, s) ppm ;MS (m/z) : 599 (M+, 1), 419 (28), 337 (34), 293 (8), 199 (46), 139, (100), 107 (50), 79 (72) ;
[α]D 25 : +1.49 (c=1.75, CHCl3).
【0080】
f)(2S,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.b.4(R=H, P=TBDPS, A=COOCH3).
I.b.1(R=H, P=TBDMS, A=COOCH3)と同様にして、化合物2.8.b(R=H, L=OBros, P=TBDPS, A=COOCH3)(206 mg, 0.344 mmol)をI.b.4(R=H, P=TBDMS, A=COOCH3)(79 mg, 76%)に変換し、無色油状物を得た。.
IR (film) : 2952, 1725, 1428, 1113, 703 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.64 (4H, dd, J=6.20, 6.20Hz), 7.35-7.45 (6H, m), 3.89 (1H, dddd, J=7.7, 7.7, 7.7, 7.7Hz), 3.65 (3H, s), 2.28 (1H, dd, J=12.9, 8.2Hz), 2.12 (1H, dd, J=12.9, 7.1Hz), 1.91 (2H, m), 1.77 (1H, ddd, J=8.6, 5.0, 5.0Hz), 1.19 (1H, dd, J=8.6, 4.8Hz), 1.02 (9H, s), 0.44 (1H, dd, J=5.1, 5.1Hz) ppm .9, 7.1Hz), 1.91 (2H, m), 1.77 (1H, ddd, J=8.6, 5.0, 5.0Hz), 1.19 (1H, dd, J=8.6, 4.8Hz), 1.02 (9H, s), 0.44 (1H, dd, J=5.1, 5.1Hz) ppm
MS (m/z) : 394 (M+, 1), 363 (4), 337 (65), 259 (3), 213 (100), 199 (20), 135 (18), 77 (21) ;
[α]D 25 : -73.14 (c=1.75, CHCl3).
【0081】
実施例 14 :(2S,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.b.5(R=H, P=TBDPS, A=CH2OH).
I.b.4(R=H, P=TBDPS, A=COOCH3)(188 mg, 1.253 mmol)から、I.b.2(R=H, P=TBDMS, A=CH2OH)と同様にして反応を行なった。シリカゲル上のフラッシュクロマトグラフィー(イソオクタン/酢酸エチル83:17)により精製し、I.b.5(R=H, P=TBDPS, A=CH2OH)(240 mg, 96%)を粘性油状物として得た。
IR (film) : 3322, 2932, 1428, 1113, 702 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.75 (4H, m), 7.58 (6H, m), 3.97 (1H, dddd, J=7.1, 7.1, 7.1, 7.1Hz), 3.56 (2H, bs), 1.84-2.05 (3H, m), 1.12 (1H, m), 1.03 (9H, s), 0.34 (1H, dd, J=7.8, 5.4Hz), 0.13 (1H, dd, J=4.6, 4.6Hz) ppm ;
MS (m/z) :365 (M+-1, 1), 291 (3), 231 (10), 199 (100), 181 (12), 139 (27), 93 (77), 79 (24) ;
[α]D 25 : -25.74 (c=2.16, CHCl3).
【0082】
実施例 15:(2S,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.b.6(R=H, P=TBDPS, A=CHO).
I.b.5(R=H, P=TBDPS, A=CH2OH)(230 mg, 0.627 mmol)から、I.b.3(R=H, P=TBDMS, A=CHO)と同様にして反応を行なった。I.b.6(R=H, P=TBDPS, A=CHO)の収量は210 mg(92%)であった。
IR (film) : 3439, 3061, 2954, 2858, 1704, 1589, 1471, 1111, 1036, 823, 703 cm-1 ;1H-NMR (500 MHz, CDCl3) : δ 8.85 (1H, s), 7.68-7.60 (4H, m), 3.99 (1H, q, J=7.4Hz), 2.30 (1H, dd, J=13.1, 8.0Hz), 2.03-1.98 (2H, m), 1.93-1.87 (2H, m), 1.22 (1H, dd, J=8.4, 6.0Hz), 1.02 (9H, s), 0.74 (1H, dd, J=5.3, 5.3Hz) ppm ;
[α]D 25 : -90.00 (c 1.00, CHCl3).
【0083】
実施例 16:(2S,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−エチニル−ビシクロ[3.1.0]ヘキサン:I.b.7(R=H, P=TBDPS, A=C≡CH).
−78℃に冷却した(MeO)2P(O)CHN2(188 mg, 1.253 mmol)のTHF(3 ml)溶液にt−BuOK(1.26 ml, 1.26 mmol, THF中1.0 M溶液)を滴下した。得られた混合液を黄色が残っている間、−78℃で20分間攪拌した。I.b.6 (R=H, P=TBDPS, A=CHO)(380 mg, 1.043 mmol)のTHF(3 ml)溶液をゆっくり添加し、一晩攪拌した。温度は自然に−78℃から室温に上がった。水(10 ml)とEt2O(20 ml)を加えて反応を終了させ、有機層を分離した後水層をEt2O(3 ×50 ml)で抽出し、MgSO4で乾燥させた。残留物をHPLC(ヘキサン/EtOAc 96:4)で分離し、化合物I.b.7(R=H, P=TBDPS, A=C≡CH)(338 mg, 90%)を無色油状物として得た。
IR (film) : 3291, 3072, 2932, 2143, 1590, 1473, 1428, 1114, 1091, 824, 741 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.61-7.63 (4H, m), 7.34-7.43 (6H, m), 3.81 (1H, q, J=7.6Hz), 2.16 (1H, dd, J=12.5, 7.13Hz), 2.02 (1H, ddd, J=12.5, 8.1, 0.9Hz), 1.95 (1H, m), 1.93 (1H, s), 1.56 (1H, m), 1.02 (9H, s), 0.70 (1H, dd, J=8.3, 5.1Hz), 0.31 1H, t, J=5.0Hz) ppm ;
[α]D 25 : -86.30 (c=1.60, CHCl3).
【0084】
実施例17:(2S,3aR,4aR−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.f.4(R=H, P=TBDPS, A=COOCH3).
a)メチル(1R,3R,5S)−3−t−ブチルジフェニルシリルオキシ−5−ヒドロキシ−シクロヘキサンカルボキシレート:3.8.b(R=H, P=TBDPS, A=COOCH3).
2.A(R=H, A=COOCH3)及びTBDPSClから、3.7.b(R=H, P=TBDPS, A=COOCH3)を用いて、実施例4の3.8.a(R=H, P=TBDMS, A=COOCH3)と同様に反応を行なった。標題化合物を粘性油状物として得た;2段階に対して収率は92%であった。
IR (film) : 3404, 2952, 1738, 1428, 1112, 1049, 807, 710 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.66 (4H, m), 7.40 (6H, m), 3.65 (3H; s), 3.60 (1H, dddd, J=10.9, 10.9, 4.3, 4.3 Hz), 3.41 (1H, m), 2.11 (4H, m), 1.50 (1H, dd, J=12.6, 12.6 Hz), 1.41 (1H, d, J=5.2 Hz), 1.34 (3H, m) ppm ;
MS (m/z) : 412 (M+, 1), 355 (5), 323 (67), 199 (100), 153 (37), 105 (21), 79 (85) ;
[α]D 25 : -16.44 (c=1.60, CHCl3).
【0085】
b)メチル(1S,3R,5S)−3−t−ブチルジフェニルシリルオキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:3.6.b(R=H, L=OTos, P=TBDPS, A=COOCH3).
3.8.b(R=H, P=TBDPS, A=COOCH3)から、2.4.a(R=H, L=OTos, A=COOCH3)と同様に反応を行い、3.6.bを粘性油状物として得た。収率94%であった。
IR (film) : 2955, 1738, 1363, 1178, 1111, 824, 704 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.69 (2H, d, J=8.3Hz), 7.58 (4H, m), 7.28 (2H, d, J=8.1Hz), 4.18 (1H, dddd, J=11.6, 11.6, 4.6, 4.6Hz) 3.62 (3H; s), 3.48 (1H, dddd, J=11.1, 11.1; 4.1, 4.1 Hz), 2.47 (3H, s), 2.15-1.99 (4H, m), 1.52 (1H, ddd, J=5.6, 5.57, 5.6Hz), 1.42 (1H, ddd, J=12.0, 12.0, 12.0Hz), 0.98 (9H, s) ppm ;
MS (m/z) : 567 (M+, 1), 509 (9), 451 (1), 353 (49), 337 (67), 293 (38), 213 (47), 139 (32), 91 (100), 79 (77) ;
[α]D 25 : +2.39 (c=1.17, CHCl3).
【0086】
c)(2S,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.f.4(R=H, P=TBDPS, A=COOCH3).
3.6.b(R=H, L=OBros, P=TBDPS, A=COOCH3)からI.b.1(R=H, P=TBDMS, A=COOCH3) と同様に反応を行なった。収率は81%であった。
IR (film) : 3287, 2934, 1732, 1457, 1281, 1017 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 3.73 (2H, m), 3.72 (3H; s), 2.53 (1H, dddd, J=12.2, 12.2, 3.4, 3.4 Hz), 2.26 (1H, d, J=11.3Hz), 2.17 (2H, d, J=11.7 Hz), 1.30 (2H, ddd, J=12.0, 12.0, 12.0 Hz), 1.23 (1H, ddd, J=11.4, 11.4, 11.4 Hz) ppm ;
MS (m/z) : 394 (M+, 1), 337 (31), 259 (5), 199 (55), 153 (48), 107 (100), 79 (52) ;
[α]D 25 : +31.97 (c=1.71, CHCl3)
【0087】
実施例 18:(2S,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.f.5(R=H, P=TBDPS, A=CH2OH).
I.f.4(R=H, P=TBDPS, A=COOCH3)から、I.b.2(R=H, P=TBDMS, A=CH2OH)と同様に反応を行い,(2S,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサンI.f.5(R=H, P=TBDPS, A=CH2OH)を収率98%で得た。
IR (film) : 3332, 2931, 1428, 1111, 1008, 822, 702 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.62 (4H, dd, J=7.9, 1.5Hz), 7.39 (6H, m), 4.37 (1H, t, J=6.27Hz), 3.57 (2H; s), 1.90-2.02 (3H, m), 1.80 (1H, d, J=13.8Hz), 1.21 (1H, t, J=4.1Hz), 1.15 (1H, m), 1.03 (9H, s), 0.60 (1H, m) ppm ;
MS (m/z) : 365 (M+-1, 1), 291 (6), 231 (17), 199 (100), 181 (17), 139 (28), 93 (79), 79 (16) ;
[α]D 25 : +5.56 (c=1.5, CHCl3).
【0088】
実施例19 :(2S,3aR,4aR)−2−t−−ブチルジフェニルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.f.6(R=H, P=TBDPS, A=CHO).
I.f.5(R=H, P=TBDPS, A=CH2OH)から、I.b.3(R=H, P=TBDMS, A=CHO)と同様にして反応を行なった。収率は96%であった。
IR (film) : 2956, 1704, 1590, 1472, 1428, 1112, 1072, 822, 702 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 8.85 (1H, s), 7.61 (4H, m), 7.43 (2H, dt, J=7.0, 1.0Hz), 7.37 (4H, dt, J=7.0, 1.0Hz), 4.40 (1H, t, J=6.0Hz), 2.39 (1H, dd, J=14, 6.0Hz), 1.89 (1H, d, J=13.0Hz), 1.86 (1H, d, J=14.0Hz), 1.53 (1H, m), 1.04 (9H, s) ppm ;
[α]D 25 : +34.4 (c=1.6, CHCl3).
【0089】
実施例20:(2S,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−エチニル−ビシクロ[3.1.0]ヘキサン:I.f.7(R=H, P=TBDPS, A=C≡CH).
I.f.6(R=H, P=TBDPS, A=CHO)から、I.b.7(R=H, P=TBDMS, A=C≡CH)と同様にして反応を行なった。収率は88%であった。
IR (film) : 3310 (s), 3071, 2931, 2857, 2113, 1590, 1472, 1428, 1378, 1362, 1299, 1262, 1234, 1198, 1113, 1026, 933, 913, 865, 822, 701 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ7.60 (4H, m), 7.42 (2H, td, J=2, 8Hz), 7.37 (4H, td, J=1, 8Hz), 4.32 (1H, m), 2.06 (2H, m), 2.04 (1H, dt, J=6, 14Hz), 1.90 (1H, s), 1.80 (1H, d, J=14Hz), 1.65 (1H, dt, J=5, 10Hz), 1.49 (1H, t, J=5Hz), 1.03 (9H, s), 1.03 (1H, m) ;
[α]D 25: +21.4 (c=1.2, CHCl3)
【0090】
実施例 21 :(2R,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−エチニル−ビシクロ[3.1.0]ヘキサン: I.a.4 R=H, P=TBDPS, A=COOCH3)
a)メチル(1R,3S,5R)−3−t−ブチルジフェニルシリルオキシ−5−トシルオキシ−シクロヘキサンカルボキシレート:2.3.b(R=H, L=OTos, P=TBDPS, A=COOCH3).
2.5.a(R=H, L=OTos, A=COOCH3)から、2.8.a(R=H, L=OTos, P=TBDMS, A=COOCH3)と同様にして反応を行なった。収率は91%であった。
IR (film) : 2932, 2857, 1736, 1428, 1364, 1177, 1107, 929, 822, 703, 665 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.69 (2H, d, J=8.3Hz), 7.57 (4H, dm, J=7Hz), 7.44 (2H, q, J=7Hz), 7.36 (4H, t, J=8Hz), 7.28 (2H, d, J=8.4Hz), 4.16 (1H, tt, J=4, 12Hz), 3.63 (3H, s), 3.46 (1H, tt, J=4, 11Hz), 2.43 (3H, s), 2.13 (1H, dm, J=12Hz), 1.00 (9H, s) ppm ;
[α]D 25 : -3.07 (c=1.04, CHCl3).
【0091】
b)(2R,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.a.4(R=H, P=TBDPS, A=COOCH3)
2.3.b(R=H, L=OTos, P=TBDPS, A=COOCH3) から、I.b.1(R=H, P=TBDMS, A=COOCH3)と同様にして反応を行なった。収率は75%であった。
IR (film): 2932, 2857, 1723, 1589, 1472, 1428, 1297, 1148, 1112, 1088, 702 cm-1;
1H-NMR (500 MHz, CDCl3) : δ 7.61 (4H, dd, J=1, 7Hz), 7.42 (2H, t, J=7Hz), 7.37 (4H, t, J=7Hz), 4.36 (1H, t, 6.1Hz), 3.63 (3H, s), 2.37 (1H, ddd, J=1, 6.4, 14Hz), 1.99 (1H, d, J=14hz), 1.96 (1H, dd, J=6, 14Hz), 1.87 (1H, dt, J=5, 9Hz), 1.82 (1H, d, J=14Hz), 1.63 (1H, dd, J=4, 5Hz), 1.50 (1H, dm, J=9Hz), 1.03 (9H, s) ppm ;
[α]D 25 : -30.8 (c=0.46, CHCl3).
【0092】
実施例 22 :(2R,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.a.5(R=H, P=TBDPS, A=CH2OH).
I.a.4(R=H, P=TBDPS, A=COOCH3)から、I.b.2(R=H, P=TBDMS, A=CH2OH)と同様にして反応を行い、計量可能な収量であった。.
IR (film): 3346, 2930, 1589, 1472, 1428, 1111, 1092, 1076, 1031, 822, 701 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.26 (4H, dd, J=1, 7Hz), 7.41 (2H, t, J=7Hz), 7.36 (4H, t, J=7Hz), 4.38 (1H, t, J=6.3Hz), 3.57 (2H, s), 2.00 (1H, dd, J=6, 13Hz), 1.95 (1H, dd, J=7, 14Hz), 1.92 (1H, d, J=14Hz), 1.80 (1H, dd, J=14Hz), 1.22 (2H, m), 1.15 (1H, m), 1.04 (9H, s), 0.60 (1H, m) ppm ;
[α]D 25 : -5.6 (c=1.7, CHCl3).
【0093】
実施例 23 :(2R,3aS,4aS)−2−t−ブチルジフェニルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.a.6(R=H, P=TBDPS, A=CHO).
I.a.5(R=H, P=TBDPS, A=CH2OH)から、I.b.3 (R=H, P=TBDMS, A=CHO)と同様にして反応を行なった。収率は93%であった。
IR (film) : 2931, 1701, 1589, 1472, 1196, 1008, 822, 702 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 8.85 (1H, s), 7.61 (4H, m), 7.43 (2H, t, J=7Hz), 7.37 (4H, t, J=7Hz), 4.41 (1H, t, J=6Hz), 2.39 (1H, dd, J=6, 14Hz), 1.04 (9H, s) ppm ;
[α]D 25 : -35.3 (c=1.6, CHCl3).
【0094】
実施例 24:(2R,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.h.4(R=H, P=TBDPS, A=COOCH3).
a)メチル(1S,3S,5S)−3−t−ブチルジフェニル−5−トシルオキシ−シクロヘキサンカルボキシレート:3.13.b(R=H, L=OTos, P=TBDPS, A=COOCH3).
3.12(R=H, L=OTos, A=COOCH3)(4.8g, 14.63mmol)から、2.8.a(R=H, L=OTos, P=TBDS, A=COOCH3)と同様にして反応を行なった。収率は90%であった。
IR (film) : 2954, 1731, 1272, 1176, 1107, 945, 813, 713, 664 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.53-7.25 (14H, m), 4.84 (1H, m), 3.68 (3H, s), 2.95 (1H, dt, J=3.3, 12.7Hz), 2.45 (3H, s), 2.37 (1H, d, J=12.4Hz), 1.84 (1H, d, J=12.7Hz), 1.60 (1H, m), 1.29 (3H, m) ppm ;
MS (m/z) : 566 (M+), 477, 431, 399, 353, 283, 225, 198, 139, 91 (base peak) ;
[α]D 25 : +7.82 (c=1.31, CHCl3).
【0095】
b)(2R,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−カルボメトキシ−ビシクロ[3.1.0]ヘキサン:I.h.4(R=H, P=TBDPS, A=COOCH3).
3.13.b(R=H, P=TBDPS, A=COOCH3)(7.3g, 12.89mmol)から、I.b.1(R=H, P=TBDMS, A=COOCH3)と同様にして反応を行なった。収率は79%であった。
IR (film) : 2952, 2858, 1723, 1428, 1370, 1219, 1112, 823, 741, 702 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.66-7.38 (10H, m), 3.89 (1H, m), 3.65 (3H, s), 2.12 (1H, m), 1.92 (2H, m), 1.77 (1H, m), 1.14 (2H, m), 1.02 (9H, s), 0.45 (1H, m) ppm ;
MS (m/z): 394 (M+), 393 (M+-1), 363, 351, 337, 296, 259, 213 (base peak), 183, 135, 105, 77.
[α]D 25 : +72.58 (c=1.08, CHCl3).
【0096】
実施例 25: 2R,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−(ヒドロキシメチル)−ビシクロ[3.1.0]ヘキサン:I.h.5(R=H, P=TBDPS, A=CH2OH)
I.h.4(R=H, P=TBDPS, A=COOCH3)から、I.b.2(R=H, P=TBDMS, A=CH2OH)と同様にして反応を行なった。収率は98%であった。
IR (film): 3327, 2929, 2856, 1470, 1426, 1279, 1112, 1087, 1030, 822, 739, 700 IR (film): 3327, 2929, 2856, 1470, 1426, 1279, 1112, 1087, 1030, 822, 739, 700 -1 ;
1H-NMR (500 MHz, CDCl3) : δ 7.65-7.35 (10H, m), 3.97 (1H, ddd, J=7.0, 7.2, 7.0), 3.55 (2H, bs), 2.04 (1H, m), 1.93 (1H, m), 1.87 (2H, m), 1.39 (1H, m), 1.02 (9H, s), 0.45 (1H, m), 0.13 (1H, m) ppm ;
MS (m/z) : 365 (M+-1), 322, 281, 237, 189 (base peak), 181, 139, 99, 77 ;
[α]D 25 : +24.77 (c=1.18, CHCl3).
【0097】
実施例 26 :(2R,3aR,4aR)−2−t−ブチルジフェニルシリルオキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサン:I.h.6(R=H, P=TBDPS, A=CHO)
I.h.5(R=H, P=TBDPS, A=CH2OH)から、I.b.3(R=H, P=TBDMS, A=CHO)と同様にして反応を行なった。
IR (film) : 2931, 2857, 1708, 1472, 1388, 1362, 1200, 1113, 1093, 1036, 901, 823, 742, 612 cm-1 ;
1H-NMR (500 MHz, CDCl3) : δ 8.87 (1H, s), 7.65-7.35 (10H, m), 3.98 (1H, m), 2.29 (1H, dd, J=12.9, 8.1Hz), 2.01 (2H, m), 1.89 (2H, m), 1.22 (1H, m), 1.02 (9H, s), 0.74 (1H, t, J=5.4Hz) ppm ;
MS (m/z) : 363 (M++1), 332, 307 (base peak), 289, 277, 263, 229, 211, 199, 181, 151, 139, 121, 91, 77, 57, 41 ;
[α]D 25 : +91.49 (c=0.47, CHCl3).
【0098】
実施例 27:(1R,2S,3aS,4aS)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサン:I.a.7(R=Me, P=TBDPS, A=COOCH3)
a)メチル(1S,3S,4R,5R)−3−t−ブチルジフェニルシリルオキシ−4−メチル−5−アセトキシ−シクロヘキサン 2.1.c(R=Me, P=TBDPS, A=COOCH3)
攪拌した2’B(R=Me, A=COOCH3)(0.81 g, 3.52 mmol),イミダゾール(0.72 g, 10.57 mmol, 99 %)及びDMAP(4−ジメチルアミノピリジン; 22 mg) の無水DMF(15 ml)溶液にTBDPSCl(1.8 ml, 7.04 mmol, 98 %)を滴下した。得られた混合液を20時間室温で攪拌した。終了後、反応溶液をwater−EtOAc(80 ml)に注いだ。有機層を分離し、水層を EtOAc(50 ml × 3)で抽出した。結合した抽出物を飽和食塩水(3 × 10 ml)で洗浄し、MgSO4で乾燥させ、濃縮して残留物を得た。残留物をHPLC(イソオクタン/EtOAc 9:1)で精製し、2.1.c(R=Me, P=TBDPS, A=COOCH3)(1.34 g, 84 %)を得た。
[α]D = +9.9 (CHCl3, c = 0.65)
1H-NMR (500 MHz, in CDCl3, ppm) : 7.65-7.35 (10H, m), 4.59 (1H, dt, J=12.4, 4.5 Hz), 3.72 (1H, m), 3.62 (3H, s), 2.26 (1H, m), 2.09 (1H, m), 2.02 (3H, s), 1.81 (1H, dt, J=12.6, 4.1 Hz), 1.61 (1H, m), 1.08 (10H, s), 1.05 (3H, d, J=6.4 Hz).
IR (film) : 2954, 1737, 1428, 1364, 1239, 1111, 1037, 822, 740, 702 cm-1MS (m/z) : 411 (M+-57), 369, 351, 317, 291, 259, 258, 241, 199, 181, 135, 121, 93, 43 (base peak).
【0099】
b)メチル9(1S,3S,4R,5R)−3−t−ブチルジフェニルシリルオキシ−4−メチル−5−ヒドロキシ−シクロヘキサンカルボキシレート 2.2.c(R=Me, P=TBDPS, A=COOCH3)
室温の、攪拌した2.1.c(R=Me, P=TBDPS, A=COOCH3)(392 mg, 0.992 mmol)の無水MeOH(10 ml)溶液に、無水K2CO3(30 mg)を加えた。10分後、2度目のK2CO3(19 mg)(合計 : 49 mg, 0.496 mmol)を添加した。得られた混合液を6時間攪拌し、水とEt2O(70 ml:50 ml)の混合液に注いだ。有機層を分離し、水層をEt2O(50 ml × 3)で抽出し、MgSO4で乾燥した。シリカ上のフラッシュクロマトグラフィー(イソオクタン/EtOAc9:1)により分離し、ヒドロキシ化合物2.2.c(R=Me, P=TBDPS, A=COOCH3)(344 mg, 98 %) を無色油状物として得た。
IR (film) : 3448, 2954, 2858, 1737, 1654, 1472, 1362, 1279, 1240, 1173, 1008,852, 822, 795, 741, 702, 611 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 7.65 (4H, m), 7.44 (2H,m), 7.37 (4H, m), 3.69 (1H, m), 3.64 (3H, s), 3.51 (1H, m), 2.16 (1H, m), 2.08 (1H, m), 1.77 (1H, dt, J=12.6, 4.1 Hz), 1.69 (2H, t, J=8.9 Hz), 1.56 (1H, q, J=12.4 Hz), 1.37 (1H, d, J=5.3 Hz), 1.06 (9H, s), 1.02 (3H, d, J=7.0 Hz).
MS (m/z) : 337 (7), 309 (5), 291 (35), 199 (100), 156 (85), 181 (17), 153 (34), 121 (23), 93 (68), 57 (47).
[α]D 25 : +33.0 (c=0.54, CHCl3)
【0100】
c)メチル(1S,3S,4R,5R)−3−tert−ブチルジフェニルシリルオキシ−4−メチル−5−トシルオキシ−シクロヘキサンカルボキシレート 2.3.c(R=Me, P=TBDPS, L=OTos, A=COOCH3)
2.2.c(R=Me, P=TBDMS, A=COOCH3)(279 mg, 0.828 mmol)、p−トルエンスルホニルクロライド(323 mg, 1.69 mmol, 98 %)、DMAP(5.1 mg, 0.042 mmol)の無水CH2Cl2(10 ml)混合溶液に0℃(アイスバス)でEt3N(308 μL, 2.54 mmol)を添加した。得られた混合液を3日間還流した;次に トルエンスルホニルクロライド(320 mg, 1.69 mmol, 98 %)、DMAP(5.1 mg, 0.042 mmol)及びEt3N(500 μL)を添加した。得られた溶液を2日間還流した。p−トルエンスルホニルクロライド(320 mg, 1.69 mmol, 98 %)、DMAP(5.1 mg, 0.042 mmol)及びEt3N(500 μL)を再び添加し、もう1日還流を続けた。得られた混合液を20 mlのCH2Cl2で希釈し、飽和食塩水で洗浄し、水層をEtOAc(4×50 ml)で抽出した。結合した有機層をMgSO4で乾燥させた。溶液のろ過、濃縮、及びシリカ上のフラッシュクロマトグラフィー(イソオクタン/EtOAc9:1)により2.3.c(R=Me, P=TBDPS, L=OTos, A=COOCH3)(316 mg, 83.5 %) を淡黄色油状物質として得た。
IR (film) : 2954, 2858, 1737, 1365, 1246, 1177, 1106, 955, 704, 667 cm-11H-NMR (500 MHz, in CDCl3, ppm) : 7.71 (2H, d, J=8.3 Hz), 7.58 (4H, m), 7.43 (2H, m), 7.37 (4H, m), 7.31 (2H, d, J=8.1 Hz), 4.27 (1H, dt, J=12.0, 4.7 Hz), 3.61 (3H, s), 3.57 (1H, ddd, J=10.6, 5.1, 4.6 Hz), 2.45 (3H, s), 2.17 (1H, m), 2.01 (1H, m), 1.81 (1H, dt, J=12.8, 4.2 Hz), 1.74 (1H, dd, J=12.6 Hz), 1.64 (2H,m), 1.02 (9H, s), 0.99 (3H,d,J=6.6 Hz).
MS (m/z) : 523 (25), 507 (1), 463 (1), 409 (3), 353 (94), 307 (20), 293 (18), 213 (30), 199 (32), 135 (35), 91 (100), 77 (30).
[α]D 25 : -10.0 (c=1.22, CHCl3)
【0101】
d)(1R,2S,3aS,4aS)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.a.7(R=Me, P=TBDPS, A=COOCH3)
トシレート2.3.c(R=Me, P=TBDPS, L=OTos, A=COOCH3)(240 mg, 0.415 mmol)のtert−BuOH(5 ml)とTHF(2.8 ml)溶液(45°C)にtert−BuOK(540 μL, 0.54 mmol, tert−BuOH中に1 M溶液)を滴下した。得られた混合液を45℃で1.5時間攪拌し、次に水とEtOAc(100 ml:50 ml)に注いだ。 有機層を分離し、水層をEtOAc(3 × 50 ml)で抽出し、MgSO4で乾燥させた。次に残留物をフラッシュクロマトグラフィー(イソオクタン/EtOAc100:2)により分離し、化合物I.a.7(R=Me, P=TBDPS, A=COOCH3)(122 mg, 72.0 %)を無色油状物として得た。
IR (film) : 2931, 1724, 1428, 1288, 1224, 1147, 1111, 1073, 1015, 933, 822, 740, 702, 609 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 7.61 (14H, m), 7.42 (2H, m), 7.36 (4H, t, J=7.2 Hz), 4.19 (1H, t, J=6.0 Hz), 3.62 (3H, s), 2.30 (2H, m), 1.97 (1H, d, J=14.2 Hz), 1.85 (1H, m), 1.64 (1H, t, J=4.6 Hz), 1.35 (1H, dd, J=8.7, 3.9 Hz), 1.09 (9H, s), 0.99 (3H, d, J=6.9 Hz).
MS (m/z) :
[α]D 25 : -13.2 (c=1.61, CHCl3)
【0102】
実施例 28:(1R,2S,3aS,4aS)−3a−ヒドロキシメチル−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.a.8(R=Me, P=TBDPS, A=CH2OH)
I.a.7(R=Me, P=TBDPS, A=COOCH3)(136 mg, 0.33 mmol)のTHF(15 ml)溶液(0℃)にLiAlH4(0.85 ml, 0.85 mmol, THF中に1 M溶液)を滴下した。得られた混合液をこの温度で1.5時間攪拌し、水(0.1 ml) を加えた。反応混合液をセライトを用いてろ過し、濃縮した。残留物をフラッシュクロマトグラフィー(シリカゲル:イソオクタン/EtOAc:7:3)により精製し、I.a.8(R=Me, P=TBDPS, A=CH2OH) (124 mg, 97.8 %)を無色油状物として得た。
IR (film) : 3420, 2930, 1427, 1111, 1078, 1014, 701, 611, 504 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 7.63 (4H, m), 7.42 (2H, m), 7.36 (4H, m), 4.21 (1H, t, J=6.0 Hz), 3.54 (1H, dd, J=11.4, 5.6 Hz), 3.50 (1H, dd, J=11.4, 5.6 Hz), 2.29 (1H, m), 1.95 (1H, ddd, J=13.7, 6.0, 1.4 Hz), 1.23 (1H, t, J=4.12 Hz), 1.14 (1H, m), 1.08 (9H, s), 0.99 (3H, d, J=7.0 Hz), 0.41 (1H, dd, J=8.4, 4.3 Hz), 0.80 (1H, m).
MS (m/z) : 381 (M++1, 1), 363 (22), 337 (1), 323 (22), 305 (5), 285 (9), 267 (24), 245 (63), 225 (19), 199 (83), 179 (19), 153 (29), 139 (51), 107 (100), 91 (58), 79 (72), 57 (86), 41 (78).
[α]D 25 : -2.6 (c=0.69, CHCl3)
【0103】
実施例 29:(1R, 2S, 3aS, 4aS)−3a−ホルミル−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.a.9(R=Me, P=TBDPS, A=CHO)
(COCl)2 (18 μL, 0.21 mmol)のCH2Cl2(1.5 ml)溶液(−78℃)にDMSO(32 μL, 0.42 mmol)のCH2Cl2(100 μL)溶液を滴下した。混合液を−78℃で20分間攪拌し、次にアルコールI.a.8(R=Me, P=TBDPS, A=CH2OH)(40 mg, 0.105 mmol)のCH2Cl2(1.5 ml)溶液をくわえた。得られた白濁液を−78℃で20分間攪拌した。次にこの混合液を1時間かけて室温まで温めた。冷水を加えて反応を終了させ、有機層を分離し、水層をEt2O(3 × 50 ml)で抽出した後、MgSO4で乾燥させた。残留物をHPLC(イソオクタン/EtOAc:95:5)で分離し、化合物I.a.9(R=Me, P=TBDPS, A=CHO)(30 mg, 75%)を無色油状物として得た。
IR (film) : 3420, 2930, 1427, 1111, 1078, 1014, 701, 611, 504 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 8.80 (1H, s), 7.62 (4H, m), 7.42 (6H, m), 4.24 (1H, t, J=5.8 Hz), 2.32 (1H, dd, J=14.4, 6.1 Hz), 1.96 (2H, m), 1.84 (1H, d, J=14.4 Hz), 1.36 (1H, m), 1.08 (9H, s), 1.00 (3H, d, J=7.0 Hz), 0.91 (1H, d, J=6.8 Hz).
MS (m/z) : 378 (M+, 1), 361 (4), 321 (100), 303 (10), 285 (10), 267 (24), 263 (16), 243 (74), 225 (39), 199 (100), 183 (76), 165 (39), 139 (72), 135 (48), 105 (59), 91 (34), 77 (60), 57 (95), 41 (80).
[α]D 25 = -16.2 (c=0.59, CHCl3)
【0104】
実施例 30:(1S,2R,3aR,4aR)−3a−カルボメトキシ−2−tert−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.f.8(R=Me, P=TBDPS, A=COOCH3)
a)メチル(1S,3S,4R,5R)−3−トシルオキシ−4−メチル−5−アセトキシ−シクロヘキサンカルボキシレート3.4.c(R=Me, L=OTos, A=COOCH3)
2’B(R=Me, Z=Me, A=COOCH3)(1.05 g, 4.57 mmol)から、2.3.c(R=Me, P=TBDPS, L=OTos, A=COOCH3)と同様にして反応を行った。収率は1.51 g, 89 %であった。
IR (film) : 2954, 1736, 1557, 1363, 1242, 1189, 1025, 956, 919, 667 cm-11H-NMR (500 MHz, in CDCl3, ppm) : 7.69 (2H, d, J=7.2 Hz), 7.38 (2H, d, J=7.2 Hz), 4.74 (1H, dt, J=12.2, 4.5 Hz), 4.49 (1H, dt, J=12.1, 4.7 Hz), 3.69 (3H, s), 2.46 (3H, s), 2.02 (3H, s), 1.98 (1H, dt, J=12.1, 4.7 Hz), 1.93 (1H, dt, J=12.6, 4.6 Hz), 1.81 (2H, dd, J=12.8 Hz), 1.63 (2H, dd, J=12.6 Hz), 0.97 (3H, d, J=6.9 Hz).
MS (m/z) : 384 (M+), 343, 326, 311, 300, 269, 258, 213, 170, 152, 111, 93, 43 (base peak).
[α]D 25 = +51.1 (c=0.59, CHCl3)
【0105】
b)メチル(1S,3S,4R,5R)−3−トシルオキシ−4−メチル−5−ヒドロキシ−シクロヘキサンカルボキシレート3.5.c(R=Me, L=OTos, A=COOCH3)
3.4.c(R=Me, L=OTos, A=COOCH3)から、2.2.c(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は90%であった。
IR (film) : 3439, 2988, 1732, 1439, 1353, 1176, 1097, 1021, 945, 667 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 7.78 (2H, d, J=7.2 Hz), 7.32 (2H, d, J=7.2 Hz), 4.52 (1H, dt, J=10.8, 4.7 Hz), 3.69 (1H, m), 3.68 (3H, s), 2.45 (3H, s), 2.34 (1H, m), 2.25 (1H, m), 1.94 (2H, m), 1.87 (1H, dt, J=13.2, 4.5 Hz), 1.75 (1H, bs), 1.66 (1H, dd, J=11.9 Hz), 0.91 (3H, d, J=7.0 Hz).
MS (m/z) : 340 (M+-2), 295, 278, 247, 220, 194, 170, 155, 127 (base peak), 91, 87, 57.
[α]D 25 : +18.8 (c=0.41, CHCl3)
【0106】
c)メチル(1S,3S,4R,5R)−3−トシルオキシ−4−メチル−5−tert−ブチルジフェニルシリルオキシ−シクロヘキサンカルボキシレート3.6.c(R=Me, L=OTos, P=TBDPS, A=COOCH3)
3.5.c(R=Me, L=OTos, A=COOCH3)から、2.1.c(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は86%であった。
IR (film) : 2955, 1736, 1598, 1427, 1363, 1177, 1031, 955, 914, 863, 820, 741, 703, 667 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 7.69-7.38 (14H, m), 4.27 (1H, dt, J=12.1, 4.8 Hz), 3.61 (3H, s), 3.56 (1H, m), 2.44 (3H, s), 2.17 (1H, m), 2.02 (1H, m), 1.83 (1H, dt, J=12.5, 4.3 Hz), 1.73 (1H, dd, J=12.7 Hz), 1.63 (2H, m), 1.01 (9H, s), 0.99 (3H, d, J=7.2 Hz).
MS (m/z) : 523 (M+-57), 463, 403, 353, 351, 293, 227, 213, 135, 91 (base peak), 77.
[α]D 25 : -2.6 (c=0.94, CHCl3)
【0107】
d)(1S,2R,3aR,4aR)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.f.8(R=Me, P=TBDPS, A=COOCH3)
3.6.c(R=Me, L=OTos, P=TBDPS, A=COOCH3)から、I.a.7(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。標題化合物を無色油状物として収率68%で得た。
IR (film) : 2931, 2857, 1724, 1428, 1367, 1288, 1223, 1147, 1111, 1073, 1015, 934, 822, 740, 702, 609 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 7.62-7.31 (10H, m), 4.19 (1H, t, J=5.9 Hz), 3.59 (3H, s), 2.31 (2H, dd, J=13.7, 6.3 Hz), 1.96 (1H, d, J=14.5 Hz), 1.84 (1H, m), 1.64 (1H, t, J=4.6 Hz), 1.35 (1H, dd, J=12.8, 5.0 Hz), 1.25 (1H, br.), 1.07 (9H, s), 0.99 (3H, d, J=6.9 Hz), 0.91 (1H, m).
MS (m/z) : 408 (M+), 351, 323, 273, 213, 199, 153, 121 (base peak), 77. [α]D 25 : +13.9 (c=0.65, CHCl3)
【0108】
実施例 31:(1S,2R,3aR,4aR)−3a−ヒドロキシメチル−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.f.9(R=Me, P=TBDPS, A=CH2OH)
I.f.8 R=Me, P=TBDPS, A=COOCH3)から、I.a.8(R=Me, P=TBDPS, A=CH2OH)と同様にして反応を行った。収率は98%であった。
IR (film) : 3324, 2929, 2857, 1654, 1471, 1427, 1363, 1194, 1107, 1078, 1011, 822, 740, 701, 610 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm) : 7.68-7.37 (10H, m), 4.21 (1H, t, J=6.0 Hz), 3.54 (1H, dd, J=11.4, 6.0 Hz), 3.52 (1H, dd, J=11.4, 6.0 Hz), 2.29 (1H, dd, J=11.3, 8.1 Hz), 1.94 (1H, dd, J=14.6, 5.9 Hz), 1.86 (1H, d, J=13.2 Hz), 1.23 (1H, t, J=4.1 Hz), 1.14 (1H, m), 1.07 (9H, s), 0.99 (3H, d, J=6.9 Hz), 0.89 (1H, m), 0.41 (dd, J=8.1, 4.3 Hz).
MS (m/z) : 323 (M+-57), 305, 267, 245, 199, 181, 139, 107.
[α]D 25 : +3.1 (c=0.93, CH3Cl)
【0109】
実施例 32:(1S,2R,3aR,4aR)−3a−ホルミル−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.f.10(R=Me, P=TBDPS, A=CHO)
I.f.9(R=Me, P=TBDPS, A=CH2OH)から、I.a.9(R=Me, P=TBDPS, A=CHO)と同様にして反応を行った。収率は28%であった。
[α]D 25 : +15.8 (c=0.41, CH3Cl)
1H-NMR (500 MHz, in CDCl3, ppm) : 8.80 (1H, s), 7.61-7.35 (10H, m), 4.24 (1H, t, J=5.8 Hz), 2.31 (2H, m), 1.96 (1H, m, dd, J=8.1, 5.9 Hz), 1.84 (1H, d, J=14.3 Hz), 1.37 (1H, dd, J=11.0, 7.1 Hz), 1.26 (1H, dd, J=9.7, 4.6 Hz), 1.07 (9H, s), 1.04 (3H, t, J=6.9 Hz).
IR (film) : 2959, 2857, 1703, 1471, 1391, 1383, 1274, 1215, 1191, 1111, 1109, 1009, 963, 823, 701 cm-1.
MS (m/z) : 377 (M+-1, 5), 337 (75), 321 (M+-57, 8), 319 (10), 309 (10), 293 (6), 259 (12), 231 (20), 215 (16), 199 (100), 181 (30), 153 (20), 139 (60), 121 (95).
【0110】
実施例 33:(1R,2S,3aS,4aS)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−エチル−ビシクロ[3.1.0]ヘキサンI.a.10(R=Et, P=TBDPS, A=COOCH3)
a)メチル(1S,3S,4R,5R)−3−t−ブチルジフェニルシリルオキシ−4−エチル−5−アセトキシ−シクロヘキサン2.1.d(R=Et, P=TBDPS, A=COOCH3)
2’C(R=Et, Z= Me, A=COOCH3)から、3.4.cと同様にして反応を行った。収率は92%であった。
[α]D 25 : +7.5 (c=0.59, CH3Cl)
1H-NMR (500 MHz, in CDCl3, ppm) : 7.45-7.36 (10H, m), 4.62 (1H, dt, J=12.2, 4.4 Hz), 3.69 (1H, dt, J=11.5, 4.3 Hz), 3.61 (3H, s), 2.08 (2H, tt, J=8.8, 3.9 Hz), 2.01 (3H, s), 1.85 (2H, m), 1.60 (3H, m), 1.51 (1H, m), 1.06 (9H, s), 1.02 (3H, t, J=7.5 Hz).
IR (film) : 2954, 2848, 1739, 1462, 1428, 1364, 1238, 1194, 1178, 1110, 1034, 986, 812, 740, 702 cm-1.
MS (m/z) : 482 (M+, 2), 468 (5), 451 (7), 425 (M+-57), 391 (1), 365 (80), 351 (25), 305 (15), 273 (20), 241 (100), 213 (88), 199 (92), 153 (56), 135 (75), 107 (85).
【0111】
b)メチル(1S,3S,4R,5R)−3−t−ブチルジフェニルシリルオキシ−4−エチル−5−ヒドロキシ−シクロヘキサンカルボキシレート2.2.d(R=Me, P=TBDPS, A=COOCH3)
2.1.d(R=Et, P=TBDPS, A=COOCH3)から、2.2.c(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は98%であった。
[α]D 25 : +28.7 (c=0.19, CH3Cl)
1H-NMR (500 MHz, in CDCl3, ppm) : 7.68 (10H, m), 3.68 (1H, dt, J=8.2, 4.2 Hz), 3.62 (3H, s), 3.57 (1H, dt, J=11.1, 4.6 Hz), 2.07 (1H, m), 1.85 (1H, t, J=4.1 Hz), 1.77 (1H, dt, J=8.6, 4.0 Hz), 1.71 (1H, tt, J=11.0, 4.0 Hz), 1.64 (2H, t, J=9.0), 1.59 (1H, overlap), 1.52 (1H, bs), 1.45 (1H, m), 1.06 (9H, s), 1.05 (3H, t, J=7.5).
IR (film) : 3435, 2995, 2858, 1736, 1589, 1460, 1427, 1363, 1271, 1236, 1172, 1111, 1050, 915, 875, 823, 740, 702, 647 cm-1.
MS (m/z) : 383 (M+-57, 14), 351 (16), 323 (18), 305 (90), 273 (18), 253 (10), 227 (50), 199 (100), 183 (70), 153 (80), 107 (98).
【0112】
c)メチル(1S,3S,4R,5R)−3−t−ブチルジフェニルシリルオキシ−4−エチル−5−トシルオキシ−シクロヘキサンカルボキシレート2.3.d(R=Et, P=TBDPS, L=OTos, A=COOCH3)
2.2.d(R=Et, P=TBDPS, A=COOCH3)から、2.3.c(R=Me, P=TBDPS, L=OTos, A=COOCH3)と同様にして反応を行った。収率は82%であった。
[α]D 25 : -17.9 (c=0.59, CH3Cl)
1H-NMR (500 MHz, in CDCl3, ppm) : 7.72-7.30 (14H, m), 4.28 (1H, dt, J=12.5, 4.5 Hz), 3.59 (3H, s), 3.55 (1H, dt, J=11.4, 4.3 Hz), 2.45 (3H, s), 1.96 (1H, tt, J=8.5, 4.1 Hz), 1.91 (1H, t, J=4.2Hz), 1.84 (1H, dt, J=8.5, 4.1 Hz), 1.77 (1H, m), 1.73 (1H, m), 1.53 (2H, m), 1.47 (1H, m), 1.02 (9H, s), 0.97 (3H, t, J=7.5 Hz).
IR (film) : 2957, 2858, 1738, 1598, 1487, 1462, 1428, 1360, 1277, 1189, 1111, 1030, 953, 885, 822, 741, 704 cm-1.
MS (m/z) : 357 (M+-57, 45), 353 (100), 293 (22), 227 (5), 199 (48), 135 (70).
【0113】
d)(1R,2S,3aS,4aS)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−エチル−ビシクロ[3.1.0]ヘキサンI.a.10(R=Et, P=TBDPS, A=COOCH3)
2.3.d(R=Et, P=TBDPS, L=OTos, A=COOCH3)から、I.a.7(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は71%であった。
[α]D 25 : -33.3 (c=0.27, CH3Cl)
1H-NMR (500 MHz, in CDCl3, ppm) : 7.63-7.35 (10H, m), 4.18 (1H, t, J=5.9 Hz), 3.61 (3H, s), 2.26 (1H, m), 2.06 (1H, m), 1.98 (1H, d, J=14.3 Hz), 1.92 (1H, m), 1.67 (1H, t, J=4.3 Hz), 1.48 (2H, m), 1.36 (1H, dd, J=8.7, 3.9 Hz), 1.05 (9H, s), 0.89 (3H, J=7.4 Hz).
IR (film) : 2958, 1723, 1427, 1366, 1298, 1224, 1148, 1111, 1064, 1028, 926, 821, 740, 610, 507 cm-1.
MS (m/z) : 422 (M+, 2), 391 (4), 365 (M+-57, 40), 337 (8), 287 (12), 259 (10), 225 (8), 199 (65), 135 (100), 105 (38).
【0114】
実施例 34:(1S,2R,3aR,4aR)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−エチル−ビシクロ[3.1.0]ヘキサンI.f.11(R=Et, P=TBDPS, A=COOCH3).
a)メチル(1S,3S,4R,5R)−3−メシルオキシ−4−エチル−5−アセトキシ−シクロヘキサン カルボキシレート 3.4.d (R=Et, L=OMs, A=COOCH3).
モノアセテート2’C(A=COOCH3, R=Et, Z=Me)(0.1 g, 0.41 mmol)、Et3N(0.30 ml, 2.10 mmol)のCH2Cl2(5 ml)溶液にMsCl(96 μL, 1.23 mmol)を室温で滴下した。得られた混合液を室温で10時間攪拌した。反応溶液を氷水に注ぎ、AcOEt(3 × 50 ml)で抽出した。結合した抽出物を飽和食塩水(3 × 5 ml)で洗浄し、MgSO4で乾燥させ、 濃縮して残留物を得た。得られた残留物をイソオクタン/EtOAc(90:10)を溶離液としたHPLCで精製し、メシレート3.4.d(A=COOCH3, R=Et, L=OMs)(0.11 g, 85 %)を得た。
IR (film) : 2954, 1737, 1641, 1357, 1241, 1175, 952 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 4.87 (1H, dt, J=10.9, 4.2 Hz), 4.75 (1H, dt, J=4.5, 10.9 Hz), 3.69 (3H, s), 3.00 (3H, s), 2.48 (1H, m), 2.23 (1H, bs), 2.13 (1H, dt, J=4.2, 11.8 Hz), 2.05 (3H, s), 2.01 (1H, d, J=8.8 Hz), 1.96 (1H, dt, J=13.3, 4.5 Hz), 1.83 (1H, m), 1.58 (2H, m), 1.01 (3H, s).
MS (m/z) : 322 (M+), 309, 291, 248, 227, 199, 166, 135, 107, 78, 43 (base peak).
[α]D 25 : +2.6 (c=1.08, CHCl3)
【0115】
b)メチル(1S,3S,4R,5R)−3−メシルオキシ−4−エチル−5−ヒドロキシ−シクロヘキサンカルボキシレート3.5.d(A=COOCH3, R=Et, L=OMs)
3.4.d(R=Et, L=OMs, A=COOCH3)から、2.5.a(R=H, L=OTos, A=COOCH3)と同様にして反応を行った。収率は90%であった。
IR (film) : 3439, 2957, 1729, 1438, 1351, 1277, 1174, 944, 877, 838, 757,
530 cm-1
1H-NMR (500 MHz, in CDCl3, ppm) : 4.87 (1H, t, J=3.1 Hz), 3.91 (1H, t, J=2.9 Hz), 3.74 (3H, s), 3.00 (3H, s), 2.69 (1H, bs), 2.44 (1H, bs), 2.17 (1H, bs), 2.00 (2H, m), 1.84 (2H, dt, J=14.3, 4.7 Hz), 1.71 (2H, m), 1.03 (3H, t, J=7.4 Hz).
MS (m/z) : 281 (M++1), 263, 249, 236, 200, 184, 166, 141, 125, 111, 87, 78, 55 (base peak).
[α]D 25 : +51.3 (c=0.61, CHCl3)
【0116】
c)メチル(1S,3S,4R,5R)−3−メシルオキシ−4−エチル−5−t−ブチルジフェニルシリルオキシ−シクロヘキサンカルボキシレート3.6.d(R=Et, L=OMs, P=TBDPS, A=COOCH3)
3.5.d(R=Et, L=OMs, A=COOCH3)から、2.8.a(R=H, L=OTos, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は86%であった。
IR (film) : 2957, 2857, 1738, 1588, 1462, 1427, 1358, 1276, 1177, 1111, 1030, 949, 885, 823, 741, 703, 614 cm-11H-NMR (500 MHz, in CDCl3, ppm) : 7.65-7.35 (10H, m), 4.44 (1H, dt, J=12.2, 4.6 Hz), 3.67 (1H, dt, J=11.6, 4.2 Hz), 3.63 (3H, s), 2.79 (3H, s), 2.09 (1H, dt, J=12.9, 3.9 Hz), 2.06 (1H, m), 2.02 (2H, m), 1.85 (1H, m), 1.79 (1H, dd, J=12.8 Hz), 1.65, 1H, dt, J=13.1, 4.0 Hz), 1.49 (1H, m), 1.06 (9H, s), 1.04 (3H, t, J=7.5 Hz).
MS (m/z) : 461 (M+-57), 401, 365, 351, 305, 277, 231, 199, 167, 135, 107 (base peak).
[α]D 25 : -2.3 (c=0.35, CHCl3)
【0117】
d)(1S,2R,3aR,4aR)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−エチル−ビシクロ[3.1.0]ヘキサンI.f.11(R=Et, P=TBDPS, A=COOCH3).
3.6.d(R=Et, L=OMs, P=TBDPS, A=COOCH3)から、I.a.7(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は71 %であった。
IR (film) : 2958, 1723, 1427, 1366, 1298, 1224, 1148, 1111, 1064, 1028, 926, 821, 740, 610, 507 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm) : 7.63-7.35 (10H, m), 4.18 (1H, t, J=5.9 Hz), 3.61 (3H, s), 2.26 (1H, m), 2.06 (1H, m), 1.98 (1H, d, J=14.3 Hz), 1.92 (1H, m), 1.67 (1H, t, J=4.3 Hz), 1.48 (2H, m), 1.36 (1H, dd, J=8.7, 3.9 Hz), 1.05 (9H, s), 0.89 (3H, J=7.4 Hz).
MS (m/z) : 422 (M+, 2), 391 (4), 365 (M+-57, 40), 337 (8), 287 (12), 259 (10), 225 (8), 199 (65), 135 (100), 105 (38).
[α]D 25 : +28.4 (c=0.75, CHCl3)
【0118】
実施例 35:(1R,2S,3aR,4aR)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.e.1(R=Me, P=TBDPS, A=COOCH3)
a)メチル(1S,3S,4R,5S)−3−t−ブチルジフェニルシリルオキシ−4−メチル−5−ヒドロキシ−シクロヘキサン カルボキシレート3.2.c(R=Me, P=TBDPS, A=COOCH3).
2.2.c(R=Me, P=TBDPS, A=COOCH3)(167 mg, 0.392 mmol),ピコリン酸(257 mg, 2.092 mmol)及びトリフェニルホスフィン(548 mg, 2.092 mmol)のTHF溶液(−38℃)にDIAD(ジイソプロピルアゾジカルボキシレート ; 412 μL, 2.092 mmol)を4分かけて滴下した。反応溶液を4.5時間攪拌し、一晩で室温まで戻った。得られた混合液を水とEtOAc(50ml:50ml)に注いだ。有機層を分離し、水層をEtOAc(3 × 50 ml)で抽出し、MgSO4で乾燥させた。残留物をHPLC(イソオクタン/EtOAc 98:2)によって分離し、(4S,6S)−4−カルボメトキシ−6−t−ブチルジフェニルシリルオキシ−1−メチルシクロヘキサン(142 mg, 88.8%)を無色油状物として得た。
IR (film): 2953, 2856, 1738, 1428, 1247, 1168, 1111, 1068, 999, 893, 820, 741, 702, 614 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 7.71 (4H, m), 7.43 (2H, m), 7.38 (4H, m), 5.39 (1H, m), 4.25 (1H, bs), 3.60 (3H, s), 2.39 (1H, m), 2.19 (1H, m), 2.13 (1H, m), 2.04 (1H, m), 1.75 (1H, dd, J=22.3, 12.5Hz), 1.66 (3H, bs), 1.08 (9H, s).
MS (m/z): 387 (1), 361 (1), 351 (75), 319 (5), 273 (5), 273 (5), 213 (100), 183 (70), 137 (65), 105 (30), 77 (85).
[α]D 25 : +81.9 (c=1.91, CHCl3)
【0119】
攪拌したシクロヘキサン(110 mg, 0.27 mmol)のdiglyme(2 ml)溶液(0℃)にボラン−THF錯体溶液(1.0 M, 325 μL, 0.325 mmol, 1.5 eq)を滴下した。得られた溶液を4時間、0℃で攪拌した。THFを除去し、TAO(トリメチルアミンN−オキサイド, 90 mg, 0.81 mmol)を加えた。混合液を加熱し、2時間還流した。得られた混合液を室温まで冷却し、EtOAc (4 エ 40 ml)で抽出し、MgSO4で乾燥させた。残留物をシリカ上のフラッシュクロマトグラフィーで分離し、HPLC(シクロヘキサン/EtOAc:9:1)で精製して化合物3.2.c(R=Me, P=TBDPS, A=COOCH3)(46 g, 40.5%)を無色油状物として得た。
IR (film, cm-1): 3453, 2954, 2858, 1737, 1462, 1428, 1379, 1272, 1195, 1111, 1032, 934, 823, 702.
1H-NMR (500 MHz, in CDCl3, ppm): 7.66 (4H, m), 7.42 (2H, m), 7.38 (4H, m), 4.17 (1H, dt, J=10.7, 4.7Hz), 3.88 (1H, bs), 3.62 (3H, s), 2.61 (1H, m), 1.85〜1.65 (5H, m), 1.06 (9H, s), 0.96 (3H, d, J=7.2Hz).
[α]D 25 : +39.4 (c=0.95, CHCl3)
【0120】
b)メチル(1S,3S,4R,5S)−3−t−ブチルジフェニルシリルオキシ−5−メシルオキシ−4−メチル−シクロヘキサンカルボキシレート3.3.c(R=Me, L=OMs, P=TBDPS, A=COOCH3)
3.2.c(R=Me, P=TBDPS, A=COOCH3)から、3.4.d(R=Et, L=OMs, A=COOCH3)と同様にして反応を行った。収率は84.5%であった。
IR (film): 2952, 1732, 1470, 1427, 1357, 1275, 1177, 1112, 1029, 929, 904 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm) : 7.65 (4H, t, J=8.0 Hz), 7.40 (6H, m), 4.80 (1H, bs), 4.06 (1H, m), 3.65 (3H, s), 2.70 (3H, s), 2.58 (1H, m), 2.04 (1H, bs), 1.98〜1.76 (4H, m), 1.06 (9H, s), 1.03 (3H, d, J=7.2 Hz).[α]D 25 : +30.3 (c=0.52, CHCl3)
【0121】
c)(1R,2S,3aR,4aR)−3a−カルボメトキシ−2−t−ブチルジフェニルシリルオキシ−1−メチル−ビシクロ[3.1.0]ヘキサンI.e.1(R=Me, P=TBDPS, A=COOCH3)
3.3.c(R=Me, L=OMs, P=TBDPS, A=COOCH3)から、I.a.7(R=Me, P=TBDPS, A=COOCH3)と同様にして反応を行った。収率は68.8%であった。
IR (film): 2951, 1725, 1428, 1259, 1238, 1111, 880, 814, 742, 702 cm-1.1H-NMR (500 MHz, in CDCl3, ppm) : 7.63 (4H, m), 7.45〜7.35 (6H, m), 3.84 (1H, m), 3.64 (3H, s), 2.23 (1H, m), 2.02 (1H, m), 1.93 (1H, m), 1.60 (1H, m), 1.17 (1H, m), 1.04 (12H, bs), 0.56 (1H, m).
【0122】
実施例 36:(2R,3aS,4aS)−2−メチル−2−ヒドロキシ−3a−ヒドロキシメチル−ビシクロ[3.1.0] ヘキサン:I.i.1(A=CH2OH, R1=Me :スキーム4)
a)(2R,3aS,4aS)−2−ヒドロキシ−3a−[(ベンゾイルオキシ)メチル]−ビシクロ[3.1.0]ヘキサン:4.1
I.a.5(R=H, P=TBDPS, A=CH2OH)(4.451 g, 12.15 mmol)、DMAP(250 mg, 2.27 mmol)及びEt3N(16.5 ml, 121.1 mmol)のCH2Cl2 (50 ml)溶液(0℃)にベンゾイルクロライドを滴下した。混合液を22時間室温で攪拌し、70mlのCH2Cl2で希釈した。有機層を分離し,飽和食塩水(3 × 100 ml)で洗浄し、MgSO4で乾燥させた。残留物をフラッシュクロマトグラフィー(シリカゲル, イソオクタン/EtOAc:100:2.5)で精製し,対応するベンゾエート(5.51 g, 96.5%)を無色油状物として得た。このベンゾエート(2.22 g, 4.72 mmol)のTHF(40 ml)溶液にTBAF(14 ml, 14 mmol, THF中1M)を加え、得られた溶液を室温で14時間攪拌した。溶媒を真空下で蒸発させた。残留物を短いシリカゲルカラム(イソオクタン/EtOAc:7:3)に通した。粗精製物をHPLC(イソオクタン/EtOAc:7:3)で精製し、化合物4.1(1.03g, 94.0%)を無色油状物として得た。
IR (film): 3413.8, 2928.3, 1714.1, 1602.1, 1452.1, 1277.5, 1115.1, 1070.0, 958.3, 808.3, 711.5 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.06 (2H, d, J=7.8Hz), 7.56 (1H, t, J=7.3Hz), 7.45 (1H, t, J=7.7Hz), 4.48 (1H, m), 4.34 (2H, dd, J=19.4, 11.5Hz), 2.23 (2H, m), 1.94 (1H, d, J=14.0Hz), 1.78 (1H, d, J=14.2Hz), 1.38 (1H, ddd, J=8.3, 4.3, 4.3Hz), 1.30 (1H, bs), 1.06 (1H, t, J=4.4Hz), 0.75 (1H, m)
MS (m/z): 232 (M+, 1), 214 (1), 199 (1), 189 (1), 161 (1), 149 (1), 127 (1), 110 (13), 105 (100), 77 (43). 67 (14).
[α]D 25 : -27.96 (c=1.47, CHCl3).
【0123】
b)(3aS,4aS)−3a−[(ベンゾイルオキシ)メチル]−ビシクロ[3,1,0]ヘキサン−2−オン:4.2
アルコール4.1(209 mg, 0.904 mmol)のCH2Cl2(30 ml)溶液にピリジニウムジクロメート(PDC, 1.072 g, 4.97 mmol)を加え、得られた混合液を室温で16時間攪拌した。得られた溶液を直接的にフラッシュクロマトグラフィー(シリカゲルカラム 3×15 cm)(イソオクタン/EtOAc:9:1〜8:2)で精製し、化合物4.2(197 mg, 95%)を無色油状物として得た。
IR (film): 1745.0, 1715.9, 1451.2, 1355.4, 1272.1, 1155.7, 1111.3, 1069.9,
711.0 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.05 (2H, d, J=8.9Hz), 7.58 (1H, t, J=7.4Hz), 7.46 (2H, t, J=7.6Hz), 4.41 (2H, dd, J=29.6, 12.7Hz), 2.75 (2H, m), 2.41 (1H, d, J=9.0Hz), 2.28 (1H, d, J=9.3Hz), 1.68 (1H, m), 1.10 (1H, t, J=7.0Hz), 0.37 (1H, t, J=5.1Hz).
MS (m/z): 230 (M+, 1), 212 (1), 202 (6.9), 183 (1), 161 (1), 149 (1), 125 (1), 106 (13), 105 (100), 77 (46), 51 (20).
[α]D 25 : -36.50 (c=4.07, CHCl3)
【0124】
c)(2R,3aS,4aS)−2−メチル−2−ヒドロキシ−3a−ヒドロキシメチル−ビシクロ[3.1.0]ヘキサンI.i.1(R1=Me, A=CH2OH)
ケトン4.2(120 mg, 0.52 mmol)のTHF(4 ml)溶液にMeMgBrのEt2O(1.5 ml, 3.0 M)溶液を5分かけて−78℃で滴下した。得られた混合液をこの温度で6時間攪拌し、次に室温まで一晩で戻した。氷冷した飽和NH4Cl水溶液(0.2 ml)を加えて反応を終了させた。得られた混合液を、MgSO4を有する短いシリカゲルカラムに通した。残留物をHPLC(イソオクタン/EtOAc:5:5)で分離し、化合物I.i.1(R1=Me, A=CH2OH)(55 mg, 74%) を白色固形物として得た。
IR (film): : 3288.4, 2931.3, 2858.5, 1459.1, 1370.2, 1260.7, 1183.9, 1135.7,1111.5, 1064.0, 1016.0, 922.6 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 3.58 (2H, s), 2.08 (1H, d, J=13.7Hz), 2.03 (1H, dd, J=13.8, 5.0Hz), 1.88 (1H, d, J=13.7Hz), 1.76 (1H, d, J=13.8Hz), 1.34 (3H, s), 1.29 (1H, bs), 1.21 (1H, m), 1.14 (1H, t, J=4.3Hz), 1.11 (1H, s), 0.57 (1H, dd, J=8.4, 4.5Hz).
MS (m/z): 124 (2), 109 (6), 93 (12), 81 (12), 71 (10), 67 (10), 55 (11), 43 (100).
[α]D 25 : -33.10 (c=1.17, MeOH)
【0125】
実施例 37:(2R,3aS,4aS)−2−メチル−2−ヒドロキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサンI.i.2(R1=Me, A=CHO)
SO3−ピリジン複合体(2.5 eq, 140 mg)のDMSO:CH2Cl2(500 μL:250 μL)及びEt3N(2.5 eq, 120 μL)溶液に、I.i.1(R1=Me, A=CH2OH)(1 eq, 50 mg, 35 μmol)のDMSO:CH2Cl2(500 μL:250 μL)及びEt3N(2.5 eq, 120 μL)溶液を−15℃で加えた。−10℃〜−5℃で1時間攪拌した後、混合液をEt2O:飽和食塩水に注いだ。次に有機層を乾燥させた(MgSO4)。溶媒を蒸発させた後、残留物をカラムクロマトグラフィー(Et2O:イソオクタン 1:1〜Et2O:イソオクタン:メタノール: CH2Cl2 100:100:1:20)で精製し、I.i.2(R1=Me, A=CHO)を無色油状物として得た(37 mg, 75%)。
IR (film) : 3441, 2929, 1694, 1435, 1258, 1105, 1049, 963, 893 cm-1
1H-NMR (500 MHz, in CDCl3, ppm): 8.81 (1H, s), 2.47 (1H, d, J=14Hz), 2.03 (2H, m), 1.91 (1H, t, J=5Hz), 1.88 (1H, d, J=13Hz), 1.81 (1H, d, J=14Hz), 1.49 (1H, ddt, J=9,5, 1Hz), 1.36 (3H, s).
[α]D 25 : -79.7 (c=1.22, CHCl3)
【0126】
実施例38:(2R,3aS,4aS)−2−エチル−2−ヒドロキシ−3a−ヒドロキシメチル−ビシクロ[3.1.0]ヘキサンI.i.3(A=CH2OH, R1=Et) (スキーム 4)
4.2から、I.i.1(R1=Me, A=CH2OH)と同様にして反応を行った。収率は66.6%であった。
IR (film): : 3275.4, 2921.3, 2858.5, 1431.8, 1284.3, 1237.3, 1122.3, 1068.0, 1027.8, 930.7 cm-1
1H-NMR (500 MHz, in CDCl3, ppm): 3.59 (2H, d, J=5.6Hz), 2.03 (1H, d, J=13.6Hz), 1.99 (1H, dd, J=13.9, 4.9Hz), 1.83 (1H, d, J=13.7Hz), 1.72 (1H, d, J=13.8Hz), 1.55 (2H, q, J=6.4), 1.23 (2H, m), 1.16 (1H, t, J=4.2Hz), 1.04 (1H, s), 0.92 (3H, t, 7.4Hz), 0.54 (1H, dd, J=8.4, 4.3Hz).
MS (m/z): 138 (2), 123 (4), 109 (12.9), 97 (2), 91 (6), 79 (20), 72 (6), 67 (12.9), 57 (100), 43 (8).
[α]D 25 : -34.90 (c=0.928, MeOH)
【0127】
実施例 39:(2R,3aS,4aS)−2−エチル−2−ヒドロキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサンI.i.4(A=CHO, R1=Et)
I.i.3(R1=Et, A=CH2OH)から、I.i.2(R1=Me, A=CHO)と同様にして反応を行った。収率は50%であった。
IR (film): 3418, 2966, 1689, 1114, 1057, 982, 632 cm-1 ;
1H-NMR (500 MHz, in CDCl3, ppm): 8.80 (1H, s), 2.09 (2H, m), 1.92 (1H, t, J=5.0Hz), 1.83 (1H, d, J=13.3Hz), 1.69 (1H, d, J=10.0Hz), 1.57 (2H, m), 1.49 (1H, m), 1.15 (1H, s), 0.93 (3H, t, J=7.4Hz).
[α]D 25 : -68.1 (c=0.30, CHCl3)
【0128】
実施例 40:(2R,3aS,4aS)−2−[(t−ブチルジフェニルシリルオキシ)−メチル]−3a−ヒドロキシメチル−ビシクロ[3.1.0]ヘキサンI.j.1(A=CH2OH, P=TBDPS)(スキーム 4)
a)(3aS,4aS)−2−メチレン−3a−[(ベンゾイルオキシ)メチル]−ビシクロ[3.1.0]ヘキサン 4.3
攪拌した鉛粉末の(5.75 g)CH2Br2(2.02 ml)及びTHF(40 ml)溶液に−78℃で10分かけてTiCl4を滴下した。混合液を8℃まで加熱し、この温度で72時間攪拌し、活性成分の濃いグレーのスラリーを得た(Lombardo試薬)。
【0129】
ケトン4.2(98 mg, 0.426 mmol)のCH2Cl2(8 ml)溶液に、ケトンがなくなるまで分割してLombardo試薬を室温で添加した(TLC)。反応混合液をEt2O(40 ml)で希釈し、飽和NaHCO3を加え、攪拌を30分間継続し、2つの透明な層を形成した。水層をEt2O(3×25 ml)及びCH2Cl2(2×25 ml)で抽出した。結合した有機層をMgSO4で乾燥させた。残留物をフラッシュクロマトグラフィー (シリカゲル:ペンタン/エーテル:100:1)で精製し、化合物4.3(66 mg, 67.9%)を無色油状物として得た。
IR (film): 2925.8, 1715.6, 1451.5,1269.7, 1111.0, 1069.0, 1026.1, 741.9, 710.7 IR (film): 2925.8, 1715.6, 1451.5,1269.7, 1111.0, 1069.0, 1026.1, 741.9, 710.7 -1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.07 (2H, d, J=7.3Hz), 7.56 (1H, t, J=7.4Hz), 7.45 (2H, t, J=7.7Hz), 4.81 (2H, d, J=12.4Hz), 4.38 (2H, s), 2.68 (2H, m), 2.43 (1H, d, J=15.4Hz), 2.28 (1H, d, J=15.6Hz), 1.36 (1H, m), 0.68 (1H, t, J=6.5Hz), 0.39 (1H, t, J=4.5Hz).
MS (m/z): 228 (M+, 1), 213 (1), 199 (1), 181 (2), 169 (1), 141 (1), 123 (5), 105 (100), 91 (88), 77 (57), 65 (7), 51 (20).
[α]D 25 : -51.90 (c=1.73, CHCl3)
【0130】
b)(2R,3aS,4aS)−2−[(t−ブチルジフェニルシリルオキシ)−メチル] −3a−ヒドロキシメチル−ビシクロ[3.1.0] ヘキサンI.j.1 (A=CH2OH, P= TBDPS)及び(2S,3aS,4aS)−2−[(t−ブチルジフェニルシリルオキシ)−メチル]−3a−ヒドロキシメチル−ビシクロ[3.1.0]ヘキサンI.k.1(A=CH2OH, P=TBDPS)
アルケン4.3(49 mg, 0.21 mmol)のTHF(6 ml)溶液に−5℃でBH3.THFを加えた、次に反応混合液をこの温度で3.5時間攪拌した反応を飽和NaHCO3水溶液(3.9 ml)及びH2O2(30 %)(3.9 ml)で終了させた。反応液を室温まで温め、1.5時間攪拌した。この溶液をEt2O(2×20 ml)及びEtOAc(2×20 ml)抽出した。結合した有機層をMgSO4で乾燥させ、濃縮した。残留物を短いシリカゲルカラムに通し、粗生成物をHPLC(イソオクタン/EtOAc:7:3)で精製して、エピマーヒドロキシル化生成物(2R:2S; ratio, 75:25, 39 mg, 73.7%)を無色油状物として得た。
この混合液(35 mg, 0.142 mmol)、イミタゾール(49 mg, 0.720 mmol, 5 eq.)及びDMAP(7.8mg, 0.064mmol, 0.45eq.)のDMF(3ml)溶液にTBDPSClを−0℃で滴下した;得られた混合液を室温で19時間攪拌した。反応液をEt2O/水(50 ml/40 ml)に注いだ。そして、水層をEt2O(3×20 ml)及びEtOAc(2×20 ml)で抽出した。結合した有機層をMgSO4で乾燥させ、濃縮した。残留物をフラッシュクロマトグラフィー (シリカゲル:イソオクタン/EtOAc:100:2)で精製し、対応するシリルエーテル(56 mg, 81.3 %)無色油状物として得た。
攪拌した、この混合液(50 mg, 0.106 mmol)のMeOH(0.2 ml H2Oを有する6 ml)溶液に室温でK2CO3(50 mg, 0.505 mmol)を加えた。混合液を室温で20時間攪拌し、固形物をろ過し、ろ液をEt2O(50 ml)で希釈し、飽和食塩水(2×20 ml)で洗浄し、MgSO4で乾燥させ、溶媒を蒸発させた。残留物を短いシリカゲルカラムに通し、HPLC(イソオクタン/EtOAc:75:25)で分離し、 化合物I.j.1(A=CH2OH, P=TBDPS)(24 mg, 61.8 %)及びI.k.1(A=CH2OH, P=TBDPS)(8 mg, 20.4 %)を無色油状物として得た。
MS (m/z): 379 (M+−1, 1), 305 (1), 275 (2), 229 (2), 199 (47), 181 (7), 107 (100), 79 (53).
化合物I.j.1(A=CH2OH, P=TBDPS)
IR (film): 3342.5, 2930.3, 2858.0, 1471.8, 1427.7, 1389.8, 1111.9, 1008.2, 823.7, 739.7, 701.6 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 7.64 (4H, d, J=7.8Hz), 7.45〜7.35 (6H, m), 3.54 (2H, dd, J=14.4, 11.2Hz), 3.41(2H, d, J=7.4Hz), 2.61 (1H, m), 2.19〜2.09 (2H, m), 1.64 (1H, dd, J=13.5, 4.8Hz), 1.47 (1H, dd, J=13.6, 4.6Hz), 1.26 (1H, bs), 1.18 (1H, dt, J=8.6, 4.3, 4.3Hz), 1.02 (9H, s), 0.62 (1H, dd, J=8.4, 4.7Hz), 0.35 (1H, t, J=4.4Hz).
[α]D 25 :-13.05 (c=1.40, CHCl3)
【0131】
化合物I.k.1(A=CH2OH, P=TBDPS)
IR (film): 3342.5, 2929.9, 2856.7, 1471.6, 1427.7, 1388.8, 1111.9, 1086.1, 1031.5, 1008.5, 823.7, 739.3, 701.5 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 7.64 (4H, d, J=6.7Hz), 7.39 (6H, m), 3.64 (1H, d, J=11.2Hz), 3.57 (3H, d, J=7.8Hz), 1.97〜1.87 (2H, m), 1.80 (1H, dd, J=12.3, 7.0Hz), 1.56 (2H, m), 1.22 (1H, m), 1.15 (1H, ddd, J=8.3, 4.1, 4.1Hz), 1.02 (9H, s), 0.52 (1H, t, J=4.3Hz), 0.41 (1H, dd, J=8.0, 5.0Hz).
[α]D 25 : −6.16 (c=1.65, CHCl3)
【0132】
実施例 41:(2R,3aS,4aS)−2−[(t−ブチルジフェニルシリルオキシ)−メチル]−3a−ホルミル−ビシクロ [3.1.0] ヘキサンI.j.2(A=CHO, P=TBDPS)(スキーム 4)
(COCl)2(30 μl, 0.344 mmol)のCH2Cl2(1 ml)溶液に、−78℃でDMSO(36.6 μL, 0.515 mmol)のCH2Cl2(100 μL)溶液を滴下した。混合液を−78℃で20分間攪拌し、I.j.1(A=CH2OH, P=TBDPS)(14 mg, 0.37 mmol)のCH2Cl2(0.5 ml)溶液を加えた。得られた白濁液を−78℃で20分間攪拌し、Et3N(0.2 ml, 1.435 mmol)を滴下して、20分間攪拌した。 次に混合液を1時間かけて室温まで加熱した。冷水を加えて反応を終了させ、有機層を分離し、水層をEt2O(3×50 ml)で抽出してMgSO4で乾燥させた。残留物をHPLC(ヘキサン/EtOAc 95:5)で分離し、化合物I.j.2(A=CHO, P=TBDPS)(4 mg, 28.7 %)を無色油状物として得た。
IR (film): 2931, 2858, 1699, 1428, 1112, 824, 740, 613 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.83 (1H, s), 7.63 (4H, d, J=7.4Hz), 7.68-7.35 (6H, m), 3.43 (2H, d, J=5.5Hz), 2.68 (2H, m), 2.18 (1H, m), 2.02 (1H, m), 1.59 (1H, m), 1.51 (1H, d, J=8.0Hz), 1.25 (1H, bs), 1.02 (9H, s), 0.90 (1H, m).
MS (m/z): 337 (4), 307 (2), 293 (4), 259 (2), 217 (9), 199 (54), 183 (20), 135 (24), 105 (30), 93 (100)
[α]D 25 : -52.6 (c=0.27, CHCl3).
【0133】
実施例 42:(2S,3aS,4aS)−2−[(t−ブチルジフェニルシリルオキシ)−メチル]−3a−ホルミル−ビシクロ[3.1.0]ヘキサンI.k.2(A=CHO, P=OTBDPS)(スキーム 4)
I.k.1(A=CH2OH, P=TBDPS)から、I.j.2(A=CHO, P=TBDPS)と同様にして反応を行った。収率は92.8%であった。
IR (film): 2932, 2858, 1703, 1471, 1427, 1112, 824, 741, 702 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.96 (1H, s), 7.63 (4H, m), 7.48-7.35 (6H, m), 3.58 (2H, m), 2.05-1.88 (5H, m), 1.62 (1H, m), 1.34 (1H, dd, J=8.5, 5.5Hz), 1.20 (1H, t, J=5.4Hz), 1.02 (9H, s).
MS (m/z): 337 (15), 259 (14), 231 (30), 199 (100), 137 (20), 93 (60), 77 (70).
【0134】
実施例 43:(2S,3aS,4aS)−2−メチル−2−ヒドロキシ−3a−ヒドロキシメチル−ビシクロ[3.1.0]ヘキサンI.l.1(A=CH2OH, R1=CH3)(スキーム 4)
Hg(OAc)2(350 mg, 1.10 mmol)の水(1.5 ml)溶液にオレフィン4.3(164 mg, 0.719 mmol)のTHF(1.5 ml)溶液を滴下した。30分間室温で攪拌した後、NaOH水溶液(1.5 ml, 3N)、次に0.5M NaBH4の3N NaOH溶液(1.5 ml)を加えた。ほとんどの水銀が凝固するまで、得られた混合液を室温で2時間攪拌した。固形物をろ過した。ろ液をEt2O(2×30 ml) 及びEtOAc(2×30 ml)で抽出した。残留物にK2CO3(500 mg, 5.05 mmol)及びMeOH(2 ml)を加えた。混合液を室温で20時間攪拌し、反応混合液を短いシリカゲルカラムに通した。粗生成物をHPLC(シクロヘキサン/EtOAc: 62:45)で精製し、化合物I.l.1(A=CH2OH, R1=Me)及びI.i.1(A=CH2OH, R1=Me)(ratio: 3:1, 68 mg, 66.6%)を無色油状物として得た。
IR (film): : 3288.4, 2931.3, 2858.5, 1459.1, 1370.2, 1260.7, 1183.9, 1135.7,1111.5, 1064.0, 1016.0, 922.6 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 4.02 (1H, d, J=10.7Hz), 3.07 (1H, d, J=10.7Hz), 2.05 (2H, m), 1.65 (1H, bs), 1.52 (1H, d, J=12.8Hz), 1.37 (3H, m), 1.25 (3H, s), 1.05 (1H, dd, J=8.0, 4.8Hz), 0.49 (1H, t, J=4.3Hz).
【0135】
実施例 44:(2S,3aS,4aS)−2−メチル−2−ヒドロキシ−3a−ホルミル−ビシクロ[3.1.0]ヘキサンI.l.2(A=CHO, R1=Me)(スキーム 4)
I.l.1(A=CH2OH, R1=Me)から、I.j.2(A=CHO, P=TBDPS)と同様にして反応を行った。収率は48.2%であった。
IR (film) : 3429, 2967, 2929, 1691, 1377, 1249, 1102, 1036, 668 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.90 (1H, s), 2.66 (1H, dd, J=14.3, 2.4Hz), 1.98 (2H, m), 1.88 (1H, dd, J=8.5, 5.2Hz), 1.65 (1H, bs), 1.51 (2H, t, J=14.2Hz), 1.31 (3H, s), 1.14, (1H, t, J=5.2Hz).
MS (m/z) : 140 (M+, 2), 123 (10), 111 (10), 97 (15), 85 (25), 71 (25), 67 (30), 48 (100).
[α]D 25 : -99.3 (c=1.06, CHCl3)
【0136】
実施例 45:(2S,3aS,4aS)−2−ヒドロキシ−2−ヒドロキシメチル−3a−[(ベンジルオキシ)メチル]−ビシクロ[3.1.0]ヘキサンI.m(A=CH2OCOPh)(スキーム 4)
4.3(65 mg, 0.285 mmol)及びNMO(48 mg, 0.344 mmol, 1.21 eq)のアセトン/水(5ml:2.5ml)溶液に,OsO4 水溶液(121 μl, 0.02 mmol, 4 wt%, 0.07 eq)を0℃で加えた。得られた溶液を39時間室温で攪拌し、 亜ジチオン酸ナトリウム(70 mg)及びフロリジル(150 mg)を加えた。黒色沈殿物をろ過して除去し、Et2O(200 ml)で洗浄した。溶媒を真空化で蒸発して除去した。残留物をわずかなアセトンを有するEt2O(100:5)に溶解し、フロリジルを通してろ過した。粗混合物をHPLC (シクロヘキサン/EtOAc:7:3)で分離し、ほとんど少数の生成物であるC−2エピマーの化合物I.mを(ratio 85.15)無色油状物として合わせて収率64%で得た。
IR (film): : 3385.5, 2927.8, 1713.7, 1451.6, 1315.2, 1274.6, 1114.7, 1070.3, 1026.2, 934.5, 711.5 cm-1.
1H-NMR (500 MHz, in CDCl3, ppm): 8.06 (2H, d, J=7.3Hz), 7.57 (1H, t, J=7.4Hz), 7.46 (2H, t, J=7.6Hz), 4.48 (1H, d, J=11.5Hz), 4.21 (1H, d, J=11.5Hz), 3.49 (2H, m), 2.58 (1H, s), 2.36 (1H, s), 2.16 (1H, d, J=14.6Hz), 2.12 (1H, dd, J=14.2, 6.3Hz), 1.94 (1H, t, J=14.1Hz), 1.89 (1H, t, J=14.1Hz), 1.65 (1H, d, J=14.2Hz), 1.07 (1H, dd, J=8.4, 5.3Hz), 0.47 (1H, t, J=4.6Hz).
MS (m/z): 262 (M+, 1), 244 (1), 232 (3), 213 (4), 203 (3), 176 (1), 163 (4), 145 (4), 123 (16), 105 (100), 77 (52), 67 (13).
[α]D 25 : -11.86 (c=1.53, CHCl3).[0001]
The present invention relates to precursors effectively used in the synthesis of 19-nor-vitamin D analogs, as well as methods and intermediates for preparing them. More specifically, the present invention relates to an A-ring precursor of the above vitamin D analog. This A ring is represented by the following structure (see, for example, Mazur et al., Tetrahedron Letters 1995, 2987).
[0002]
[Chemical 8]
[0003]
A technique for synthesizing a bicyclo [3.1.0] hexane derivative as a 19-nor-A-ring precursor from (−)-quinic acid or cyclohexane-triol is described in M.M. Vandwalle et al. (Tetrahedron Letters, 1995, 36 (45), 8299-8302) have also been developed and are based on the known sigmatropic rearrangement from cyclopropyl alcohols to homoaryl alcohols. This possibility of rearrangement in natural vitamin D was first demonstrated by Mazur et al. (Op. Cit.). In addition, a synthesis technique from 2,4-pentane-dione was also reported (SZ Zhou, S. Anne, M. Vandwalle, Tetrahedron Letters, 1996, 37 (42), 7737-7640). 3-Cyclopentenol was also used as a precursor for the above preparation (W. Yong, M. Vandwalle; Synlett, 1996, 9, 911-912).
[0004]
These methods, however, have the following disadvantages:
The preparation from-(-)-quinic acid involves radical deoxygenation reactions which are difficult to control in mass production and use toxic tributyltin hydride;
The process from cyclohexanetriol is carried out through a number of steps (12) and requires two enzymatic reactions;
The starting material 3-cyclopentenol is not commercially available. It must be prepared from cyclopentadiene using a low yield hydroboration step. Furthermore, the cyclopropanation and introduction of formyl groups is cumbersome;
Synthesis starting from -2,4-pentanedione (10 steps) results in low yields in the first step to prepare the intermediate bisepoxide. Furthermore, because of their low molecular weight, some intermediates are volatile and difficult to purify in large scale processes.
[0005]
A wide range of 19-nor-A-ring precursors have been found to be prepared by starting from 3,5-dihydroxybenzoic acid derivatives or their 4-alkyl substituted analogs. These precursors can be obtained on a large scale by methods that are more effective than previously disclosed methods.
[0006]
Accordingly, in a first aspect, the present invention provides a compound of formula (I):
[0007]
[Chemical 9]
[0008]
Where
-A is -CH2OH group, -CH2-OCOR 'group, -COR "group, -CSR" group or ethynyl group;
-R is hydrogen or (C1-C6A) alkyl;
-R1Is hydrogen, (C1-C6) Alkyl or-(CH2)n-An OP group;
-R2Is hydrogen or an -OP group;
-R 'is (C1-C6) Alkyl or phenyl;
-R "is hydrogen, hydroxyl, (C1-C6) Alkyl, (C1-C6) Alkoxy, (C1-C6) Alkylthio or di (C1-C3) Alkylamino;
-P is hydrogen; (C1-C6) Alkanoyl; (C1-C4) Benzoyl optionally substituted with phenyl by alkyl, halogen or nitro;1-C6) Alkoxycarbonyl; each R3Independently (C1-C6) -Si (R) representing alkyl or phenyl3)3Group; mono or di (C1-C6) Alkoxy (C1-C6) Alkyl; tetrahydrofuranyl; or tetrahydropyranyl;
-N is 0, 1, 2, 3, or 4:
A method for preparing a compound of
(I) Formula1
[0009]
Embedded image
[0010]
Where A is (C1-C6) Alkoxycarbonyl, preferably methoxycarbonyl or di (C1-C3) Alkylaminocarbonyl, R is as defined above;
Reacting the compound of claim 1 with a lipase in a vinyl fatty acid or acid anhydride,
(Ii) the resulting formula2Or2’
[0011]
Embedded image
[0012]
Where Z is (C1-C6) Alkyl, such as alkyl, preferably (C1-C3) Alkyl;
Converting the compound of formula I to the corresponding compound of formula (I);
It is related with the preparation method which consists of.
[0013]
As shown in General Scheme 1, the starting material used to prepare the A-ring precursor is hydrogenated to methyl 3,5-dihydroxy-benzoic acid or its ester, or its 4-alkyl substituted homologous ester. , P.M. Wang and J.W. It is obtained by performing a slightly modified method from the method described by Adams in J Am Chem Soc 1994, 116, 3296-3305.
[0014]
The first step consists of 1-alkoxy (or dialkylamino) carbonyl-3,5-dihydroxy-cyclohexane or a 4-alkyl substituted analogue thereof, for example a vinyl alkanoate such as vinyl acetate, vinyl propionate or vinyl butyrate. SAM II (lipase derived from Pseudomonas fluorescens), CCL (lipase derived from Candida cylindracea), PPL (lipase derived from porcine pancreas), in a solvent of an acid anhydride such as acetic anhydride, propionic anhydride, or butyric anhydride Using lipases such as PSL (lipase derived from Pseudomonas cepacia), GCL (lipase derived from Gotrichum candidum), etc. Preferably it consists of over 6 to 72 hours at 20 ° C., to non Hitoshika made to have catalyzed by the enzyme. By this step the corresponding alkyl (or dialkyl) (1S, 3S, 5R) -3-alkylcarbonyloxy-5-hydroxy or (1S, 3S, 4R, 5R) -4-alkyl-3-alkylcarbonyloxy-5 Hydroxy-cyclohexanecarboxylate (or carboxamide) 2 or the corresponding alkyl (or dialkyl) (1S, 3S, 5R) -5-alkylcarbonyloxy-3-hydroxy or (1S, 3S, 4R, 5R) -4 -Alkyl-5-alkylcarbonyloxy-3-hydroxy-cyclohexanecarboxylate (or carboxyamide) 2 'is obtained.
[0015]
Furthermore, asymmetric reaction by hydrolyzing the diester 3 by catalyzing the diester 3 with an enantioselective enzyme can occur because it leads to the same family of compounds.
[0016]
Schemes 2 and 3 include compounds described in Scheme 1.2Or2′, R = H, R2Describes a method for synthesizing all diastereoisomers of general formula (I) with = OP.
[0017]
Compound to Compound (I) as shown in these schemes2Or2The transformation of 'is performed using one or more of the following steps which can be performed partially or totally in various orders depending on the resulting diastereoisomers: (1) Hydroxy groups Protection (eg, P = TBDMS, TBDPS), (2) ester hydrolysis, (3) inversion of 3 or 5-hydroxy groups, (4) formation of leaving groups (eg, L = OTos, OBros, OMs) (5) Base-containing ring closure reaction to the desired bicyclo [3.1.0] hexane, (6) Conversion of the carboalkoxy or carbamoyl functional group (A) to the desired substituent A.
[0018]
Steps (2) and (4) are known reactions well known to those skilled in the art. Step (1) consists of J. Am. Chem. Soc. (1972, 94, 6190) or Protective groups in Organic Synthesis, T .; W. Can be performed according to Greene, John Wiley Sons (New York). Step (3) can be carried out according to Synthesis (1981, 1) or by a two-step process (elimination reaction, hydroboration reaction). Step (5) may be performed according to Tetrahedron Letters, 1995, 36 (45), 8299-8302. Step (6) Gen. Chem. USSR 1964, 34, 1021.
[0019]
Scheme 2 specifically describes the synthesis of all diastereoisomers with a 3aS configuration (α-oriented cyclopropyl ring).
[0020]
Scheme 3 specifically describes the synthesis of all diastereoisomers with a 3aR configuration (β-oriented cyclopropyl ring).
[0021]
As shown in general scheme 4, R = H and A = CH2The 3a hydroxymethyl-substituted bicyclo [3.1.0] hexane compound (I) of OH can be useful for the synthesis of A-ring precursors to vitamin D analogs that are modified with C-1. The possibility is that I.I. uses ketone 4.2 as an important intermediate. a (R = H, P = TBDPS, A = CH2OH). Grignard reaction (eg R1= Tertiary alcohols diastereoselectively by Me or Et). i is obtained, and at the same time removal of the protected ester functionality occurs. On the other hand, 4.3 is obtained by methyleneation of 4.2. The best results (68% yield) are obtained by the Lombardo method (Tetrahedron Lett., 1982, 23, 4293). Also, yields of 39% and 54% are obtained by Wittig or Tube reaction (J. Org. Chem., 1985, 50, 1212), respectively.
[0022]
The dihydroxylation of 4.3 leads to the desired diol I.D as the next major product of epimer 4.4. m. (Ratio 85:15: not shown here). On the other hand, the hydroboration of 4.3 gives 2R and 2S hydroxymethyl compounds in a ratio of 75:25 (73%). These epimeric alcohols were separated and formed after TBDPS ether formation I.D. j is obtained (81%) and then after ester hydrolysis I. k is obtained (81%). In 4.3, tertiary alcohol I.V. l, then I.I. i is obtained in a ratio of 75:25.
[0023]
The new method of preparing 19-nor A-ring precursors from 3,5-dihydroxybenzoic acid derivatives is shorter than previously described methods. The practical importance of the above pathway is mainly due to the fact that most of the intermediates are crystalline and can be purified by crystallization which is easier on a large scale than the traditional purification method by silica gel chromatography, Guarantees the high purity of the isomers.
[0024]
Embedded image
[0025]
Embedded image
[0026]
Embedded image
[0027]
Embedded image
[0028]
All the compounds (I) thus prepared have the configurations 2S, 3aS, 4aS (A is a formyl group, a hydroxymethyl group, an ethynyl group or a methoxycarbonyl group, and R and R2Are both hydrogen and R1Is -OSi (R3)3The compound is new).
[0029]
Accordingly, these novel compounds represent another feature of the present invention.
Preferred compounds (I) include
-A is -CH2OH group, -CH2-OCOR 'group, -COR "group or ethynyl group;
-R1Is (C1-C6) Alkyl or-(CH2)n-An OP group;
-R 'is phenyl;
-R "is hydrogen;
-P is hydrogen or -Si (R3)3A group;
-N is 0 or 1
Compounds.
[0030]
Compound (I) is, for example, Tetrahedron Letters, 1996;37 (42): Vitamin D (19-nor, 1α, 25 (OH) according to the following scheme described in 7637-76402-D3).
[0031]
Embedded image
[0032]
The present invention further relates to intermediates for preparing compound (I). In particular, the invention relates to formula (II):
[0033]
Embedded image
[0034]
In the formula:
-A and R are as defined above,
-R4And R5Each independently represents a P group, a mesyl group, a tosyl group, a brosyl group, or a trifluoromesyl group as defined above,
However, when A is methoxycarbonyl and R is hydrogen, the configuration of compound (II) is not 1R, 3R, 5R:
Of diastereoisomeric compounds of
[0035]
Also the formula2Or2':
[0036]
Embedded image
Where
-A and R are as defined above,
-Z is alkyl:
A compound of the formula1:
[0037]
Embedded image
[0038]
Where A is the same as defined above and R is (C1-C6) Is alkyl:
These compounds are also within the scope of the present invention.
[0039]
In this specification and the appended claims, “(C1-C3) Alkyl "," (C1-C4) Alkyl "or" (C1-C6The term “alkyl” refers to 1 to 3 groups (4 or 4 respectively) such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl, isopentyl or hexyl. It is to be understood that a straight or branched hydrocarbon chain containing 6) carbon atoms is intended.
[0040]
"(C1-C6) Alkoxy "or" (C1-C6) "Alkylthio" means that R is (C1-C6It is to be understood that each of the OR and SR groups that are alkyl) is intended.
The invention will now be illustrated by the following preparation methods and examples.
[0041]
Preparation of intermediates of formula I
a) Cis, cis-3,5-dihydroxy-1- (methoxycarbonyl) cyclohexane: 1. A (R = H, A = COOCH3)
Peng Wang and Julian Adams described J. W. et al. Am. Chem. Soc. Methyl 3,5-dihydroxybenzoate was hydrogenated in MeOH under conditions similar to those described in (1994, 116, 3296-3305).
5% Rh / Al containing methyl 3,5-dihydroxybenzoate (57.6 g, 0.629 mol, 97%), 0.1% AcOH2O3A solution of (5.76 g) in MeOH (400 ml) was added to the autoclave (1 L). Steam was applied twice using hydrogen in the autoclave (130 atm to 40 atm). The hydrogen pressure reached 130 atm and the temperature rose to 80-85 ° C. The hydrogen pressure decreases as the temperature rises. When the pressure dropped to 90 atm, the hydrogen pressure rose again to 130 atm. Hydrogenation was carried out at 80-85 ° C. and 130 atm for 12 hours, then heated to 150 ° C., correspondingly reaching a pressure of about 155 atm. The reaction lasted 36 hours. The catalyst is filtered, the filtrate is concentrated and the residue is crystallized from EtOAC / isooctane. A was obtained (31.1 g, yield 50%).
mp: 135.9 ° C;
UV (EtOH): 211.4 nm (ε = 90.9);
IR (KBr): 3284, 1734, 1259, 1015 cm-1 ;
1H-NMR (DMSO-d6): δ1.13 (3H, m); 2.06 (3H, m); 2.30 (1H, m); 3.47 (2H, m); 3.61 (3H, s); 4.70 (2H, d) ppm.
[0042]
The same reaction as described above was performed except that methyl 3,5-dihydroxybenzoate was replaced with the following compound:
-Methyl 3,5-dihydroxy-4-methylbenzoate, or
-Methyl 3,5-dihydroxy-4-ethylbenzoate:
The following compounds were obtained:
-Methylol-cis-3,5-dihydroxy-4-methyl-cyclohexanecarboxylate: 1. B (R = Me, A = COOCH3)
mp: 123 ° C;
1H-NMR (500 MHz, CDThreeOD): δ3.698 (2H, dt, J = 4.0,12.0 Hz); 3.666 (3H, s); 2.40 (2H, tt, J = 4.0,13.0 Hz); 2.23 (1H, m); (2H, dt, J = 4.0,13.0 Hz); 1.54 (2H, q, J = 13.0 Hz); 0.88 (3H, d, J = 7.08 Hz) ppm.
-Methylol-cis-4-ethyl-3,5-dihydroxy-cyclohexanecarboxylate: 1. C (R = Et, A = COOCH3)
mp: 94-96 ° C;
1H-NMR (500 MHz, MeOD): δ3.72 (2H, dt, J = 10.9, 4.1 Hz), 3.66 (3H, s), 2.42 (1H, m), 1.86 (1H, bs), 1.79 (2H , dt, J = 12.8, 4.1 Hz), 1.59 (2H, d, J = 9.0 Hz), 1.46 (2H, m), 1.02 (3H, t, J = 7.5 Hz) ppm.
[0043]
Preparation of intermediates of formula 2 and 2 ′ (Scheme 1)
I) Enzymatic esterification of general formula (I) with diol
Ia) Methyl (1S, 3S, 5R) -3-acetoxy-5-hydroxy-cyclohexanecarboxylate: 2. A (R = H, Z = Me, A = COOCH3)
Methyl cis, cis-3,5-dihydroxy-cyclohexanecarboxylate A (R = H, A = COOCH3) (15.2 g, 87 mmol) and lipase derived from porcine pancreas (PPL-16.8 U / mg, 9.12 g) in a round flask, followed by addition of vinyl acetate (450 ml) at room temperature It was. The flask was replaced with nitrogen and the suspension was stirred in the dark for 22 hours. It was then filtered through a pad of celite to remove the lipase. The filtrate was evaporated and concentrated. The residue was isolated by filtration through a pad of silica gel (70-200 mesh, 45 g). Elution with toluene (210 mL), followed by a mixture of toluene / ethyl acetate = 75/25 (V / V, 210 mL), followed by a mixture of toluene / ethyl acetate = 50/50 (V / V, 210 mL) Elute and finally elute with ethyl acetate (240 mL) and after concentration 2. A (R = H, Z = Me, A = COOCH3) (22.3 g, yield) was obtained as a yellow oil.
IR (film): 3447, 1734, 1243 cm-1 ;
1H-NMR (CDClThree): δ1.4 (3H, m), 2.1 (3H, s), 2.3 (5H, m), 3.7 (3H, s), 3.75 (1H, m), 4.7 (1H, m) ppm;
[α]D twenty five : +22.4 (c = 1.25, CHClThree).
[0044]
Ib) Methyl (1R, 3S, 4S, 5R) -5-acetoxy-3-hydroxy-4-methylcyclohexanecarboxylate: 2 '. B (R = Me, Z = Me, A = COOCH3) And methyl (1R, 3S, 4S, 5R) -5-acetoxy-3-hydroxy-4-ethylcyclohexanecarboxylate: 2 '. C (R = Et, Z = Me, A = COOCH3)
From each of the following compounds by a procedure similar to that described for Ia except that PPL is replaced with SAM II, PSL or CCL:
-Methylolcis-3,5-dihydroxy-4-methyl-cyclohexanecarboxylate: 1. B (R = Me, A = COOCH3)
-Methylolcis dihydroxy-4-ethyl-3,5-cyclohexanecarboxylate: 1. C (R = Et, A = COOCH3)
The following compounds were obtained:
-Methyl (1R, 3S, 4S, 5R) -5-acetoxy-3-hydroxy-4-methyl-cyclohexanecarboxylate: 2 '. B (R = Me, Z = Me, A = COOCH3):
IR (film): 3434, 1731, 1439, 1243, 1027 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ4.84 (1H, dt, J = 4.3, 4.3 Hz); 3.82 (1H, m); 3.69 (3H, s); 2.45 (1H, m); 2.32 (1H, d, J = 6.4 Hz) ; 2.05 (3H, s); 1.92 (2H, dt, J = 4.0,
4.0 Hz); 1.77 (3H, m); 0.96 (3H, d, J = 7.0 Hz) ppm;
MS (m / z): 231 (M +, 1); 213; 199; 186; 170; 152; 127; 111; 83; 87; 67; 43 (base peak);
[α]D twenty five : -22.7 (c = 0.38, CHClThree).
Methyl (1R, 3S, 4S, 5R) -5-acetoxy-4-ethyl-3-hydroxy-cyclohexanecarboxylate: 2 '. C (R = Et, Z = Me, A = COOCH3):
IR (film): 3421, 2958, 2360, 1733, 1437, 1239, 1027, 739 cm-1
1H-NMR (500 MHz, CDClThree): δ4.98 (1H, t, J = 4.1 Hz), 3.87 (1H, m), 3.69 (3H, s), 2.60 (1H, bs), 2.16 (2H, m), 2.02 (3H, s) , 1.84 (2H, m), 1.72 (1H, bs), 1.59 (2H, m), 1.47 (1H, m), 0.97 (3H, t, J = 7.5 Hz) ppm;
MS (m / z): 245 (M++1), 233, 206, 184, 166, 141, 125, 111, 95, 87, 57, 43 (base peak).
[α]D twenty five: -50.2 (c = 1.08, CHClThree).
[0045]
II) Enzymatic hydrolysis of diesters of formula 3
IIa) Methyl (1S, 3S, 5R) -3-acetoxy-5-hydroxy-cyclohexane-carboxylate: 2. A (R = H, Z = Me, A = COOCH3)
2. Meso-diacetate A (R = H, Z = Me, A = COOCH3) (92.1 mg, 0.36 mmol) of 3.0 ml CH3To the CN solution was added 27.0 ml buffer (pH = 7.0), followed by SAM II (13.8 mg, 46.8 U / mg). The resulting mixture was stirred at room temperature and an accurately measured 1.0 M NaOH solution was added to keep the pH at 7.0. The reaction was measured by thin layer chromatographic analysis. NaCl was added to terminate the reaction and saturate the reaction solution. The reaction mixture was extracted with AcOEt (3 × 50 ml). The combined organic extracts were washed with saturated brine (3 x 10 ml) and MgSO4Dried and concentrated. The residue was purified by HPLC eluting with isooctane / EtOAc (6: 4) and monoacetate2. A (R = H, Z = Me, A = COOCH3) (30.1 mg, 38.9%) was obtained as a colorless oil.
[0046]
IIb) Methyl (1S, 3R, 4R, 5S) -3-butanoyloxy-5-hydroxy-4-methyl-cyclohexane-carboxylate: 2B (R = Me, Z = n-C)3H7, A = COOCH3)
1. B (R = Me, A = COOCH3) (0.2 g, 1.10 mmol) CH2Cl2To the (2 ml) solution was added butyric anhydride (538 μl, 3.29 mmol) at room temperature, followed by a solution of TMSoTf (trimethylsilyl triflate) (25 μl, 1M). The mixture was stirred at room temperature for 30 minutes, 2.5 ml of MeOH was added and stirred for an additional 2 hours, 5% NaHCO 3.3The reaction was terminated. The reaction solution was washed with saturated brine (3 × 20 ml), washed with MgSO 44And concentrated to give a residue. The residue was purified by silica gel chromatography using isooctane: AcOEt (9: 1) as an eluent. B (R = Me, Z = n-C3H7, A = COOCH3) (3.9 g, 98.8%) as a colorless oil. This meso-diester (110 mg, 0.34 mmol) in CH3To the CN (2.0 ml) solution was added 22.0 ml of buffer (pH = 7.0) followed by SAM II (37 mg, 46.8 U / mg). The resulting mixture was stirred at room temperature and an accurately measured 1.0 M NaOH solution was added to keep the pH at 7.0. The reaction was measured by thin layer chromatographic analysis. NaCl was added to the reaction solution to terminate the reaction. The reaction mixture was extracted with EtOAc (3 x 50 ml) and MgSO4And concentrated to give a residue. The residue was purified by HPLC eluting with isooctane / EtOAc (7: 3) to give monobutyrate2. B (R = Me, Z = n-C3H7, A = COOCH3) (78 mg, 90%) was obtained as a colorless oil.
IR (film): 3495, 2964, 2878, 1731, 1438, 1281, 1183, 990 cm-1,
1H-NMR (CDClThree): 4.83 (1H, dt), 3.83 (1H, m), 3.68 (3H, s), 2.45 (1H, m), 2.32 (1H, m), 2.28 (2H, t, J = 7.9 Hz), 1.91 (2H, m), 1.82-1.62 (5H, m), 0.95 (6H, m).
[α]D twenty five : +16.2 (c = 2.09, CHClThree)
MS: 259 (M++1), 227, 214, 187, 170, 152, 127, 111, 93, 71, 43
[0047]
IIc) Methyl (1S, 3R, 4R, 5S) -3-acetoxy-5-hydroxy-4-methyl-cyclohexanecarboxylate: 2. C (R = Me, Z = Me, A = COOCH3)
2. Meso-diacetate C (R = Me, Z = Me, A = COOCH3To IIa) as described.
[α]D twenty five : +20 (c = 2.9, CHClThree)
[0048]
IId) Methyl (1R, 3S, 4S, 5R) -5-acetoxy-3-hydroxy-4-methyl-cyclohexanecarboxylate: 2 '. B (R = Me, Z = Me, A = COOCH3)
2. Meso-diacetate, except that PPL was used as the lipase. C (R = Me, Z = Me, A = COOCH3To IIa) as described.
[α]D twenty five : -19.5 (c = 2.88, CHClThree)
[0049]
Example 1: (2S, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. b. 1 (A = COOCH3, R = H, P = TBDMS)
a) Methyl (1R, 3S, 5R) -3-acetoxy-5-tosyloxy-cyclohexanecarboxylate: 2.4. a (R = H, L = OTos, A = COOCH3)
1. Methyl (1S, 3S, 5R) -3-acetoxy-5-hydroxycyclohexanecarboxylate in a mixture of triethylamine (50 ml) and methylene chloride (10 ml) A (R = H, Z = Me, A = COOCH3) (10.1 g, 43.7 mmol) and dimethylamino-pyridine (0.1 g) solution was added p-toluenesulfonyl chloride (13.3 g, 70 mmol) at 0 ° C. The resulting solution was stirred at 0 ° C. for 1 hour and then at room temperature for 22 hours. The reaction was terminated with water (300 ml) and extracted with methylene chloride. The organic layer is washed with water and MgSO4Dried, filtered, and concentrated. The crude product is crystallized from EtOH, 2.4. a (R = H, L = OTos, A = COOCH3) (13.2 g, 81.6%).
mp: 83.1 ° C;
IR (KBr): 1734, 1175 cm-1 ;
1H-NMR (CDClThree): δ 1.5 (3H, m), 2.0 (3H, s), 2.28 (4H, m), 2.47 (3H, s), 3.68 (3H, s), 4.4 (1H, m), 4.68 (1H, m ), 7.35 (1H, d, J = 8.5Hz), 7.8 (2H, d, J = 8.5 Hz) ppm.
[0050]
b) Methyl (1R, 3S, 5R) -3-hydroxy-5-tosyloxy-cyclohexanecarboxylate: 2.5. a (R = H, L = OTos, A = COOCH3)
2.4. a (R = H, L = OTos, A = COOCH3) (23.35 g, 63 mmol) in MeOH suspension was added potassium carbonate (4.36 g, 31 mmol). The resulting suspension was stirred for 30 minutes and poured into water (1.5 L). The precipitate is filtered and dried to 2.5. a was obtained (R = H, L = OTos, A = COOCH3) (18.5 g, 89%).
mp: 98.4 ° C;
UV (EtOH): 225 nm (ε = 11935);
IR (KBr): 3447, 1719, 1176 cm-1 ;
1H-NMR (CDClThree): δ1.52 (4H, m), 2.25 (4H, m), 2.45 (3H, s), 3.6 (1H, m), 3.68 (3H, s), 4.42 (1H, m), 7.35 (2H, d, J = 8.5Hz), 7.8 (2H, d, J = 8.5 Hz) ppm; [α]D twenty five : -19 (c = 1.00, EtOH)
[0051]
c) Methyl (1R, 3R, 5R) -3-benzoyloxy-5-tosyloxy-cyclohexanecarboxylate: 2.6. a (R = H, L = OTos, A = COOCH3)
0 ° C., 2.5. a (R = H, L = OTos, A = COOCH3) (18.35 g, 56 mmol), triphenylphosphine (18.4 g, 70 mmol), and benzoic acid (8.53 g, 70 mmol) in toluene (180 ml) and THF (70 ml). To was added diethyl azodicarboxylate (11 ml, 70 mmol). The resulting mixture was stirred at room temperature for 30 minutes, heptane (735 ml) was added, and the filtrate was concentrated by filtration. Toluene was added to the crude product and the resulting solution was filtered using a silica gel pad (30-70 mesh). Elution with toluene, followed by elution with a toluene / methylene chloride mixture and concentration gave a residue. The residue is crystallized from EtOH to 2.6. a (R = H, L = OTos, A = COOCH3) (19.77 g, 82%).
mp: 76.2 ° C;
UV (EtOH): 227 nm (ε = 20840);
IR (KBr): 1709, 1177 cm-1 ;
1H-NMR (CDClThree): δ1.7 (3H, m), 2.14 (2H, m), 2.35 (3H, s), 2.48 (1H, m), 2.83 (1H, m), 3.18 (3H, s), 4.75 (1H, m), 5.43 (1H, m), 7.2 (2H, d, J = 11.4Hz), 7.5 (2H, d, J = 8.5Hz), 7.6 (1H, m), 7.75 (2H, d, J = 11.4 Hz), 7.94 (2H, d, J = 8.5Hz) ppm;
[α]D twenty five : -65.8 (c = 0.98, EtOH).
[0052]
d) Methyl (1R, 3R, 5R) -3-hydroxy-5-tosyloxy-cyclohexanecarboxylate: 2.7. a (R = H, L = OTos, A = COOCH3 )
2.6. a (R = H, L = OTos, A = COOCH3) (19.77 g, 46 mmol) in MeOH suspension was added potassium carbonate (3.16 g, 22.9 mmol). The resulting mixture was stirred at room temperature for 6 hours and poured into water (1 L). The aqueous layer is extracted with diisopropyl oxide and MgSO.4, Filtered and concentrated to 2.7. a (R = H, L = OTos, A = COOCH3) (17.45 g, quantitative analysis) was obtained as an oil.
UV (EtOH): 224 nm (ε = 12262);
IR (KBr): 3525, 1731, 1174 cm-1 ;
1H-NMR (CDClThree): δ1.67 (3H, m), 2.1 (3H, m), 2.45 (3H, s), 2.85 (1H, m), 3.7 (3H, s), 4.3 (1H, s), 4.82 (1H, m), 7.35 (2H, d, J = 8.5Hz), 7.8 (2H, d, J = 8.5Hz) ppm;
[α]D twenty five : -36.7 (c = 1.06, CHClThree)
[0053]
e) Methyl (1R, 3R, 5R) -3-t-butyldimethylsilyloxy-5-tosyloxy-cyclohexanecarboxylate: 2.8. a (R = H, L = OTos, P = TBDMS, A = COOCH3)
2.7. a (R = H, L = OTos, A = COOCH3) (17.45 g, 46 mmol) and imidazole (3.9 g, 57 mmol) in anhydrous dimethylformamide (80 ml) were added t-butyldimethylsilyl chloride (8.6 g, 57 mmol). It was. The resulting mixture was stirred at room temperature for 1.5 hours, poured onto water and extracted with toluene. The organic layer was washed with water and concentrated. The crude product is crystallized from heptane 2.8. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (13.94 g, 69%).
mp: 68.2 ° C;
UV (EtOH): 225 nm (ε = 12390);
IR (KBr): 2853, 1726, 1436, 1359, 1173, 831 cm-1 ;
1H-NMR (CDClThree): δ0.02 (3H, s), 0.05 (3H, s), 0.82 (9H, s), 1.55 (4H, m), 1.85 (2H, m), 2.45 (3H, s), 2.8 (1H, m), 3.67 (3H, s), 4.2 (1H, bs), 4.7 (1H, m), 7.33 (2H, d, J = 8.5Hz), 7.8 (2H, d, J = 8.5Hz) ppm;
[α]D twenty five : -41.6 (c = 1.00, EtOH).
[0054]
f) (2S, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. b. 1 (R = H, P = TBDMS, A = COOCH3)
Stir 2.8 at 64 ° C. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (378.5 g, 856 mmol) in t-butanol was slowly added t-butanol solution (1.02 L) in potassium t-butyrate over 1 hour. Five minutes after the end of the addition, the resulting suspension was cooled to 30 ° C. and a saturated solution of ammonium chloride (3 L) was added. After 10 minutes, the aqueous layer was extracted with diisopropyl oxide. The organic layer is washed with water and MgSO4Dried, filtered, and concentrated. The residue was purified by flash chromatography on silica gel eluting with a heptane / ethyl acetate mixture. b. 1 (R = H, P = TBDMS, A = COOCH3) (211.3 g, 91.3%) as a yellow oil.
Eb760 : 135 ° C;
UV (EtOH): 201 nm (ε = 742);
IR (film) 1726 cm-1, 1458 cm-1, 1437 cm-1, 1254 cm-1, 837 cm-1 ;
1H-NMR (CDClThree): δ0.01 (6H, s), 0.83 (9H, s), 1.28 (2H, m), 1.8 (2H, m), 2.11 (3H, m), 3.65 (3H, s), 3.9 (1H, m) ppm;
[α]D twenty five : -43 (c = 1.04, EtOH).
[0055]
Example 2: (2S, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. b. 2 (R = H, P = TBDMS, A = CH2OH)
(2S, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane b. 1 (R = H, P = TBDMS, A = COOCH3) (207.5 g, 768 mmol) in toluene (2.1 L) (-70 ° C.) was added 1.5 M diisobutylammonium hydride in toluene (1.25 L) over 1.5 hours. . After the addition was complete, a saturated solution of potassium sodium tartrate was slowly added and heated to 0 ° C. After stirring for 2 hours, the reaction mixture was extracted with toluene and the organic layer was washed with MgSO.4And concentrated to the title compound I.I. b. There were obtained 142.9 g (88%) of 2 as a yellow oil.
IR (KBr): 3355, 1471, 1255, 835, 774 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.32 (1H, m), 0.5 (1H, m), 0.83 (9H, s), 1.16 (1H, m), 1.87 (5H, m), 3.54 (2H, m) , 4.0 (1H, m) ppm
[0056]
Example 3: (2S, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. b. 3 (R = H, P = TBDMS, A = CHO)
I. b. 2 (R = H, P = TBDMS, A = CH2OH) (69.6 g, 287 mmol) in methylene chloride (700 ml) was added pyridinium chlorochromate (68 g, 315 mmol) at room temperature. The resulting mixture was stirred vigorously for 1 hour. Heat to 35 ° C and then cool to 25 ° C. The suspension was filtered through a pad of celite and washed with methylene chloride and diisopropyl oxide. The organic layer was washed sequentially with water, a saturated solution of sodium bicarbonate, and water at pH 6-7. Combined organic layer is MgSO4Dried, filtered, and concentrated. The residue (66.8 g) was purified by flash chromatography over florisil using heptane / ethyl acetate = 95/5 (V / V) as eluent. b. 3 (R = H, P = TBDMS, A = CHO) was obtained as a yellow oil (50.33 g, 73%).
UV (EtOH): 204 nm (ε = 6292);
IR (KBr): 1726, 1253, 1119, 838 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.87 (9H, s), 1.3 (2H, m), 1.85 (2H, m), 2.1 (3H, m), 4 (1H, m), 8.9 (1H, s) ppm;
[α]D twenty five : -49.4 (c = 1.06, EtOH).
[0057]
Example 4: (2R, 3aR, 4aR) 2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. h. 1 (R = H, A = COOCH3, P = TBDMS)
a) Methyl (1R, 3S, 5S) -3-acetoxy-5-benzoyloxy-cyclohexanecarboxylate: 3.9. a (R = H, A = COOCH32.6. a (R = H, L = OTos, A = COOCH3) Methyl (1S, 3S, 5R) -3-acetoxy-5-hydroxy-cyclohexanecarboxylate 2. A (R = H, Z = Me, A = COOCH3) (25 g, 111.3 mmol) methyl (1R, 3S, 5S) 3-acetoxy-5-benzoyloxy-cyclohexanecarboxylate 3.9. a (R = H, A = COOCH3) (32.4 g, 91%).
1H-NMR (CDClThree): δ1.68 (3H, m), 2.05 (3H, s), 2.34 (3H, m), 2.92 (1H, m), 3.70 (3H, s), 5.18 (1H, m), 5.55 (1H, m), 7.50 (3H, m), 8.05 (2H, m) ppm;
[α]D twenty five: +42.3 (c = 0.82, CHClThree)
[0058]
b) Methyl (1R, 3S, 5S) -5-benzoyloxy-3-hydroxy-cyclohexanecarboxylate: 3.10. a (R = H, A = COOCH3) Methyl (1R, 3S, 5S) -3-acetoxy-5-benzoyloxy-cyclohexanecarboxylate: 3.9. a (R = H, A = COOCH3) (32.4 g, 151, 9 mmol) 2.5. a (R = H, L = OTos, A = COOCH3). The crude product is purified by flash chromatography on silica gel and 3.10. a (R = H, A = COOCH3) (22.38 g, 79.5%).
1H-NMR (CDClThree): δ 1.63 (4H, m), 1.92 (1H, s), 2.3 (2H, m), 2.86 (1H, m), 3.7 (3H, s), 4.1 (1H, m), 5.53 (1H, m ), 7.5 (3H, m), 8.0 (2H, m) ppm;
[α]D twenty five : -13.5 (c = 1.43, CHClThree)
[0059]
c) Methyl (1S, 3S, 5S) -5-benzoyloxy-3-tosyloxy-cyclohexanecarboxylate: 3.11. a (R = H, L = OTos, A = COOCH3)
Alcohol 3.10. a (R = H, A = COOCH3) (25.2 g, 90.88 mmol) in 2.4. a (R = H, L = OTos, A = COOCH3Tosylate. Purify by flash chromatography (heptane / ethyl acetate = 7/3) and crystallize from heptane / EtOH to give 3.11. a (R = H, L = OTos, A = COOCH3) (39.75 g) was obtained in a measurable yield.
mp: 128.4 ° C;
IR (KBr): 2950, 1715, 1175, 939 cm-1 ;
1H-NMR (CDClThree): δ1.7 (3H, m), 2.18 (2H, m), 2.38 (3H, s), 2.5 (1H, m), 2.85 (1H, m), 3.68 (3H, s), 4.76 (1H, m), 5.43 (1H, m), 7.19 (2H, d), 7.5 (2H, d), 7.58 (1H, m), 7.77 (2H, d), 7.96 (2H, d) ppm;
[α]D twenty five : +69 (c = 1.014, CHClThree).
[0060]
d) Methyl (1S, 3S, 5S) -5-hydroxy-3-tosyloxy-cyclohexanecarboxylate: 3.12. a (R = H, L = OTos, A = COOCH3)
3.11. a (R = H, L = OTos, A = COOCH3) (38.25 g, 88.4 mmol) to 2.7. a (R = H, L = OTos, A = COOCH3 ) And methyl (1S, 3S, 5S) -5-hydroxy-3-tosyloxy-cyclohexanecarboxylate 3.12. a (R = H, L = OTos, A = COOCH3) (29.25 g) was obtained as a yellow oil in a measurable yield.
1H-NMR (CDClThree): δ1.6 (4H, m), 2.08 (3H, m), 2.47 (3H, s), 2.83 (1H, m), 3.68 (3H, s), 4.3 (1H, m), 4.82 (1H, m), 7.36 (2H, d), 7.8 (2H, d) ppm.
[0061]
e) Methyl (1S, 3S, 5S) -5-t-butyldimethylsilyloxy-3-tosyloxy-cyclohexanecarboxylate: 3.13. a (R = H, L = OTos, P = TBDMS, A = COOCH3)
3.12. a (R = H, L = OTos, A = COOCH3) (29.2 g, 89.07 mmol) to 2.8. a (R = H, L = OTos, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as in (1). Purification by flash chromatography on silica gel (heptane / ethyl acetate = 8/2) 3.13. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (34.8 g, 88%) as a yellow oil.
IR (film): 2953, 2855, 1725, 1278, 1177, 949 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, d), 0.85 (9H, s), 1.55 (3H, m), 1.88 (2H, m), 2.38 (1H, s), 2.48 (3H, s), 2.82 (1H, m) , 3.7 (3H, s), 4.2 (1H, m), 4.7 (1H, m), 7.8 (2H, d), 8.09 (2H, d) ppm;
[α]D twenty five : +29.5 (c = 1.06, EtOH)
[0062]
f) (2R, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. h. 1 (R = H, P = TBDMS, A = COOCH3)
3.13. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (33.2 g, 75 mmol). b. 1 (A = COOCH3, R = H, P = TBDMS). Purification by flash chromatography on silica gel (heptane / ethyl acetate = 95/5) and (2R, 3aR, 4aR) -2-tert-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] Hexane I. h. 1 (R = H, P = TBDMS, A = COOCH3) (15.5 g, 78%) as a yellow oil.
IR (film): 2952, 2856, 1724, 1113, 837 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.85 (9H, s), 1.11 (1H, d), 1.27 (2H, m), 1.6 (3H, s), 1.8 (1H, m), 2.11 (3H, m) , 3.65 (3H, s), 3.9 (1H, m) ppm;
[α]D twenty five : +38.3 (c = 1.122, EtOH)
[0063]
Example 5: (2R, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. h. 2 (R = H, P = TBDMS, A = CH2OH)
(2R, 3aR, 4aR) -2-tert-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane h. 1 (R = H, P = TBDMS, A = COOCH3) (15.15 g, 56 mmol). b. 2 (R = H, P = TBDMS, A = CH2OH) using conditions similar to h. 2 (R = H, P = TBDMS, A = CH2OH) (11.85 g, 87%).
IR (film): 3354, 2928, 2856, 1255, 835 cm-1 ;
1H-NMR (CDClThree): δ 0.1 (6H, s), 0.35 (1H, t), 0.5 (1H, t), 0.86 (9H, s), 1.17 (1H, s), 1.85 (5H, m), 3.52 (2H, m ), 4.0 (1H, m) ppm;
[α]D twenty five : +17.4 (c = 1.15, EtOH)
[0064]
Example 6: (2R, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. h. 3 (R = H, P = TBDMS, A = CHO)
I. h. 2 (R = H, P = TBDMS, A = CH2OH) (11.3 g, 46.6 mmol) to I.I. b. 3 (R = H, P = TBDMS, A = CHO). h. 3 (R = H, P = TBDMS, A = CHO) (6.2 g, 55%) was obtained as a yellow oil.
UV (EtOH): 204.5 mm (ε = 6600);
IR (film): 2930, 2880, 2856, 1705, 1119, 1097, 836 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.83 (9H, s), 0.95 (1H, t), 1.22 (2H, m), 1.85 (2H, m), 2.1 (3H, m), 4.0 (1H, quintuplet) , 8.87 (1H, s) ppm;
[α]D twenty five : +53.6 (c = 1.008, EtOH)
[0065]
Example 7: (2R, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. a. 1 (R = H, P = TBDMS, A = COOCH3)
a. Methyl (1R, 3S, 5R) -3-tert-butyldimethylsilyloxy-5-tosyloxy-cyclohexanecarboxylate: 2.3. a (R = H, L = OTos, P = TBDMS, A = COOCH3)
Methyl (1R, 3S, 5R) -3-hydroxy-5-tosyloxy-cyclohexanecarboxylate: 2.5. a (R = H, L = OTos, A = COOCH3) (29.3 g, 89.2 mmol) has a hydroxy functionality of 2.8. a (R = H, L = OTos, P = TBDMS, A = COOCH3Protected in the same manner as 2.3). a (R = H, L = OTos, P = TBDMS, A = COOCH3) (36,75 g, 93%).
mp: 70.9 ° C;
IR (KBr): 2957, 2855, 1734, 1174, 923 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.82 (9H, s), 1.41 (3H, m), 2.16 (4H, m), 2.46 (3H, s), 3.54 (1H, m), 3.69 (3H, s) , 4.41 (1H, m), 7.34 (2H, d), 7.8 (2H, d) ppm;
[α]D twenty five : -8.2 (c = 1.2, EtOH)
[0066]
b) (2R, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. a. 1 (R = H, P = TBDMS, A = COOCH3)
2.3. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (34.81 g, 78.6 mmol). b. 1 (A = COOCH3, R = H, P = TBDMS). Purification by flash chromatography on silica gel (heptane / ethyl acetate = 5/5) a. 1 (R = H, P = TBDMS, A = COOCH3) (16.6 g, 78%) as a yellow oil.
IR (film): 2953, 2855, 1726, 1148, 836 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.86 (9H, s), 1.5 (5H, m), 2.1 (1H, m), 2.48 (1H, m), 3.68 (3H, s), 4.33 (1H, t) ppm;
[α]D twenty five : -60.1 (c = 0.998, EtOH)
[0067]
Example 8: (2R, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. a. 2 (R = H, P = TBDMS, A = CH2OH).
I. a. 1 (R = H, P = TBDMS, A = CH2OH) (15.6 g, 57.7 mmol) to I.V. b. 2 (R = H, P = TBDMS, A = CH2Reaction was carried out in the same manner as (OH). I. a. 2 (R = H, P = TBDMS, A = CH2OH) (11.7 g, 83.7%) was obtained as a yellow oil.
IR (film): 3331, 2927, 2855, 1254, 1094, 1006, 835 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.5 (1H, m), 0.88 (9H, s), 1.19 (3H, m), 1.72 (2H, m), 2.1 (2H, m), 3.6 (2H, s) , 4.34 (1H, t) ppm;
[α]D twenty five : -23.5 (c = 1.062, EtOH)
[0068]
Example 9: (2R, 3aS, 4aS) -2-t-butyldimethylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. a. 3 (R = H, P = TBDMS, CHO).
I. a. 2 (R = H, P = TBDMS, A = CH2OH) (11.1 g, 45.5 mmol). b. 3 (R = H, P = TBDMS, A = CHO). a. 3 (R = H, P = TBDMS, A = CHO) (8.8 g, 80%) was obtained as a yellow oil.
UV (EtOH): 204.7 nm (ε = 6991);
IR (film): 2928, 2855, 1702, 1255, 1072, 837 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.85 (9H, s), 1.45 (1H, m), 1.78 (3H, m), 2.02 (2H, m), 2.5 (1H, m), 4.35 (1H, m) , 8.81 (1H, s) ppm;
[α]D twenty five : -71.8 (c = 1.406, EtOH)
[0069]
Example 10: (2S, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: f. 1 (R = H, P = TBDMS, A = COOCH3).
a) Methyl (1R, 3S, 5R) -3-acetoxy-5-t-butyldimethylsilyloxy-cyclohexanecarboxylate: 3.7. a (R = H, P = TBDMS, A = COOCH3)
1. methyl (1S, 3S, 5R) -3-acetoxy-5-hydroxy-cyclohexanecarboxylate A (R = H, A = COOCH3) (45.5 g, 0.210 mmol) of 2.8. a (R = H, L = OTos, P = TBDMS, A = COOCH3). Purified by flash chromatography on silica gel with a heptane / ethyl acetate (9/1) mixture as the eluent 3.7. a (R = H, P = TBDMS, A = COOCH3) (69.97 g, 92%) was obtained as a yellow oil.
IR (film): 2953, 2856, 1736, 1240 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.8 (9H, s), 1.33 (4H, m), 2 (3H, s), 2.1 (2H, m), 2.32 (1H, m), 3.55 (1H, m) , 3.62 (3H, s), 4.66 (1H, m) ppm
[0070]
b) Methyl (1R, 3S, 5R) -5-t-butyldimethylsilyloxy-3-hydroxy-cyclohexanecarboxylate: 3.8. a (R = H, P = TBDMS, A = COOCH3)
3.7. a (R = H, P = TBDMS, A = COOCH3) (63.67 g, 0.1926 mmol) to 2.5. a (R = H, L = OTos, A = COOCH3The reaction was carried out in the same manner as in (1). Purified by flash chromatography on silica gel using heptane / ethyl acetate (7/3) as the eluent 3.8. a (R = H, P = TBDMS, A = COOCH3) (46, 24 g, 83%) was obtained as a yellow oil.
IR (film): 3404, 2952, 2856, 1736, 837 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.81 (9H, s), 1.3 (3H, m), 1.67 (1H, m), 2.13 (4H, m), 3.56 (2H, m), 3.63 (3H, s) ppm;
[α]D twenty five : +6.8 (c = 1.036, CHClThree).
[0071]
c) Methyl (1S, 3S, 5R) -5-t-butyldimethylsilyloxy-3-tosyloxy-cyclohexanecarboxylate: 3.6. a (R = H, L = OTos, P = TBDMS, A = COOCH3)
3.8. a (R = H, P = TBDMS, A = COOCH3) (45.99 g, 0.159 mmol) to 2.4. a (R = H, L = OTos, A = COOCH3The reaction was carried out in the same manner as above. Purified by flash chromatography on silica gel with heptane / ethyl acetate (8/2) as eluent, then crystallized from EtOH 3.6. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (53.7 g, 76%).
mp: 71 ° C;
IR (KBr): 2957, 2855, 1734, 1174, 923 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.82 (9H, s), 1.41 (3H, m), 2.16 (4H, m), 2.46 (3H, s), 3.54 (1H, m), 3.69 (3H, s) , 4.41 (1H, m), 7.34 (2H, d), 7.8 (2H, d) ppm;
[α]D twenty five : +6.8 (c = 1.032, EtOH).
[0072]
d) (2S, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. f. 1 (R = H, P = TBDMS, A = COOCH3).
3.6. a (R = H, L = OTos, P = TBDMS, A = COOCH3) (53.7 g, 0.121 mmol). b. 1 (R = H, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as in (1). I. f. 1 (R = H, P = TBDMS, A = COOCH3) (24.48 g, 74.6%) was obtained as a pale yellow oil.
IR (film): 2953, 2856, 1726, 1148, 836 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.86 (9H, s), 1.5 (5H, m), 2.1 (1H, m), 2.48 (1H, m), 3.68 (3H, s), 4.33 (1H, t) ppm;
[α]D twenty five : +62.9 (c 1.066, EtOH).
[0073]
Example 11 : (2S, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. f. 2 (R = H, P = TBDMS, A = CH2OH)
I. f. 1 (R = H, P = TBDMS, A = COOCH3) (10 g, 0.037 mmol). b. 2 (R = H, P = TBDMS, A = CH2The reaction was carried out in the same manner as in (OH). I. f. 2 (R = H, P = TBDMS, A = CH2OH) was obtained in measurable yield (10 g) as an oil.
IR (film): 3331, 2927, 2855, 1254, 1094, 1006, 835 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.5 (1H, m), 0.88 (9H, s), 1.19 (3H, m), 1.72 (2H, m), 2.1 (2H, m), 3.6 (2H, s) , 4.34 (1H, t) ppm;
[α]D twenty five : +23.2 (c = 0.99, EtOH)
[0074]
Example 12: (2S, 3aR, 4aR) -2-t-butyldimethylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. f. 3 (R = H, P = TBDMS, A = CHO).
I. b. 3 (R = H, P = TBDMS, A = CHO) f. 2 (R = H, P = TBDMS, A = CH2OH) (10 g, 0.037 mmol) as a pale yellow oil. f. 3 (R = H, P = TBDMS, A = CHO) (5.3 g, 59.7%).
IR (film): 2928, 2855, 1702, 1255, 1072, 837 cm-1 ;
1H-NMR (CDClThree): δ0 (6H, s), 0.85 (9H, s), 1.45 (1H, m), 1.78 (3H, m), 2.02 (2H, m), 2.5 (1H, m), 4.35 (1H, m) , 8.81 (1H, s) ppm;
UV (EtOH): 205 nm;
[α]D twenty five : +70.4 (c = 1.1, EtOH).
[0075]
Example 13 : (2S, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-ccarbomethoxy-bicyclo [3.1.0] hexane: I. b. 4 (R = H, P = TBDPS, A = COOCH3).
a) Methyl (1R, 3S, 5R) -3-acetoxy-5- (4-bromobenzenesulfonyloxy) -cyclohexanecarboxylate: 2.4. b (R = H, L = OBros, A = COOCH3).
2. From A (R = H) (1.4 g, 6.47 mmol) and 4-bromobenzenesulfonyl chloride (4.22 g, 16.19 mmol) to 2.4. The reaction was carried out in the same manner as a (R = H, L = OTos). 2.4. b (R = H, L = OBros, A = COOCH3) (2.6 g, 96%) was obtained as white crystals.
mp: 110-111 ° C;
IR (film): 2956, 1734, 1363, 1246, 1188, 822, 742 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.76 (2H, d, J = 8.6Hz), 7.70 (2H, d, J = 8.6Hz), 4.68 (1H, dddd, J = 11.6, 11.6, 4.37, 4.37Hz), 4.46 (1H, dddd, 11.6, 11.6, 4.6, 4.6Hz), 3.69 (3H, s), 2.37 (1H, m), 2.28 (2H, m), 2.02 (3H, s), 1.58 (2H, m), 1.39 (1H , dd, J = 24.0, 12.4Hz) ppm;
MS (m / z): 419 (M+, 1), 405 (1), 363 (3), 221 (10), 157 (34), 138 (70), 107 (15), 79 (68);
[α]D twenty five : -10.65 (c = 1.50, CHClThree).
[0076]
b) Methyl (1R, 3S, 5R) -5- (4-bromobenzenesulfonyloxy) -3-hydroxy-cyclohexanecarboxylate: 2.5. b (R = H, L = OBros, A = COOCH3).
2.4. b (R = H, L = OBros, A = COOCH3) (2.55 g, 6.08 mmol from 2.5.a (R = H, L = OTos) and the reaction was carried out in the same manner as 2.5.b (R = H, L = OBros, A = COOCH3) (2.25 g, 98%) was obtained as white crystals.
mp: 95-98 ° C;
IR (film): 3397, 2954, 1734, 1396, 1186, 815, 740 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.76 (2H, d, J = 8.6Hz), 7.70 (2H, d, J = 8.6Hz), 4.46 (1H, dddd, J = 11.5, 11.5, 4.5, 4.5Hz), 3.68 (3H, s), 3.64 (1H, m), 2.25 (4H, m), 1.60 (1H, dd, J = 24.2, 12.5Hz), 1.48 (1H, dd, J = 23.0, 11.5Hz), 1.35 (1H, dd , J = 23.8, 12.5Hz) ppm;
MS (m / z): 377 (M+, 1), 328 (3), 235 (10), 221 (13), 156 (85), 113 (100), 97 (52), 79 (53);
[α]D twenty five : -17.13 (c = 1.48, CHClThree).
[0077]
c) Methyl (1R, 3R, 5R) -3-benzoyloxy-5- (4-bromobenzenesulfonyloxy) -cyclohexanecarboxylate: 2.6. b (R = H, L = OBros, A = COOCH3)
2.5. b (R = H, L = OBros, A = COOCH3) (1.15 g, 3.05 mmol) to 2.6. a (R = H, L = OTos, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 1.13 g (73%).
mp: 131-133 ° C;
IR (film): 3420, 2948, 1717, 1362, 1186, 817, 707 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.95 (2H, d, J = 7.4Hz), 7.72 (2H, d, J = 8.5Hz), 7.60 (1H, t, J = 7.4Hz), 7.58 (2H, d, J = 8.5Hz) , 7.49 (2H, t, 7.7Hz), 5.46 (1H, m), 4.81 (1H, dddd, J = 11.3, 11.3, 4.4, 4.4Hz), 2.85 (1H, dddd, J = 12.5, 12.5, 3.7, 3.7Hz), 2.47 (1H, m), 2.20 (2H, m), 1.73 (3H, m) ppm;
MS (m / z): 497 (M+, 1), 391 (4), 377 (10), 260 (100), 237 (8), 221 (25);
[α]D twenty five : -59.32 (c = 1.79, CHClThree).
[0078]
d) Methyl (1R, 3R, 5R-5- (4-bromobenzenesulfonyloxy) -3-hydroxy-cyclohexanecarboxylate: 2.7.b (R = H, L = OBros, A = COOCH)3).
2.6. b (R = H, L = OBros, A = COOCH3) (240 mg, 0.483 mmol) to 2.7. a (R = H, L = OTos, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 167 mg (88%).
mp: 107-108 ° C.
IR (film): 3527, 2954, 1732, 1577, 1365, 1187, 940, 818 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.78 (2H, d, J = 8.6Hz), 7.70 (2H, d, J = 8.6Hz), 4.87 (1H, dddd, J = 10.9, 10.9, 4.5, 4.5 Hz), 4.31 (1H, m), 3.69 (3H, s), 2.86 (1H, dddd, J = 12.1, 12.1, 3.7, 3.7Hz), 2.24 (1H, d, J = 12.7Hz), 2.04 (1H, d, J = 11.7Hz) ), 1.94 (1H, d, J = 14.0Hz), 1.65 (3H, m) ppm;
MS (m / z): 394 (M++1, 1), 295 (2), 221 (4), 157 (11), 97 (10);
[α]D twenty five : -38.75 (c = 0.80, CHClThree).
[0079]
e) Methyl (1R, 3R, 5R) -5- (4-bromobenzenesulfonyloxy) -3-tert-butyldiphenylsilyloxy-cyclohexanecarboxylate: 2.8. b (R = H, L = OBros, P = TBDPS, A = COOCH3).
2.7. b (R = H, L = OBros, A = COOCH3) (299 mg, 0.760 mmol) to 2.8. a (R = H, L = OTos, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). 2.8. b (R = H, L = OBros, P = TBDPS, A = COOCH3) (198 mg, 93%) as a viscous oil.
IR (film): 2955, 1738, 1577, 1472, 1370, 1180, 947, 821, 703 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.71 (2H, d, J = 8.8Hz), 7.34-7.60 (12H, m), 4.87 (1H, m), 4.17 (1H, bs), 3.78 (3H, m), 2.98 (1H, dddd, J = 9.1, 9.1, 3.5, 3.5 Hz), 2.39 (1H, d, J = 11.9Hz), 1.89 (1H, d, J = 13.9Hz), 1.79 (1H, d, J = 12.3Hz), 1.63 (1H, m), 1.34 (2H, m), 1.02 (9H, s), 0.91 (3H, s) ppm; MS (m / z): 599 (M+, 1), 419 (28), 337 (34), 293 (8), 199 (46), 139, (100), 107 (50), 79 (72);
[α]D twenty five : +1.49 (c = 1.75, CHClThree).
[0080]
f) (2S, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. b. 4 (R = H, P = TBDPS, A = COOCH3).
I. b. 1 (R = H, P = TBDMS, A = COOCH3)) And compound 2.8. b (R = H, L = OBros, P = TBDPS, A = COOCH3) (206 mg, 0.344 mmol). b. 4 (R = H, P = TBDMS, A = COOCH3) (79 mg, 76%) to give a colorless oil. .
IR (film): 2952, 1725, 1428, 1113, 703 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.64 (4H, dd, J = 6.20, 6.20Hz), 7.35-7.45 (6H, m), 3.89 (1H, dddd, J = 7.7, 7.7, 7.7, 7.7Hz), 3.65 (3H, s ), 2.28 (1H, dd, J = 12.9, 8.2Hz), 2.12 (1H, dd, J = 12.9, 7.1Hz), 1.91 (2H, m), 1.77 (1H, ddd, J = 8.6, 5.0, 5.0 Hz), 1.19 (1H, dd, J = 8.6, 4.8Hz), 1.02 (9H, s), 0.44 (1H, dd, J = 5.1, 5.1Hz) ppm .9, 7.1Hz), 1.91 (2H, m ), 1.77 (1H, ddd, J = 8.6, 5.0, 5.0Hz), 1.19 (1H, dd, J = 8.6, 4.8Hz), 1.02 (9H, s), 0.44 (1H, dd, J = 5.1, 5.1 Hz) ppm
MS (m / z): 394 (M+, 1), 363 (4), 337 (65), 259 (3), 213 (100), 199 (20), 135 (18), 77 (21);
[α]D twenty five : -73.14 (c = 1.75, CHClThree).
[0081]
Example 14: (2S, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. b. 5 (R = H, P = TBDPS, A = CH2OH).
I. b. 4 (R = H, P = TBDPS, A = COOCH3) (188 mg, 1.253 mmol). b. 2 (R = H, P = TBDMS, A = CH2The reaction was carried out in the same manner as in (OH). Purified by flash chromatography on silica gel (isooctane / ethyl acetate 83:17). b. 5 (R = H, P = TBDPS, A = CH2OH) (240 mg, 96%) was obtained as a viscous oil.
IR (film): 3322, 2932, 1428, 1113, 702 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.75 (4H, m), 7.58 (6H, m), 3.97 (1H, dddd, J = 7.1, 7.1, 7.1, 7.1Hz), 3.56 (2H, bs), 1.84-2.05 (3H, m ), 1.12 (1H, m), 1.03 (9H, s), 0.34 (1H, dd, J = 7.8, 5.4Hz), 0.13 (1H, dd, J = 4.6, 4.6Hz) ppm;
MS (m / z): 365 (M+-1, 1), 291 (3), 231 (10), 199 (100), 181 (12), 139 (27), 93 (77), 79 (24);
[α]D twenty five : -25.74 (c = 2.16, CHClThree).
[0082]
Example 15: (2S, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. b. 6 (R = H, P = TBDPS, A = CHO).
I. b. 5 (R = H, P = TBDPS, A = CH2OH) (230 mg, 0.627 mmol). b. 3 (R = H, P = TBDMS, A = CHO). I. b. The yield of 6 (R = H, P = TBDPS, A = CHO) was 210 mg (92%).
IR (film): 3439, 3061, 2954, 2858, 1704, 1589, 1471, 1111, 1036, 823, 703 cm-1 ;1H-NMR (500 MHz, CDClThree): δ 8.85 (1H, s), 7.68-7.60 (4H, m), 3.99 (1H, q, J = 7.4Hz), 2.30 (1H, dd, J = 13.1, 8.0Hz), 2.03-1.98 (2H , m), 1.93-1.87 (2H, m), 1.22 (1H, dd, J = 8.4, 6.0Hz), 1.02 (9H, s), 0.74 (1H, dd, J = 5.3, 5.3Hz) ppm;
[α]D twenty five : -90.00 (c 1.00, CHClThree).
[0083]
Example 16: (2S, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-ethynyl-bicyclo [3.1.0] hexane: I. b. 7 (R = H, P = TBDPS, A = C≡CH).
Cooled to -78 ° C (MeO)2P (O) CHN2To a solution of (188 mg, 1.253 mmol) in THF (3 ml) was added t-BuOK (1.26 ml, 1.26 mmol, 1.0 M solution in THF) dropwise. The resulting mixture was stirred at −78 ° C. for 20 minutes while the yellow color remained. I. b. 6 (R = H, P = TBDPS, A = CHO) (380 mg, 1.043 mmol) in THF (3 ml) was slowly added and stirred overnight. The temperature naturally rose from −78 ° C. to room temperature. Water (10 ml) and Et2The reaction was terminated by adding O (20 ml), the organic layer was separated and the aqueous layer was Et.2Extract with O (3 x 50 ml), MgSO4And dried. The residue was separated by HPLC (hexane / EtOAc 96: 4) and compound I.I. b. 7 (R = H, P = TBDPS, A = C≡CH) (338 mg, 90%) was obtained as a colorless oil.
IR (film): 3291, 3072, 2932, 2143, 1590, 1473, 1428, 1114, 1091, 824, 741 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.61-7.63 (4H, m), 7.34-7.43 (6H, m), 3.81 (1H, q, J = 7.6Hz), 2.16 (1H, dd, J = 12.5, 7.13Hz), 2.02 (1H , ddd, J = 12.5, 8.1, 0.9Hz), 1.95 (1H, m), 1.93 (1H, s), 1.56 (1H, m), 1.02 (9H, s), 0.70 (1H, dd, J = 8.3 , 5.1Hz), 0.31 1H, t, J = 5.0Hz) ppm;
[α]D twenty five : -86.30 (c = 1.60, CHClThree).
[0084]
Example 17: (2S, 3aR, 4aR-2-t-butyldiphenylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: If4 (R = H, P = TBDPS, A = COOCH3).
a) Methyl (1R, 3R, 5S) -3-t-butyldiphenylsilyloxy-5-hydroxy-cyclohexanecarboxylate: 3.8. b (R = H, P = TBDPS, A = COOCH3).
2. A (R = H, A = COOCH3) And TBDPSCl, 3.7. b (R = H, P = TBDPS, A = COOCH3) Of Example 4 of 3.8. a (R = H, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as in). The title compound was obtained as a viscous oil; the yield was 92% for the two steps.
IR (film): 3404, 2952, 1738, 1428, 1112, 1049, 807, 710 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.66 (4H, m), 7.40 (6H, m), 3.65 (3H; s), 3.60 (1H, dddd, J = 10.9, 10.9, 4.3, 4.3 Hz), 3.41 (1H, m), 2.11 (4H, m), 1.50 (1H, dd, J = 12.6, 12.6 Hz), 1.41 (1H, d, J = 5.2 Hz), 1.34 (3H, m) ppm;
MS (m / z): 412 (M+, 1), 355 (5), 323 (67), 199 (100), 153 (37), 105 (21), 79 (85);
[α]D twenty five : -16.44 (c = 1.60, CHClThree).
[0085]
b) Methyl (1S, 3R, 5S) -3-t-butyldiphenylsilyloxy-5-tosyloxy-cyclohexanecarboxylate: 3.6. b (R = H, L = OTos, P = TBDPS, A = COOCH3).
3.8. b (R = H, P = TBDPS, A = COOCH3) To 2.4. a (R = H, L = OTos, A = COOCH3) And the same reaction as in 3.6. b was obtained as a viscous oil. The yield was 94%.
IR (film): 2955, 1738, 1363, 1178, 1111, 824, 704 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.69 (2H, d, J = 8.3Hz), 7.58 (4H, m), 7.28 (2H, d, J = 8.1Hz), 4.18 (1H, dddd, J = 11.6, 11.6, 4.6, 4.6Hz ) 3.62 (3H; s), 3.48 (1H, dddd, J = 11.1, 11.1; 4.1, 4.1 Hz), 2.47 (3H, s), 2.15-1.99 (4H, m), 1.52 (1H, ddd, J = 5.6, 5.57, 5.6Hz), 1.42 (1H, ddd, J = 12.0, 12.0, 12.0Hz), 0.98 (9H, s) ppm;
MS (m / z): 567 (M+, 1), 509 (9), 451 (1), 353 (49), 337 (67), 293 (38), 213 (47), 139 (32), 91 (100), 79 (77);
[α]D twenty five : +2.39 (c = 1.17, CHClThree).
[0086]
c) (2S, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. f. 4 (R = H, P = TBDPS, A = COOCH3).
3.6. b (R = H, L = OBros, P = TBDPS, A = COOCH3) To I. b. 1 (R = H, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as). The yield was 81%.
IR (film): 3287, 2934, 1732, 1457, 1281, 1017 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 3.73 (2H, m), 3.72 (3H; s), 2.53 (1H, dddd, J = 12.2, 12.2, 3.4, 3.4 Hz), 2.26 (1H, d, J = 11.3Hz), 2.17 (2H , d, J = 11.7 Hz), 1.30 (2H, ddd, J = 12.0, 12.0, 12.0 Hz), 1.23 (1H, ddd, J = 11.4, 11.4, 11.4 Hz) ppm;
MS (m / z): 394 (M+, 1), 337 (31), 259 (5), 199 (55), 153 (48), 107 (100), 79 (52);
[α]D twenty five : +31.97 (c = 1.71, CHClThree)
[0087]
Example 18: (2S, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. f. 5 (R = H, P = TBDPS, A = CH2OH).
I. f. 4 (R = H, P = TBDPS, A = COOCH3From I.). b. 2 (R = H, P = TBDMS, A = CH2OH) and (2S, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane f. 5 (R = H, P = TBDPS, A = CH2OH) was obtained in 98% yield.
IR (film): 3332, 2931, 1428, 1111, 1008, 822, 702 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.62 (4H, dd, J = 7.9, 1.5Hz), 7.39 (6H, m), 4.37 (1H, t, J = 6.27Hz), 3.57 (2H; s), 1.90-2.02 (3H, m ), 1.80 (1H, d, J = 13.8Hz), 1.21 (1H, t, J = 4.1Hz), 1.15 (1H, m), 1.03 (9H, s), 0.60 (1H, m) ppm;
MS (m / z): 365 (M+-1, 1), 291 (6), 231 (17), 199 (100), 181 (17), 139 (28), 93 (79), 79 (16);
[α]D twenty five : +5.56 (c = 1.5, CHClThree).
[0088]
Example 19 : (2S, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. f. 6 (R = H, P = TBDPS, A = CHO).
I. f. 5 (R = H, P = TBDPS, A = CH2OH) to I.I. b. 3 (R = H, P = TBDMS, A = CHO). The yield was 96%.
IR (film): 2956, 1704, 1590, 1472, 1428, 1112, 1072, 822, 702 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 8.85 (1H, s), 7.61 (4H, m), 7.43 (2H, dt, J = 7.0, 1.0Hz), 7.37 (4H, dt, J = 7.0, 1.0Hz), 4.40 (1H, t , J = 6.0Hz), 2.39 (1H, dd, J = 14, 6.0Hz), 1.89 (1H, d, J = 13.0Hz), 1.86 (1H, d, J = 14.0Hz), 1.53 (1H, m ), 1.04 (9H, s) ppm;
[α]D twenty five : +34.4 (c = 1.6, CHClThree).
[0089]
Example 20: (2S, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a-ethynyl-bicyclo [3.1.0] hexane: I. f. 7 (R = H, P = TBDPS, A = C≡CH).
I. f. 6 (R = H, P = TBDPS, A = CHO). b. 7 (R = H, P = TBDMS, A = C≡CH). The yield was 88%.
IR (film): 3310 (s), 3071, 2931, 2857, 2113, 1590, 1472, 1428, 1378, 1362, 1299, 1262, 1234, 1198, 1113, 1026, 933, 913, 865, 822, 701 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ7.60 (4H, m), 7.42 (2H, td, J = 2, 8Hz), 7.37 (4H, td, J = 1, 8Hz), 4.32 (1H, m), 2.06 (2H, m) , 2.04 (1H, dt, J = 6, 14Hz), 1.90 (1H, s), 1.80 (1H, d, J = 14Hz), 1.65 (1H, dt, J = 5, 10Hz), 1.49 (1H, t , J = 5Hz), 1.03 (9H, s), 1.03 (1H, m);
[α]D twenty five: +21.4 (c = 1.2, CHClThree)
[0090]
Example 21 : (2R, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-carbomethoxy-ethynyl-bicyclo [3.1.0] hexane: I. a. 4 R = H, P = TBDPS, A = COOCH3)
a) Methyl (1R, 3S, 5R) -3-t-butyldiphenylsilyloxy-5-tosyloxy-cyclohexanecarboxylate: 2.3. b (R = H, L = OTos, P = TBDPS, A = COOCH3).
2.5. a (R = H, L = OTos, A = COOCH3) To 2.8. a (R = H, L = OTos, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 91%.
IR (film): 2932, 2857, 1736, 1428, 1364, 1177, 1107, 929, 822, 703, 665 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.69 (2H, d, J = 8.3Hz), 7.57 (4H, dm, J = 7Hz), 7.44 (2H, q, J = 7Hz), 7.36 (4H, t, J = 8Hz), 7.28 ( 2H, d, J = 8.4Hz), 4.16 (1H, tt, J = 4, 12Hz), 3.63 (3H, s), 3.46 (1H, tt, J = 4, 11Hz), 2.43 (3H, s), 2.13 (1H, dm, J = 12Hz), 1.00 (9H, s) ppm;
[α]D twenty five : -3.07 (c = 1.04, CHClThree).
[0091]
b) (2R, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. a. 4 (R = H, P = TBDPS, A = COOCH3)
2.3. b (R = H, L = OTos, P = TBDPS, A = COOCH3) To I.V. b. 1 (R = H, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 75%.
IR (film): 2932, 2857, 1723, 1589, 1472, 1428, 1297, 1148, 1112, 1088, 702 cm-1;
1H-NMR (500 MHz, CDClThree): δ 7.61 (4H, dd, J = 1, 7Hz), 7.42 (2H, t, J = 7Hz), 7.37 (4H, t, J = 7Hz), 4.36 (1H, t, 6.1Hz), 3.63 ( 3H, s), 2.37 (1H, ddd, J = 1, 6.4, 14Hz), 1.99 (1H, d, J = 14hz), 1.96 (1H, dd, J = 6, 14Hz), 1.87 (1H, dt, J = 5, 9Hz), 1.82 (1H, d, J = 14Hz), 1.63 (1H, dd, J = 4, 5Hz), 1.50 (1H, dm, J = 9Hz), 1.03 (9H, s) ppm;
[α]D twenty five : -30.8 (c = 0.46, CHClThree).
[0092]
Example 22 : (2R, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. a. 5 (R = H, P = TBDPS, A = CH2OH).
I. a. 4 (R = H, P = TBDPS, A = COOCH3From I.). b. 2 (R = H, P = TBDMS, A = CH2The reaction was carried out in the same manner as (OH), and the yield was measurable. .
IR (film): 3346, 2930, 1589, 1472, 1428, 1111, 1092, 1076, 1031, 822, 701 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.26 (4H, dd, J = 1, 7Hz), 7.41 (2H, t, J = 7Hz), 7.36 (4H, t, J = 7Hz), 4.38 (1H, t, J = 6.3Hz), 3.57 (2H, s), 2.00 (1H, dd, J = 6, 13Hz), 1.95 (1H, dd, J = 7, 14Hz), 1.92 (1H, d, J = 14Hz), 1.80 (1H, dd, J = 14Hz), 1.22 (2H, m), 1.15 (1H, m), 1.04 (9H, s), 0.60 (1H, m) ppm;
[α]D twenty five : -5.6 (c = 1.7, CHClThree).
[0093]
Example 23: (2R, 3aS, 4aS) -2-t-butyldiphenylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. a. 6 (R = H, P = TBDPS, A = CHO).
I. a. 5 (R = H, P = TBDPS, A = CH2OH) to I.I. b. 3 (R = H, P = TBDMS, A = CHO). The yield was 93%.
IR (film): 2931, 1701, 1589, 1472, 1196, 1008, 822, 702 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 8.85 (1H, s), 7.61 (4H, m), 7.43 (2H, t, J = 7Hz), 7.37 (4H, t, J = 7Hz), 4.41 (1H, t, J = 6Hz), 2.39 (1H, dd, J = 6, 14Hz), 1.04 (9H, s) ppm;
[α]D twenty five : -35.3 (c = 1.6, CHClThree).
[0094]
Example 24: (2R, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. h. 4 (R = H, P = TBDPS, A = COOCH3).
a) Methyl (1S, 3S, 5S) -3-t-butyldiphenyl-5-tosyloxy-cyclohexanecarboxylate: 3.13. b (R = H, L = OTos, P = TBDPS, A = COOCH3).
3.12 (R = H, L = OTos, A = COOCH3) (4.8 g, 14.63 mmol) to 2.8. a (R = H, L = OTos, P = TBDS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 90%.
IR (film): 2954, 1731, 1272, 1176, 1107, 945, 813, 713, 664 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.53-7.25 (14H, m), 4.84 (1H, m), 3.68 (3H, s), 2.95 (1H, dt, J = 3.3, 12.7Hz), 2.45 (3H, s), 2.37 (1H , d, J = 12.4Hz), 1.84 (1H, d, J = 12.7Hz), 1.60 (1H, m), 1.29 (3H, m) ppm;
MS (m / z): 566 (M+), 477, 431, 399, 353, 283, 225, 198, 139, 91 (base peak);
[α]D twenty five : +7.82 (c = 1.31, CHClThree).
[0095]
b) (2R, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a-carbomethoxy-bicyclo [3.1.0] hexane: I. h. 4 (R = H, P = TBDPS, A = COOCH3).
3.13. b (R = H, P = TBDPS, A = COOCH3) (7.3 g, 12.89 mmol). b. 1 (R = H, P = TBDMS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 79%.
IR (film): 2952, 2858, 1723, 1428, 1370, 1219, 1112, 823, 741, 702 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.66-7.38 (10H, m), 3.89 (1H, m), 3.65 (3H, s), 2.12 (1H, m), 1.92 (2H, m), 1.77 (1H, m), 1.14 (2H , m), 1.02 (9H, s), 0.45 (1H, m) ppm;
MS (m / z): 394 (M+), 393 (M+-1), 363, 351, 337, 296, 259, 213 (base peak), 183, 135, 105, 77.
[α]D twenty five : +72.58 (c = 1.08, CHClThree).
[0096]
Example 25: 2R, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a- (hydroxymethyl) -bicyclo [3.1.0] hexane: I. h. 5 (R = H, P = TBDPS, A = CH2OH)
I. h. 4 (R = H, P = TBDPS, A = COOCH3From I.). b. 2 (R = H, P = TBDMS, A = CH2The reaction was carried out in the same manner as in (OH). The yield was 98%.
IR (film): 3327, 2929, 2856, 1470, 1426, 1279, 1112, 1087, 1030, 822, 739, 700 IR (film): 3327, 2929, 2856, 1470, 1426, 1279, 1112, 1087, 1030 , 822, 739, 700-1 ;
1H-NMR (500 MHz, CDClThree): δ 7.65-7.35 (10H, m), 3.97 (1H, ddd, J = 7.0, 7.2, 7.0), 3.55 (2H, bs), 2.04 (1H, m), 1.93 (1H, m), 1.87 ( 2H, m), 1.39 (1H, m), 1.02 (9H, s), 0.45 (1H, m), 0.13 (1H, m) ppm;
MS (m / z): 365 (M+-1), 322, 281, 237, 189 (base peak), 181, 139, 99, 77;
[α]D twenty five : +24.77 (c = 1.18, CHClThree).
[0097]
Example 26: (2R, 3aR, 4aR) -2-t-butyldiphenylsilyloxy-3a-formyl-bicyclo [3.1.0] hexane: I. h. 6 (R = H, P = TBDPS, A = CHO)
I. h. 5 (R = H, P = TBDPS, A = CH2OH) to I.I. b. 3 (R = H, P = TBDMS, A = CHO).
IR (film): 2931, 2857, 1708, 1472, 1388, 1362, 1200, 1113, 1093, 1036, 901, 823, 742, 612 cm-1 ;
1H-NMR (500 MHz, CDClThree): δ 8.87 (1H, s), 7.65-7.35 (10H, m), 3.98 (1H, m), 2.29 (1H, dd, J = 12.9, 8.1Hz), 2.01 (2H, m), 1.89 (2H , m), 1.22 (1H, m), 1.02 (9H, s), 0.74 (1H, t, J = 5.4Hz) ppm;
MS (m / z): 363 (M++1), 332, 307 (base peak), 289, 277, 263, 229, 211, 199, 181, 151, 139, 121, 91, 77, 57, 41;
[α]D twenty five : +91.49 (c = 0.47, CHClThree).
[0098]
Example 27: (1R, 2S, 3aS, 4aS) -3a-carbomethoxy-2-t-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane: I. a. 7 (R = Me, P = TBDPS, A = COOCH3)
a) Methyl (1S, 3S, 4R, 5R) -3-tert-butyldiphenylsilyloxy-4-methyl-5-acetoxy-cyclohexane 2.1. c (R = Me, P = TBDPS, A = COOCH3)
Stirred 2'B (R = Me, A = COOCH3) (0.81 g, 3.52 mmol), imidazole (0.72 g, 10.57 mmol, 99%) and DMAP (4-dimethylaminopyridine; 22 mg) in anhydrous DMF (15 ml) in TBDPSCl (1.8 ml, 7.04 mmol, 98%) was added dropwise. The resulting mixture was stirred for 20 hours at room temperature. After completion, the reaction solution was poured into water-EtOAc (80 ml). The organic layer was separated and the aqueous layer was extracted with EtOAc (50 ml × 3). The combined extracts were washed with saturated brine (3 x 10 ml) and MgSO4And concentrated to give a residue. The residue was purified by HPLC (isooctane / EtOAc 9: 1), 2.1. c (R = Me, P = TBDPS, A = COOCH3) (1.34 g, 84%).
[α]D = +9.9 (CHClThree, c = 0.65)
1H-NMR (500 MHz, in CDClThree, ppm): 7.65-7.35 (10H, m), 4.59 (1H, dt, J = 12.4, 4.5 Hz), 3.72 (1H, m), 3.62 (3H, s), 2.26 (1H, m), 2.09 ( 1H, m), 2.02 (3H, s), 1.81 (1H, dt, J = 12.6, 4.1 Hz), 1.61 (1H, m), 1.08 (10H, s), 1.05 (3H, d, J = 6.4 Hz ).
IR (film): 2954, 1737, 1428, 1364, 1239, 1111, 1037, 822, 740, 702 cm-1MS (m / z): 411 (M+-57), 369, 351, 317, 291, 259, 258, 241, 199, 181, 135, 121, 93, 43 (base peak).
[0099]
b) Methyl 9 (1S, 3S, 4R, 5R) -3-tert-butyldiphenylsilyloxy-4-methyl-5-hydroxy-cyclohexanecarboxylate 2.2. c (R = Me, P = TBDPS, A = COOCH3)
2. Stir at room temperature 2.1. c (R = Me, P = TBDPS, A = COOCH3) (392 mg, 0.992 mmol) in anhydrous MeOH (10 ml)2CO3(30 mg) was added. 10 minutes later, second K2CO3(19 mg) (total: 49 mg, 0.496 mmol) was added. The resulting mixture was stirred for 6 hours with water and Et.2Poured into a mixture of O (70 ml: 50 ml). The organic layer is separated and the aqueous layer is Et.2Extract with O (50 ml x 3), MgSO4And dried. Separation by flash chromatography on silica (isooctane / EtOAc 9: 1), hydroxy compound 2.2. c (R = Me, P = TBDPS, A = COOCH3) (344 mg, 98%) was obtained as a colorless oil.
IR (film): 3448, 2954, 2858, 1737, 1654, 1472, 1362, 1279, 1240, 1173, 1008,852, 822, 795, 741, 702, 611 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 7.65 (4H, m), 7.44 (2H, m), 7.37 (4H, m), 3.69 (1H, m), 3.64 (3H, s), 3.51 (1H, m), 2.16 (1H, m), 2.08 (1H, m), 1.77 (1H, dt, J = 12.6, 4.1 Hz), 1.69 (2H, t, J = 8.9 Hz), 1.56 (1H, q, J = 12.4 Hz), 1.37 ( 1H, d, J = 5.3 Hz), 1.06 (9H, s), 1.02 (3H, d, J = 7.0 Hz).
MS (m / z): 337 (7), 309 (5), 291 (35), 199 (100), 156 (85), 181 (17), 153 (34), 121 (23), 93 (68 ), 57 (47).
[α]D twenty five : +33.0 (c = 0.54, CHClThree)
[0100]
c) Methyl (1S, 3S, 4R, 5R) -3-tert-butyldiphenylsilyloxy-4-methyl-5-tosyloxy-cyclohexanecarboxylate 2.3. c (R = Me, P = TBDPS, L = OTos, A = COOCH3)
2.2. c (R = Me, P = TBDMS, A = COOCH3) (279 mg, 0.828 mmol), p-toluenesulfonyl chloride (323 mg, 1.69 mmol, 98%), DMAP (5.1 mg, 0.042 mmol) in anhydrous CH2Cl2(10 ml) to the mixed solution at 0 ° C. (ice bath)3N (308 μL, 2.54 mmol) was added. The resulting mixture was refluxed for 3 days; then toluenesulfonyl chloride (320 mg, 1.69 mmol, 98%), DMAP (5.1 mg, 0.042 mmol) and Et.3N (500 μL) was added. The resulting solution was refluxed for 2 days. p-Toluenesulfonyl chloride (320 mg, 1.69 mmol, 98%), DMAP (5.1 mg, 0.042 mmol) and Et3N (500 μL) was added again and reflux was continued for another day. The resulting mixture was added to 20 ml of CH2Cl2Diluted with brine, washed with brine and the aqueous layer was extracted with EtOAc (4 × 50 ml). Combined organic layer is MgSO4And dried. Filtration, concentration of the solution and flash chromatography on silica (isooctane / EtOAc 9: 1) 2.3. c (R = Me, P = TBDPS, L = OTos, A = COOCH3) (316 mg, 83.5%) was obtained as a pale yellow oil.
IR (film): 2954, 2858, 1737, 1365, 1246, 1177, 1106, 955, 704, 667 cm-11H-NMR (500 MHz, in CDClThree, ppm): 7.71 (2H, d, J = 8.3 Hz), 7.58 (4H, m), 7.43 (2H, m), 7.37 (4H, m), 7.31 (2H, d, J = 8.1 Hz), 4.27 (1H, dt, J = 12.0, 4.7 Hz), 3.61 (3H, s), 3.57 (1H, ddd, J = 10.6, 5.1, 4.6 Hz), 2.45 (3H, s), 2.17 (1H, m), 2.01 (1H, m), 1.81 (1H, dt, J = 12.8, 4.2 Hz), 1.74 (1H, dd, J = 12.6 Hz), 1.64 (2H, m), 1.02 (9H, s), 0.99 (3H , d, J = 6.6 Hz).
MS (m / z): 523 (25), 507 (1), 463 (1), 409 (3), 353 (94), 307 (20), 293 (18), 213 (30), 199 (32 ), 135 (35), 91 (100), 77 (30).
[α]D twenty five : -10.0 (c = 1.22, CHClThree)
[0101]
d) (1R, 2S, 3aS, 4aS) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane a. 7 (R = Me, P = TBDPS, A = COOCH3)
Tosylate 2.3. c (R = Me, P = TBDPS, L = OTos, A = COOCH3) (240 mg, 0.415 mmol) in tert-BuOH (5 ml) and THF (2.8 ml) (45 ° C) in tert-BuOK (540 μL, 0.54 mmol, in tert-BuOH) 1 M solution) was added dropwise. The resulting mixture was stirred at 45 ° C. for 1.5 hours and then poured into water and EtOAc (100 ml: 50 ml). The organic layer was separated and the aqueous layer was extracted with EtOAc (3 x 50 ml), MgSO4And dried. The residue was then separated by flash chromatography (isooctane / EtOAc 100: 2). a. 7 (R = Me, P = TBDPS, A = COOCH3) (122 mg, 72.0%) was obtained as a colorless oil.
IR (film): 2931, 1724, 1428, 1288, 1224, 1147, 1111, 1073, 1015, 933, 822, 740, 702, 609 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 7.61 (14H, m), 7.42 (2H, m), 7.36 (4H, t, J = 7.2 Hz), 4.19 (1H, t, J = 6.0 Hz), 3.62 (3H, s), 2.30 (2H, m), 1.97 (1H, d, J = 14.2 Hz), 1.85 (1H, m), 1.64 (1H, t, J = 4.6 Hz), 1.35 (1H, dd, J = 8.7, 3.9 Hz) , 1.09 (9H, s), 0.99 (3H, d, J = 6.9 Hz).
MS (m / z):
[α]D twenty five : -13.2 (c = 1.61, CHClThree)
[0102]
Example 28: (1R, 2S, 3aS, 4aS) -3a-hydroxymethyl-2-tert-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane a. 8 (R = Me, P = TBDPS, A = CH2OH)
I. a. 7 (R = Me, P = TBDPS, A = COOCH3) (136 mg, 0.33 mmol) in THF (15 ml) in LiAlH4(0.85 ml, 0.85 mmol, 1 M solution in THF) was added dropwise. The resulting mixture was stirred at this temperature for 1.5 hours and water (0.1 ml) was added. The reaction mixture was filtered using celite and concentrated. The residue was purified by flash chromatography (silica gel: isooctane / EtOAc: 7: 3). a. 8 (R = Me, P = TBDPS, A = CH2OH) (124 mg, 97.8%) was obtained as a colorless oil.
IR (film): 3420, 2930, 1427, 1111, 1078, 1014, 701, 611, 504 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 7.63 (4H, m), 7.42 (2H, m), 7.36 (4H, m), 4.21 (1H, t, J = 6.0 Hz), 3.54 (1H, dd, J = 11.4, 5.6 Hz) , 3.50 (1H, dd, J = 11.4, 5.6 Hz), 2.29 (1H, m), 1.95 (1H, ddd, J = 13.7, 6.0, 1.4 Hz), 1.23 (1H, t, J = 4.12 Hz), 1.14 (1H, m), 1.08 (9H, s), 0.99 (3H, d, J = 7.0 Hz), 0.41 (1H, dd, J = 8.4, 4.3 Hz), 0.80 (1H, m).
MS (m / z): 381 (M++1, 1), 363 (22), 337 (1), 323 (22), 305 (5), 285 (9), 267 (24), 245 (63), 225 (19), 199 (83) , 179 (19), 153 (29), 139 (51), 107 (100), 91 (58), 79 (72), 57 (86), 41 (78).
[α]D twenty five : -2.6 (c = 0.69, CHClThree)
[0103]
Example 29: (1R, 2S, 3aS, 4aS) -3a-formyl-t-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane a. 9 (R = Me, P = TBDPS, A = CHO)
(COCl)2(18 μL, 0.21 mmol) CH2Cl2DMSO (32 μL, 0.42 mmol) in CH (1.5 ml) solution (−78 ° C.)2Cl2(100 μL) solution was added dropwise. The mixture is stirred at −78 ° C. for 20 minutes, then alcohol I.V. a. 8 (R = Me, P = TBDPS, A = CH2OH) (40 mg, 0.105 mmol) in CH2Cl2(1.5 ml) Added solution. The resulting cloudy liquid was stirred at −78 ° C. for 20 minutes. The mixture was then warmed to room temperature over 1 hour. Cold water is added to terminate the reaction, the organic layer is separated, and the aqueous layer is2Extraction with O (3 x 50 ml) followed by MgSO4And dried. The residue was separated by HPLC (isooctane / EtOAc: 95: 5) and compound I.I. a. 9 (R = Me, P = TBDPS, A = CHO) (30 mg, 75%) was obtained as a colorless oil.
IR (film): 3420, 2930, 1427, 1111, 1078, 1014, 701, 611, 504 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 8.80 (1H, s), 7.62 (4H, m), 7.42 (6H, m), 4.24 (1H, t, J = 5.8 Hz), 2.32 (1H, dd, J = 14.4, 6.1 Hz) , 1.96 (2H, m), 1.84 (1H, d, J = 14.4 Hz), 1.36 (1H, m), 1.08 (9H, s), 1.00 (3H, d, J = 7.0 Hz), 0.91 (1H, d, J = 6.8 Hz).
MS (m / z): 378 (M+, 1), 361 (4), 321 (100), 303 (10), 285 (10), 267 (24), 263 (16), 243 (74), 225 (39), 199 (100), 183 (76), 165 (39), 139 (72), 135 (48), 105 (59), 91 (34), 77 (60), 57 (95), 41 (80).
[α]D twenty five = -16.2 (c = 0.59, CHClThree)
[0104]
Example 30: (1S, 2R, 3aR, 4aR) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane f. 8 (R = Me, P = TBDPS, A = COOCH3)
a) Methyl (1S, 3S, 4R, 5R) -3-tosyloxy-4-methyl-5-acetoxy-cyclohexanecarboxylate 3.4. c (R = Me, L = OTos, A = COOCH3)
2'B (R = Me, Z = Me, A = COOCH3) (1.05 g, 4.57 mmol) to 2.3. c (R = Me, P = TBDPS, L = OTos, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 1.51 g, 89%.
IR (film): 2954, 1736, 1557, 1363, 1242, 1189, 1025, 956, 919, 667 cm-11H-NMR (500 MHz, in CDClThree, ppm): 7.69 (2H, d, J = 7.2 Hz), 7.38 (2H, d, J = 7.2 Hz), 4.74 (1H, dt, J = 12.2, 4.5 Hz), 4.49 (1H, dt, J = 12.1, 4.7 Hz), 3.69 (3H, s), 2.46 (3H, s), 2.02 (3H, s), 1.98 (1H, dt, J = 12.1, 4.7 Hz), 1.93 (1H, dt, J = 12.6 , 4.6 Hz), 1.81 (2H, dd, J = 12.8 Hz), 1.63 (2H, dd, J = 12.6 Hz), 0.97 (3H, d, J = 6.9 Hz).
MS (m / z): 384 (M+), 343, 326, 311, 300, 269, 258, 213, 170, 152, 111, 93, 43 (base peak).
[α]D twenty five = +51.1 (c = 0.59, CHClThree)
[0105]
b) Methyl (1S, 3S, 4R, 5R) -3-tosyloxy-4-methyl-5-hydroxy-cyclohexanecarboxylate 3.5. c (R = Me, L = OTos, A = COOCH3)
3.4. c (R = Me, L = OTos, A = COOCH3) To 2.2. c (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 90%.
IR (film): 3439, 2988, 1732, 1439, 1353, 1176, 1097, 1021, 945, 667 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 7.78 (2H, d, J = 7.2 Hz), 7.32 (2H, d, J = 7.2 Hz), 4.52 (1H, dt, J = 10.8, 4.7 Hz), 3.69 (1H, m), 3.68 (3H, s), 2.45 (3H, s), 2.34 (1H, m), 2.25 (1H, m), 1.94 (2H, m), 1.87 (1H, dt, J = 13.2, 4.5 Hz), 1.75 ( 1H, bs), 1.66 (1H, dd, J = 11.9 Hz), 0.91 (3H, d, J = 7.0 Hz).
MS (m / z): 340 (M+-2), 295, 278, 247, 220, 194, 170, 155, 127 (base peak), 91, 87, 57.
[α]D twenty five : +18.8 (c = 0.41, CHClThree)
[0106]
c) Methyl (1S, 3S, 4R, 5R) -3-tosyloxy-4-methyl-5-tert-butyldiphenylsilyloxy-cyclohexanecarboxylate 3.6. c (R = Me, L = OTos, P = TBDPS, A = COOCH3)
3.5. c (R = Me, L = OTos, A = COOCH3) To 2.1. c (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 86%.
IR (film): 2955, 1736, 1598, 1427, 1363, 1177, 1031, 955, 914, 863, 820, 741, 703, 667 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 7.69-7.38 (14H, m), 4.27 (1H, dt, J = 12.1, 4.8 Hz), 3.61 (3H, s), 3.56 (1H, m), 2.44 (3H, s), 2.17 ( 1H, m), 2.02 (1H, m), 1.83 (1H, dt, J = 12.5, 4.3 Hz), 1.73 (1H, dd, J = 12.7 Hz), 1.63 (2H, m), 1.01 (9H, s ), 0.99 (3H, d, J = 7.2 Hz).
MS (m / z): 523 (M+-57), 463, 403, 353, 351, 293, 227, 213, 135, 91 (base peak), 77.
[α]D twenty five : -2.6 (c = 0.94, CHClThree)
[0107]
d) (1S, 2R, 3aR, 4aR) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane f. 8 (R = Me, P = TBDPS, A = COOCH3)
3.6. c (R = Me, L = OTos, P = TBDPS, A = COOCH3From I.). a. 7 (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The title compound was obtained as a colorless oil in 68% yield.
IR (film): 2931, 2857, 1724, 1428, 1367, 1288, 1223, 1147, 1111, 1073, 1015, 934, 822, 740, 702, 609 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 7.62-7.31 (10H, m), 4.19 (1H, t, J = 5.9 Hz), 3.59 (3H, s), 2.31 (2H, dd, J = 13.7, 6.3 Hz), 1.96 (1H, d, J = 14.5 Hz), 1.84 (1H, m), 1.64 (1H, t, J = 4.6 Hz), 1.35 (1H, dd, J = 12.8, 5.0 Hz), 1.25 (1H, br.), 1.07 (9H, s), 0.99 (3H, d, J = 6.9 Hz), 0.91 (1H, m).
MS (m / z): 408 (M+), 351, 323, 273, 213, 199, 153, 121 (base peak), 77. [α]D twenty five : +13.9 (c = 0.65, CHClThree)
[0108]
Example 31: (1S, 2R, 3aR, 4aR) -3a-hydroxymethyl-2-t-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane f. 9 (R = Me, P = TBDPS, A = CH2OH)
I. f. 8 R = Me, P = TBDPS, A = COOCH3From I.). a. 8 (R = Me, P = TBDPS, A = CH2Reaction was carried out in the same manner as in (OH). The yield was 98%.
IR (film): 3324, 2929, 2857, 1654, 1471, 1427, 1363, 1194, 1107, 1078, 1011, 822, 740, 701, 610 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 7.68-7.37 (10H, m), 4.21 (1H, t, J = 6.0 Hz), 3.54 (1H, dd, J = 11.4, 6.0 Hz), 3.52 (1H, dd, J = 11.4, 6.0 Hz), 2.29 (1H, dd, J = 11.3, 8.1 Hz), 1.94 (1H, dd, J = 14.6, 5.9 Hz), 1.86 (1H, d, J = 13.2 Hz), 1.23 (1H, t, J = 4.1 Hz), 1.14 (1H, m), 1.07 (9H, s), 0.99 (3H, d, J = 6.9 Hz), 0.89 (1H, m), 0.41 (dd, J = 8.1, 4.3 Hz).
MS (m / z): 323 (M+-57), 305, 267, 245, 199, 181, 139, 107.
[α]D twenty five : +3.1 (c = 0.93, CHThreeCl)
[0109]
Example 32: (1S, 2R, 3aR, 4aR) -3a-formyl-2-t-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane f. 10 (R = Me, P = TBDPS, A = CHO)
I. f. 9 (R = Me, P = TBDPS, A = CH2OH) to I.I. a. The reaction was carried out in the same manner as 9 (R = Me, P = TBDPS, A = CHO). The yield was 28%.
[α]D twenty five : +15.8 (c = 0.41, CHThreeCl)
1H-NMR (500 MHz, in CDClThree, ppm): 8.80 (1H, s), 7.61-7.35 (10H, m), 4.24 (1H, t, J = 5.8 Hz), 2.31 (2H, m), 1.96 (1H, m, dd, J = 8.1 , 5.9 Hz), 1.84 (1H, d, J = 14.3 Hz), 1.37 (1H, dd, J = 11.0, 7.1 Hz), 1.26 (1H, dd, J = 9.7, 4.6 Hz), 1.07 (9H, s ), 1.04 (3H, t, J = 6.9 Hz).
IR (film): 2959, 2857, 1703, 1471, 1391, 1383, 1274, 1215, 1191, 1111, 1109, 1009, 963, 823, 701 cm-1.
MS (m / z): 377 (M+-1, 5), 337 (75), 321 (M+-57, 8), 319 (10), 309 (10), 293 (6), 259 (12), 231 (20), 215 (16), 199 (100), 181 (30), 153 (20) , 139 (60), 121 (95).
[0110]
Example 33: (1R, 2S, 3aS, 4aS) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-ethyl-bicyclo [3.1.0] hexane a. 10 (R = Et, P = TBDPS, A = COOCH3)
a) Methyl (1S, 3S, 4R, 5R) -3-tert-butyldiphenylsilyloxy-4-ethyl-5-acetoxy-cyclohexane 2.1. d (R = Et, P = TBDPS, A = COOCH3)
2'C (R = Et, Z = Me, A = COOCH3) To 3.4. Reaction was carried out in the same manner as c. The yield was 92%.
[α]D twenty five : +7.5 (c = 0.59, CHThreeCl)
1H-NMR (500 MHz, in CDClThree, ppm): 7.45-7.36 (10H, m), 4.62 (1H, dt, J = 12.2, 4.4 Hz), 3.69 (1H, dt, J = 11.5, 4.3 Hz), 3.61 (3H, s), 2.08 ( 2H, tt, J = 8.8, 3.9 Hz), 2.01 (3H, s), 1.85 (2H, m), 1.60 (3H, m), 1.51 (1H, m), 1.06 (9H, s), 1.02 (3H , t, J = 7.5 Hz).
IR (film): 2954, 2848, 1739, 1462, 1428, 1364, 1238, 1194, 1178, 1110, 1034, 986, 812, 740, 702 cm-1.
MS (m / z): 482 (M+, 2), 468 (5), 451 (7), 425 (M+-57), 391 (1), 365 (80), 351 (25), 305 (15), 273 (20), 241 (100), 213 (88), 199 (92), 153 (56), 135 (75), 107 (85).
[0111]
b) Methyl (1S, 3S, 4R, 5R) -3-tert-butyldiphenylsilyloxy-4-ethyl-5-hydroxy-cyclohexanecarboxylate 2.2. d (R = Me, P = TBDPS, A = COOCH3)
2.1. d (R = Et, P = TBDPS, A = COOCH3) To 2.2. c (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 98%.
[α]D twenty five : +28.7 (c = 0.19, CHThreeCl)
1H-NMR (500 MHz, in CDClThree, ppm): 7.68 (10H, m), 3.68 (1H, dt, J = 8.2, 4.2 Hz), 3.62 (3H, s), 3.57 (1H, dt, J = 11.1, 4.6 Hz), 2.07 (1H, m), 1.85 (1H, t, J = 4.1 Hz), 1.77 (1H, dt, J = 8.6, 4.0 Hz), 1.71 (1H, tt, J = 11.0, 4.0 Hz), 1.64 (2H, t, J = 9.0), 1.59 (1H, overlap), 1.52 (1H, bs), 1.45 (1H, m), 1.06 (9H, s), 1.05 (3H, t, J = 7.5).
IR (film): 3435, 2995, 2858, 1736, 1589, 1460, 1427, 1363, 1271, 1236, 1172, 1111, 1050, 915, 875, 823, 740, 702, 647 cm-1.
MS (m / z): 383 (M+-57, 14), 351 (16), 323 (18), 305 (90), 273 (18), 253 (10), 227 (50), 199 (100), 183 (70), 153 (80) , 107 (98).
[0112]
c) Methyl (1S, 3S, 4R, 5R) -3-tert-butyldiphenylsilyloxy-4-ethyl-5-tosyloxy-cyclohexanecarboxylate 2.3. d (R = Et, P = TBDPS, L = OTos, A = COOCH3)
2.2. d (R = Et, P = TBDPS, A = COOCH3) To 2.3. c (R = Me, P = TBDPS, L = OTos, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 82%.
[α]D twenty five : -17.9 (c = 0.59, CHThreeCl)
1H-NMR (500 MHz, in CDClThree, ppm): 7.72-7.30 (14H, m), 4.28 (1H, dt, J = 12.5, 4.5 Hz), 3.59 (3H, s), 3.55 (1H, dt, J = 11.4, 4.3 Hz), 2.45 ( 3H, s), 1.96 (1H, tt, J = 8.5, 4.1 Hz), 1.91 (1H, t, J = 4.2 Hz), 1.84 (1H, dt, J = 8.5, 4.1 Hz), 1.77 (1H, m ), 1.73 (1H, m), 1.53 (2H, m), 1.47 (1H, m), 1.02 (9H, s), 0.97 (3H, t, J = 7.5 Hz).
IR (film): 2957, 2858, 1738, 1598, 1487, 1462, 1428, 1360, 1277, 1189, 1111, 1030, 953, 885, 822, 741, 704 cm-1.
MS (m / z): 357 (M+-57, 45), 353 (100), 293 (22), 227 (5), 199 (48), 135 (70).
[0113]
d) (1R, 2S, 3aS, 4aS) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-ethyl-bicyclo [3.1.0] hexane a. 10 (R = Et, P = TBDPS, A = COOCH3)
2.3. d (R = Et, P = TBDPS, L = OTos, A = COOCH3From I.). a. 7 (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 71%.
[α]D twenty five : -33.3 (c = 0.27, CHThreeCl)
1H-NMR (500 MHz, in CDClThree, ppm): 7.63-7.35 (10H, m), 4.18 (1H, t, J = 5.9 Hz), 3.61 (3H, s), 2.26 (1H, m), 2.06 (1H, m), 1.98 (1H, d, J = 14.3 Hz), 1.92 (1H, m), 1.67 (1H, t, J = 4.3 Hz), 1.48 (2H, m), 1.36 (1H, dd, J = 8.7, 3.9 Hz), 1.05 ( 9H, s), 0.89 (3H, J = 7.4 Hz).
IR (film): 2958, 1723, 1427, 1366, 1298, 1224, 1148, 1111, 1064, 1028, 926, 821, 740, 610, 507 cm-1.
MS (m / z): 422 (M+, 2), 391 (4), 365 (M+-57, 40), 337 (8), 287 (12), 259 (10), 225 (8), 199 (65), 135 (100), 105 (38).
[0114]
Example 34: (1S, 2R, 3aR, 4aR) -3a-carbomethoxy-2-t-butyldiphenylsilyloxy-1-ethyl-bicyclo [3.1.0] hexane f. 11 (R = Et, P = TBDPS, A = COOCH3).
a) Methyl (1S, 3S, 4R, 5R) -3-mesyloxy-4-ethyl-5-acetoxy-cyclohexane carboxylate 3.4. d (R = Et, L = OMs, A = COOCH3).
Monoacetate 2'C (A = COOCH3, R = Et, Z = Me) (0.1 g, 0.41 mmol), Et3N (0.30 ml, 2.10 mmol) CH2Cl2MsCl (96 μL, 1.23 mmol) was added dropwise to the (5 ml) solution at room temperature. The resulting mixture was stirred at room temperature for 10 hours. The reaction solution was poured into ice water and extracted with AcOEt (3 × 50 ml). The combined extracts were washed with saturated brine (3 x 5 ml) and MgSO4And concentrated to give a residue. The resulting residue was purified by HPLC eluting with isooctane / EtOAc (90:10) to give mesylate 3.4. d (A = COOCH3, R = Et, L = OMs) (0.11 g, 85%).
IR (film): 2954, 1737, 1641, 1357, 1241, 1175, 952 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 4.87 (1H, dt, J = 10.9, 4.2 Hz), 4.75 (1H, dt, J = 4.5, 10.9 Hz), 3.69 (3H, s), 3.00 (3H, s), 2.48 (1H, m), 2.23 (1H, bs), 2.13 (1H, dt, J = 4.2, 11.8 Hz), 2.05 (3H, s), 2.01 (1H, d, J = 8.8 Hz), 1.96 (1H, dt, J = 13.3, 4.5 Hz), 1.83 (1H, m), 1.58 (2H, m), 1.01 (3H, s).
MS (m / z): 322 (M+), 309, 291, 248, 227, 199, 166, 135, 107, 78, 43 (base peak).
[α]D twenty five : +2.6 (c = 1.08, CHClThree)
[0115]
b) Methyl (1S, 3S, 4R, 5R) -3-mesyloxy-4-ethyl-5-hydroxy-cyclohexanecarboxylate 3.5. d (A = COOCH3, R = Et, L = OMs)
3.4. d (R = Et, L = OMs, A = COOCH3) To 2.5. a (R = H, L = OTos, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 90%.
IR (film): 3439, 2957, 1729, 1438, 1351, 1277, 1174, 944, 877, 838, 757,
530 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 4.87 (1H, t, J = 3.1 Hz), 3.91 (1H, t, J = 2.9 Hz), 3.74 (3H, s), 3.00 (3H, s), 2.69 (1H, bs), 2.44 (1H, bs), 2.17 (1H, bs), 2.00 (2H, m), 1.84 (2H, dt, J = 14.3, 4.7 Hz), 1.71 (2H, m), 1.03 (3H, t, J = 7.4 Hz).
MS (m / z): 281 (M++1), 263, 249, 236, 200, 184, 166, 141, 125, 111, 87, 78, 55 (base peak).
[α]D twenty five : +51.3 (c = 0.61, CHClThree)
[0116]
c) Methyl (1S, 3S, 4R, 5R) -3-mesyloxy-4-ethyl-5-t-butyldiphenylsilyloxy-cyclohexanecarboxylate 3.6. d (R = Et, L = OMs, P = TBDPS, A = COOCH3)
3.5. d (R = Et, L = OMs, A = COOCH3) To 2.8. a (R = H, L = OTos, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 86%.
IR (film): 2957, 2857, 1738, 1588, 1462, 1427, 1358, 1276, 1177, 1111, 1030, 949, 885, 823, 741, 703, 614 cm-11H-NMR (500 MHz, in CDClThree, ppm): 7.65-7.35 (10H, m), 4.44 (1H, dt, J = 12.2, 4.6 Hz), 3.67 (1H, dt, J = 11.6, 4.2 Hz), 3.63 (3H, s), 2.79 ( 3H, s), 2.09 (1H, dt, J = 12.9, 3.9 Hz), 2.06 (1H, m), 2.02 (2H, m), 1.85 (1H, m), 1.79 (1H, dd, J = 12.8 Hz ), 1.65, 1H, dt, J = 13.1, 4.0 Hz), 1.49 (1H, m), 1.06 (9H, s), 1.04 (3H, t, J = 7.5 Hz).
MS (m / z): 461 (M+-57), 401, 365, 351, 305, 277, 231, 199, 167, 135, 107 (base peak).
[α]D twenty five : -2.3 (c = 0.35, CHClThree)
[0117]
d) (1S, 2R, 3aR, 4aR) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-ethyl-bicyclo [3.1.0] hexane f. 11 (R = Et, P = TBDPS, A = COOCH3).
3.6. d (R = Et, L = OMs, P = TBDPS, A = COOCH3From I.). a. 7 (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 71%.
IR (film): 2958, 1723, 1427, 1366, 1298, 1224, 1148, 1111, 1064, 1028, 926, 821, 740, 610, 507 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 7.63-7.35 (10H, m), 4.18 (1H, t, J = 5.9 Hz), 3.61 (3H, s), 2.26 (1H, m), 2.06 (1H, m), 1.98 (1H, d, J = 14.3 Hz), 1.92 (1H, m), 1.67 (1H, t, J = 4.3 Hz), 1.48 (2H, m), 1.36 (1H, dd, J = 8.7, 3.9 Hz), 1.05 ( 9H, s), 0.89 (3H, J = 7.4 Hz).
MS (m / z): 422 (M+, 2), 391 (4), 365 (M+-57, 40), 337 (8), 287 (12), 259 (10), 225 (8), 199 (65), 135 (100), 105 (38).
[Α]D 25 : +28.4 (c = 0.75, CHCl3)
[0118]
Example 35: (1R, 2S, 3aR, 4aR) -3a-carbomethoxy-2-t-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane e. 1 (R = Me, P = TBDPS, A = COOCH3)
a) Methyl (1S, 3S, 4R, 5S) -3-tert-butyldiphenylsilyloxy-4-methyl-5-hydroxy-cyclohexane carboxylate 3.2. c (R = Me, P = TBDPS, A = COOCH3).
2.2. c (R = Me, P = TBDPS, A = COOCH3) (167 mg, 0.392 mmol), picolinic acid (257 mg, 2.092 mmol) and triphenylphosphine (548 mg, 2.092 mmol) in THF (−38 ° C.) in DIAD (diisopropyl azodicarboxyl). Rate; 412 μL, 2.092 mmol) was added dropwise over 4 minutes. The reaction solution was stirred for 4.5 hours and allowed to return to room temperature overnight. The resulting mixture was poured into water and EtOAc (50 ml: 50 ml). The organic layer was separated and the aqueous layer was extracted with EtOAc (3 x 50 ml), MgSO4And dried. The residue was separated by HPLC (isooctane / EtOAc 98: 2) and (4S, 6S) -4-carbomethoxy-6-tert-butyldiphenylsilyloxy-1-methylcyclohexane (142 mg, 88.8%) was Obtained as a colorless oil.
IR (film): 2953, 2856, 1738, 1428, 1247, 1168, 1111, 1068, 999, 893, 820, 741, 702, 614 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 7.71 (4H, m), 7.43 (2H, m), 7.38 (4H, m), 5.39 (1H, m), 4.25 (1H, bs), 3.60 (3H, s), 2.39 (1H, m), 2.19 (1H, m), 2.13 (1H, m), 2.04 (1H, m), 1.75 (1H, dd, J = 22.3, 12.5Hz), 1.66 (3H, bs), 1.08 (9H, s ).
MS (m / z): 387 (1), 361 (1), 351 (75), 319 (5), 273 (5), 273 (5), 213 (100), 183 (70), 137 (65 ), 105 (30), 77 (85).
[α]D twenty five : +81.9 (c = 1.91, CHClThree)
[0119]
A borane-THF complex solution (1.0 M, 325 μL, 0.325 mmol, 1.5 eq) was added dropwise to a stirred diglyme (2 ml) solution of cyclohexane (110 mg, 0.27 mmol) (0 ° C.). did. The resulting solution was stirred for 4 hours at 0 ° C. THF was removed and TAO (trimethylamine N-oxide, 90 mg, 0.81 mmol) was added. The mixture was heated to reflux for 2 hours. The resulting mixture was cooled to room temperature, extracted with EtOAc (4 mL 40 ml), MgSO4And dried. The residue was separated by flash chromatography on silica and purified by HPLC (cyclohexane / EtOAc: 9: 1) to give compound 3.2. c (R = Me, P = TBDPS, A = COOCH3) (46 g, 40.5%) was obtained as a colorless oil.
IR (film, cm-1): 3453, 2954, 2858, 1737, 1462, 1428, 1379, 1272, 1195, 1111, 1032, 934, 823, 702.
1H-NMR (500 MHz, in CDClThree, ppm): 7.66 (4H, m), 7.42 (2H, m), 7.38 (4H, m), 4.17 (1H, dt, J = 10.7, 4.7Hz), 3.88 (1H, bs), 3.62 (3H, s), 2.61 (1H, m), 1.85 to 1.65 (5H, m), 1.06 (9H, s), 0.96 (3H, d, J = 7.2Hz).
[α]D twenty five : +39.4 (c = 0.95, CHClThree)
[0120]
b) Methyl (1S, 3S, 4R, 5S) -3-tert-butyldiphenylsilyloxy-5-mesyloxy-4-methyl-cyclohexanecarboxylate 3.3. c (R = Me, L = OMs, P = TBDPS, A = COOCH3)
3.2. c (R = Me, P = TBDPS, A = COOCH3) To 3.4. d (R = Et, L = OMs, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 84.5%.
IR (film): 2952, 1732, 1470, 1427, 1357, 1275, 1177, 1112, 1029, 929, 904 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 7.65 (4H, t, J = 8.0 Hz), 7.40 (6H, m), 4.80 (1H, bs), 4.06 (1H, m), 3.65 (3H, s), 2.70 (3H, s) , 2.58 (1H, m), 2.04 (1H, bs), 1.98 to 1.76 (4H, m), 1.06 (9H, s), 1.03 (3H, d, J = 7.2 Hz). [Α]D twenty five : +30.3 (c = 0.52, CHClThree)
[0121]
c) (1R, 2S, 3aR, 4aR) -3a-carbomethoxy-2-tert-butyldiphenylsilyloxy-1-methyl-bicyclo [3.1.0] hexane e. 1 (R = Me, P = TBDPS, A = COOCH3)
3.3. c (R = Me, L = OMs, P = TBDPS, A = COOCH3From I.). a. 7 (R = Me, P = TBDPS, A = COOCH3The reaction was carried out in the same manner as in (1). The yield was 68.8%.
IR (film): 2951, 1725, 1428, 1259, 1238, 1111, 880, 814, 742, 702 cm-1.1H-NMR (500 MHz, in CDClThree, ppm): 7.63 (4H, m), 7.45-7.35 (6H, m), 3.84 (1H, m), 3.64 (3H, s), 2.23 (1H, m), 2.02 (1H, m), 1.93 ( 1H, m), 1.60 (1H, m), 1.17 (1H, m), 1.04 (12H, bs), 0.56 (1H, m).
[0122]
Example 36: (2R, 3aS, 4aS) -2-methyl-2-hydroxy-3a-hydroxymethyl-bicyclo [3.1.0] hexane: I. i. 1 (A = CH2OH, R1= Me: Scheme 4)
a) (2R, 3aS, 4aS) -2-Hydroxy-3a-[(benzoyloxy) methyl] -bicyclo [3.1.0] hexane: 4.1
I. a. 5 (R = H, P = TBDPS, A = CH2OH) (4.451 g, 12.15 mmol), DMAP (250 mg, 2.27 mmol) and Et.3N (16.5 ml, 121.1 mmol) CH2Cl2Benzoyl chloride was added dropwise to the (50 ml) solution (0 ° C.). The mixture was stirred for 22 hours at room temperature and 70 ml CH2Cl2Diluted with The organic layer was separated and washed with saturated brine (3 x 100 ml), MgSO4And dried. The residue was purified by flash chromatography (silica gel, isooctane / EtOAc: 100: 2.5) to give the corresponding benzoate (5.51 g, 96.5%) as a colorless oil. TBAF (14 ml, 14 mmol, 1M in THF) was added to a solution of this benzoate (2.22 g, 4.72 mmol) in THF (40 ml) and the resulting solution was stirred at room temperature for 14 hours. The solvent was evaporated under vacuum. The residue was passed through a short silica gel column (isooctane / EtOAc: 7: 3). The crude product was purified by HPLC (isooctane / EtOAc: 7: 3) to give compound 4.1 (1.03 g, 94.0%) as a colorless oil.
IR (film): 3413.8, 2928.3, 1714.1, 1602.1, 1452.1, 1277.5, 1115.1, 1070.0, 958.3, 808.3, 711.5 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.06 (2H, d, J = 7.8Hz), 7.56 (1H, t, J = 7.3Hz), 7.45 (1H, t, J = 7.7Hz), 4.48 (1H, m), 4.34 (2H , dd, J = 19.4, 11.5Hz), 2.23 (2H, m), 1.94 (1H, d, J = 14.0Hz), 1.78 (1H, d, J = 14.2Hz), 1.38 (1H, ddd, J = 8.3, 4.3, 4.3Hz), 1.30 (1H, bs), 1.06 (1H, t, J = 4.4Hz), 0.75 (1H, m)
MS (m / z): 232 (M+, 1), 214 (1), 199 (1), 189 (1), 161 (1), 149 (1), 127 (1), 110 (13), 105 (100), 77 (43). (14).
[α]D twenty five : -27.96 (c = 1.47, CHClThree).
[0123]
b) (3aS, 4aS) -3a-[(Benzoyloxy) methyl] -bicyclo [3,1,0] hexan-2-one: 4.2
Alcohol 4.1 (209 mg, 0.904 mmol) in CH2Cl2(30 ml) To the solution was added pyridinium dichromate (PDC, 1.072 g, 4.97 mmol) and the resulting mixture was stirred at room temperature for 16 hours. The resulting solution was directly purified by flash chromatography (silica gel column 3 × 15 cm) (isooctane / EtOAc: 9: 1 to 8: 2) to give compound 4.2 (197 mg, 95%) as a colorless oil Obtained as a thing.
IR (film): 1745.0, 1715.9, 1451.2, 1355.4, 1272.1, 1155.7, 1111.3, 1069.9,
711.0 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.05 (2H, d, J = 8.9Hz), 7.58 (1H, t, J = 7.4Hz), 7.46 (2H, t, J = 7.6Hz), 4.41 (2H, dd, J = 29.6, 12.7Hz), 2.75 (2H, m), 2.41 (1H, d, J = 9.0Hz), 2.28 (1H, d, J = 9.3Hz), 1.68 (1H, m), 1.10 (1H, t, J = 7.0Hz), 0.37 (1H, t, J = 5.1Hz).
MS (m / z): 230 (M+, 1), 212 (1), 202 (6.9), 183 (1), 161 (1), 149 (1), 125 (1), 106 (13), 105 (100), 77 (46), 51 (20).
[α]D twenty five : -36.50 (c = 4.07, CHClThree)
[0124]
c) (2R, 3aS, 4aS) -2-methyl-2-hydroxy-3a-hydroxymethyl-bicyclo [3.1.0] hexane i. 1 (R1= Me, A = CH2OH)
A solution of ketone 4.2 (120 mg, 0.52 mmol) in THF (4 ml) with MeMgBr in Et.2O (1.5 ml, 3.0 M) solution was added dropwise at −78 ° C. over 5 minutes. The resulting mixture was stirred at this temperature for 6 hours and then allowed to return to room temperature overnight. Ice-cooled saturated NH4Cl aqueous solution (0.2 ml) was added to terminate the reaction. The resulting mixture was added MgSO4Through a short silica gel column with The residue was separated by HPLC (isooctane / EtOAc: 5: 5). i. 1 (R1= Me, A = CH2OH) (55 mg, 74%) was obtained as a white solid.
IR (film):: 3288.4, 2931.3, 2858.5, 1459.1, 1370.2, 1260.7, 1183.9, 1135.7,1111.5, 1064.0, 1016.0, 922.6 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 3.58 (2H, s), 2.08 (1H, d, J = 13.7Hz), 2.03 (1H, dd, J = 13.8, 5.0Hz), 1.88 (1H, d, J = 13.7Hz), 1.76 (1H, d, J = 13.8Hz), 1.34 (3H, s), 1.29 (1H, bs), 1.21 (1H, m), 1.14 (1H, t, J = 4.3Hz), 1.11 (1H, s) , 0.57 (1H, dd, J = 8.4, 4.5Hz).
MS (m / z): 124 (2), 109 (6), 93 (12), 81 (12), 71 (10), 67 (10), 55 (11), 43 (100).
[α]D twenty five : -33.10 (c = 1.17, MeOH)
[0125]
Example 37: (2R, 3aS, 4aS) -2-methyl-2-hydroxy-3a-formyl-bicyclo [3.1.0] hexane i. 2 (R1= Me, A = CHO)
SO3-DMSO: CH of pyridine complex (2.5 eq, 140 mg)2Cl2(500 μL: 250 μL) and Et3N (2.5 eq, 120 μL) solution with I.V. i. 1 (R1= Me, A = CH2OH) (1 eq, 50 mg, 35 μmol) of DMSO: CH2Cl2(500 μL: 250 μL) and Et3N (2.5 eq, 120 μL) solution was added at −15 ° C. After stirring at −10 ° C. to −5 ° C. for 1 hour, the mixture was added to Et.2O: Poured into saturated saline. The organic layer was then dried (MgSO4). After evaporating the solvent, the residue was subjected to column chromatography (Et2O: Isooctane 1: 1 to Et2O: Isooctane: Methanol: CH2Cl2100: 100: 1: 20). i. 2 (R1= Me, A = CHO) as a colorless oil (37 mg, 75%).
IR (film): 3441, 2929, 1694, 1435, 1258, 1105, 1049, 963, 893 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 8.81 (1H, s), 2.47 (1H, d, J = 14Hz), 2.03 (2H, m), 1.91 (1H, t, J = 5Hz), 1.88 (1H, d, J = 13Hz) , 1.81 (1H, d, J = 14Hz), 1.49 (1H, ddt, J = 9,5, 1Hz), 1.36 (3H, s).
[α]D twenty five : -79.7 (c = 1.22, CHClThree)
[0126]
Example 38: (2R, 3aS, 4aS) -2-ethyl-2-hydroxy-3a-hydroxymethyl-bicyclo [3.1.0] hexane i. 3 (A = CH2OH, R1= Et) (Scheme 4)
From 4.2, I.I. i. 1 (R1= Me, A = CH2Reaction was carried out in the same manner as in (OH). The yield was 66.6%.
IR (film):: 3275.4, 2921.3, 2858.5, 1431.8, 1284.3, 1237.3, 1122.3, 1068.0, 1027.8, 930.7 cm-1
1H-NMR (500 MHz, in CDClThree, ppm): 3.59 (2H, d, J = 5.6Hz), 2.03 (1H, d, J = 13.6Hz), 1.99 (1H, dd, J = 13.9, 4.9Hz), 1.83 (1H, d, J = 13.7Hz), 1.72 (1H, d, J = 13.8Hz), 1.55 (2H, q, J = 6.4), 1.23 (2H, m), 1.16 (1H, t, J = 4.2Hz), 1.04 (1H, s), 0.92 (3H, t, 7.4Hz), 0.54 (1H, dd, J = 8.4, 4.3Hz).
MS (m / z): 138 (2), 123 (4), 109 (12.9), 97 (2), 91 (6), 79 (20), 72 (6), 67 (12.9), 57 (100 ), 43 (8).
[α]D twenty five : -34.90 (c = 0.928, MeOH)
[0127]
Example 39: (2R, 3aS, 4aS) -2-ethyl-2-hydroxy-3a-formyl-bicyclo [3.1.0] hexane i. 4 (A = CHO, R1= Et)
I. i. 3 (R1= Et, A = CH2OH) to I.I. i. 2 (R1= Me, A = CHO). The yield was 50%.
IR (film): 3418, 2966, 1689, 1114, 1057, 982, 632 cm-1 ;
1H-NMR (500 MHz, in CDClThree, ppm): 8.80 (1H, s), 2.09 (2H, m), 1.92 (1H, t, J = 5.0Hz), 1.83 (1H, d, J = 13.3Hz), 1.69 (1H, d, J = 10.0Hz), 1.57 (2H, m), 1.49 (1H, m), 1.15 (1H, s), 0.93 (3H, t, J = 7.4Hz).
[α]D twenty five : -68.1 (c = 0.30, CHClThree)
[0128]
Example 40: (2R, 3aS, 4aS) -2-[(t-butyldiphenylsilyloxy) -methyl] -3a-hydroxymethyl-bicyclo [3.1.0] hexane j. 1 (A = CH2OH, P = TBDPS) (Scheme 4)
a) (3aS, 4aS) -2-Methylene-3a-[(benzoyloxy) methyl] -bicyclo [3.1.0] hexane 4.3
Stirred lead powder (5.75 g) CH2Br2(2.02 ml) and THF (40 ml) in TiCl over 10 minutes at −78 ° C.4Was dripped. The mixture was heated to 8 ° C. and stirred at this temperature for 72 hours to give a dark gray slurry of the active ingredient (Lombardo reagent).
[0129]
Ketone 4.2 (98 mg, 0.426 mmol) in CH2Cl2To the (8 ml) solution, Lombardo reagent was added at room temperature in portions until no ketone was present (TLC). The reaction mixture is Et.2Dilute with O (40 ml) and add saturated NaHCO3And stirring was continued for 30 minutes to form two clear layers. Etch the water layer2O (3 × 25 ml) and CH2Cl2Extracted (2 × 25 ml). Combined organic layer is MgSO4And dried. The residue was purified by flash chromatography (silica gel: pentane / ether: 100: 1) to give compound 4.3 (66 mg, 67.9%) as a colorless oil.
IR (film): 2925.8, 1715.6, 1451.5,1269.7, 1111.0, 1069.0, 1026.1, 741.9, 710.7 IR (film): 2925.8, 1715.6, 1451.5,1269.7, 1111.0, 1069.0, 1026.1, 741.9, 710.7-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.07 (2H, d, J = 7.3Hz), 7.56 (1H, t, J = 7.4Hz), 7.45 (2H, t, J = 7.7Hz), 4.81 (2H, d, J = 12.4Hz) ), 4.38 (2H, s), 2.68 (2H, m), 2.43 (1H, d, J = 15.4Hz), 2.28 (1H, d, J = 15.6Hz), 1.36 (1H, m), 0.68 (1H , t, J = 6.5Hz), 0.39 (1H, t, J = 4.5Hz).
MS (m / z): 228 (M+, 1), 213 (1), 199 (1), 181 (2), 169 (1), 141 (1), 123 (5), 105 (100), 91 (88), 77 (57), 65 (7), 51 (20).
[α]D twenty five : -51.90 (c = 1.73, CHClThree)
[0130]
b) (2R, 3aS, 4aS) -2-[(t-butyldiphenylsilyloxy) -methyl] -3a-hydroxymethyl-bicyclo [3.1.0] hexane j. 1 (A = CH2OH, P = TBDPS) and (2S, 3aS, 4aS) -2-[(t-butyldiphenylsilyloxy) -methyl] -3a-hydroxymethyl-bicyclo [3.1.0] hexane k. 1 (A = CH2OH, P = TBDPS)
Alkaline 4.3 (49 mg, 0.21 mmol) in THF (6 ml) at −5 ° C. with BH3. THF was added and then the reaction mixture was stirred at this temperature for 3.5 hours to react with saturated NaHCO 3.3Aqueous solution (3.9 ml) and H2O2(30%) (3.9 ml). The reaction was warmed to room temperature and stirred for 1.5 hours. This solution is2Extracted with O (2 × 20 ml) and EtOAc (2 × 20 ml). Combined organic layer is MgSO4Dried over and concentrated. The residue was passed through a short silica gel column and the crude product was purified by HPLC (isooctane / EtOAc: 7: 3) to give the epimer hydroxylated product (2R: 2S; ratio, 75:25, 39 mg, 73.7). %) As a colorless oil.
To a DMF (3 ml) solution of this mixture (35 mg, 0.142 mmol), imitazole (49 mg, 0.720 mmol, 5 eq.) And DMAP (7.8 mg, 0.064 mmol, 0.45 eq.). TBDPSCl was added dropwise at −0 ° C .; the resulting mixture was stirred at room temperature for 19 hours. The reaction solution is Et.2Poured into O / water (50 ml / 40 ml). And the water layer is Et2Extracted with O (3 × 20 ml) and EtOAc (2 × 20 ml). Combined organic layer is MgSO4Dried over and concentrated. The residue was purified by flash chromatography (silica gel: isooctane / EtOAc: 100: 2) to give the corresponding silyl ether (56 mg, 81.3%) as a colorless oil.
Stir this mixture (50 mg, 0.106 mmol) in MeOH (0.2 ml H).26 ml) solution with O at room temperature2CO3(50 mg, 0.505 mmol) was added. The mixture was stirred at room temperature for 20 hours, the solid was filtered and the filtrate was Et.2Dilute with O (50 ml) and wash with saturated brine (2 × 20 ml), MgSO 44And the solvent was evaporated. The residue was passed through a short silica gel column and separated by HPLC (isooctane / EtOAc: 75:25). j. 1 (A = CH2OH, P = TBDPS) (24 mg, 61.8%) and I.I. k. 1 (A = CH2(OH, P = TBDPS) (8 mg, 20.4%) was obtained as a colorless oil.
MS (m / z): 379 (M+-1, 1), 305 (1), 275 (2), 229 (2), 199 (47), 181 (7), 107 (100), 79 (53).
Compound I. j. 1 (A = CH2OH, P = TBDPS)
IR (film): 3342.5, 2930.3, 2858.0, 1471.8, 1427.7, 1389.8, 1111.9, 1008.2, 823.7, 739.7, 701.6 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 7.64 (4H, d, J = 7.8Hz), 7.45-7.35 (6H, m), 3.54 (2H, dd, J = 14.4, 11.2Hz), 3.41 (2H, d, J = 7.4Hz) , 2.61 (1H, m), 2.19 to 2.09 (2H, m), 1.64 (1H, dd, J = 13.5, 4.8Hz), 1.47 (1H, dd, J = 13.6, 4.6Hz), 1.26 (1H, bs ), 1.18 (1H, dt, J = 8.6, 4.3, 4.3Hz), 1.02 (9H, s), 0.62 (1H, dd, J = 8.4, 4.7Hz), 0.35 (1H, t, J = 4.4Hz) .
[α]D twenty five : -13.05 (c = 1.40, CHClThree)
[0131]
Compound I. k. 1 (A = CH2OH, P = TBDPS)
IR (film): 3342.5, 2929.9, 2856.7, 1471.6, 1427.7, 1388.8, 1111.9, 1086.1, 1031.5, 1008.5, 823.7, 739.3, 701.5 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 7.64 (4H, d, J = 6.7Hz), 7.39 (6H, m), 3.64 (1H, d, J = 11.2Hz), 3.57 (3H, d, J = 7.8Hz), 1.97 to 1.87 (2H, m), 1.80 (1H, dd, J = 12.3, 7.0Hz), 1.56 (2H, m), 1.22 (1H, m), 1.15 (1H, ddd, J = 8.3, 4.1, 4.1Hz), 1.02 (9H, s), 0.52 (1H, t, J = 4.3Hz), 0.41 (1H, dd, J = 8.0, 5.0Hz).
[Α]D 25 : -6.16 (c = 1.65, CHCl3)
[0132]
Example 41: (2R, 3aS, 4aS) -2-[(t-butyldiphenylsilyloxy) -methyl] -3a-formyl-bicyclo [3.1.0] j. 2 (A = CHO, P = TBDPS) (Scheme 4)
(COCl)2(30 μl, 0.344 mmol) of CH2Cl2(1 ml) in solution at −78 ° C. with DMSO (36.6 μL, 0.515 mmol) in CH.2Cl2(100 μL) solution was added dropwise. The mixture was stirred at −78 ° C. for 20 minutes. j. 1 (A = CH2OH, P = TBDPS) (14 mg, 0.37 mmol) in CH2Cl2(0.5 ml) solution was added. The resulting cloudy liquid was stirred at −78 ° C. for 20 minutes, and Et.3N (0.2 ml, 1.435 mmol) was added dropwise and stirred for 20 minutes. The mixture was then heated to room temperature over 1 hour. Cold water is added to terminate the reaction, the organic layer is separated, and the aqueous layer is2Extract with O (3 x 50 ml) and MgSO4And dried. The residue was separated by HPLC (hexane / EtOAc 95: 5) to give compound I.I. j. 2 (A = CHO, P = TBDPS) (4 mg, 28.7%) was obtained as a colorless oil.
IR (film): 2931, 2858, 1699, 1428, 1112, 824, 740, 613 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.83 (1H, s), 7.63 (4H, d, J = 7.4Hz), 7.68-7.35 (6H, m), 3.43 (2H, d, J = 5.5Hz), 2.68 (2H, m) , 2.18 (1H, m), 2.02 (1H, m), 1.59 (1H, m), 1.51 (1H, d, J = 8.0Hz), 1.25 (1H, bs), 1.02 (9H, s), 0.90 ( 1H, m).
MS (m / z): 337 (4), 307 (2), 293 (4), 259 (2), 217 (9), 199 (54), 183 (20), 135 (24), 105 (30 ), 93 (100)
[α]D twenty five : -52.6 (c = 0.27, CHClThree).
[0133]
Example 42: (2S, 3aS, 4aS) -2-[(t-butyldiphenylsilyloxy) -methyl] -3a-formyl-bicyclo [3.1.0] hexane k. 2 (A = CHO, P = OTBDPS) (Scheme 4)
I. k. 1 (A = CH2OH, P = TBDPS). j. The reaction was carried out in the same manner as 2 (A = CHO, P = TBDPS). The yield was 92.8%.
IR (film): 2932, 2858, 1703, 1471, 1427, 1112, 824, 741, 702 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.96 (1H, s), 7.63 (4H, m), 7.48-7.35 (6H, m), 3.58 (2H, m), 2.05-1.88 (5H, m), 1.62 (1H, m), 1.34 (1H, dd, J = 8.5, 5.5Hz), 1.20 (1H, t, J = 5.4Hz), 1.02 (9H, s).
MS (m / z): 337 (15), 259 (14), 231 (30), 199 (100), 137 (20), 93 (60), 77 (70).
[0134]
Example 43: (2S, 3aS, 4aS) -2-methyl-2-hydroxy-3a-hydroxymethyl-bicyclo [3.1.0] hexane l. 1 (A = CH2OH, R1= CH3(Scheme 4)
Hg (OAc)2A solution of olefin 4.3 (164 mg, 0.719 mmol) in THF (1.5 ml) was added dropwise to a solution of (350 mg, 1.10 mmol) in water (1.5 ml). After stirring for 30 minutes at room temperature, aqueous NaOH (1.5 ml, 3N), then 0.5M NaBH4Of 3N NaOH (1.5 ml) was added. The resulting mixture was stirred at room temperature for 2 hours until most of the mercury solidified. The solid was filtered. The filtrate is Et2Extracted with O (2 × 30 ml) and EtOAc (2 × 30 ml). K on residue2CO3(500 mg, 5.05 mmol) and MeOH (2 ml) were added. The mixture was stirred at room temperature for 20 hours and the reaction mixture was passed through a short silica gel column. The crude product was purified by HPLC (cyclohexane / EtOAc: 62:45) to give compound I.I. l. 1 (A = CH2OH, R1= Me) and I.I. i. 1 (A = CH2OH, R1= Me) (ratio: 3: 1, 68 mg, 66.6%) was obtained as a colorless oil.
IR (film):: 3288.4, 2931.3, 2858.5, 1459.1, 1370.2, 1260.7, 1183.9, 1135.7,1111.5, 1064.0, 1016.0, 922.6 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 4.02 (1H, d, J = 10.7Hz), 3.07 (1H, d, J = 10.7Hz), 2.05 (2H, m), 1.65 (1H, bs), 1.52 (1H, d, J = 12.8Hz), 1.37 (3H, m), 1.25 (3H, s), 1.05 (1H, dd, J = 8.0, 4.8Hz), 0.49 (1H, t, J = 4.3Hz).
[0135]
Example 44: (2S, 3aS, 4aS) -2-methyl-2-hydroxy-3a-formyl-bicyclo [3.1.0] hexane l. 2 (A = CHO, R1= Me) (Scheme 4)
I. l. 1 (A = CH2OH, R1= Me) from I.I. j. The reaction was carried out in the same manner as 2 (A = CHO, P = TBDPS). The yield was 48.2%.
IR (film): 3429, 2967, 2929, 1691, 1377, 1249, 1102, 1036, 668 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.90 (1H, s), 2.66 (1H, dd, J = 14.3, 2.4Hz), 1.98 (2H, m), 1.88 (1H, dd, J = 8.5, 5.2Hz), 1.65 (1H, bs), 1.51 (2H, t, J = 14.2Hz), 1.31 (3H, s), 1.14, (1H, t, J = 5.2Hz).
MS (m / z): 140 (M+, 2), 123 (10), 111 (10), 97 (15), 85 (25), 71 (25), 67 (30), 48 (100).
[α]D twenty five : -99.3 (c = 1.06, CHClThree)
[0136]
Example 45: (2S, 3aS, 4aS) -2-hydroxy-2-hydroxymethyl-3a-[(benzyloxy) methyl] -bicyclo [3.1.0] hexane m (A = CH2OCOPh) (Scheme 4)
To a solution of 4.3 (65 mg, 0.285 mmol) and NMO (48 mg, 0.344 mmol, 1.21 eq) in acetone / water (5 ml: 2.5 ml) was added OsO.4 Aqueous solution (121 μl, 0.02 mmol, 4 wt%, 0.07 eq) was added at 0 ° C. The resulting solution was stirred for 39 hours at room temperature, and sodium dithionite (70 mg) and florisil (150 mg) were added. The black precipitate is filtered off and Et2Washed with O (200 ml). The solvent was removed by evaporation under vacuum. The residue is Et with a little acetone2Dissolved in O (100: 5) and filtered through Florisil. The crude mixture was separated by HPLC (cyclohexane / EtOAc: 7: 3) and almost no product, C-2 epimeric compound I.I. m was combined as a (ratio 85.15) colorless oil to give a yield of 64%.
IR (film):: 3385.5, 2927.8, 1713.7, 1451.6, 1315.2, 1274.6, 1114.7, 1070.3, 1026.2, 934.5, 711.5 cm-1.
1H-NMR (500 MHz, in CDClThree, ppm): 8.06 (2H, d, J = 7.3Hz), 7.57 (1H, t, J = 7.4Hz), 7.46 (2H, t, J = 7.6Hz), 4.48 (1H, d, J = 11.5Hz) ), 4.21 (1H, d, J = 11.5Hz), 3.49 (2H, m), 2.58 (1H, s), 2.36 (1H, s), 2.16 (1H, d, J = 14.6Hz), 2.12 (1H , dd, J = 14.2, 6.3Hz), 1.94 (1H, t, J = 14.1Hz), 1.89 (1H, t, J = 14.1Hz), 1.65 (1H, d, J = 14.2Hz), 1.07 (1H , dd, J = 8.4, 5.3Hz), 0.47 (1H, t, J = 4.6Hz).
MS (m / z): 262 (M+, 1), 244 (1), 232 (3), 213 (4), 203 (3), 176 (1), 163 (4), 145 (4), 123 (16), 105 (100), 77 (52), 67 (13).
[α]D twenty five : -11.86 (c = 1.53, CHClThree).
Claims (11)
−Rは水素又は(C1−C6)アルキルであり、
−R1は水素、(C1−C6)アルキル又は−(CH2)n−OP基であり、
−R2は水素又は−OP基であり、
−R’は(C1−C6)アルキル又はフェニルであり、
−R’’は水素、ヒドロキシル、(C1−C6)アルキル、(C1−C6)アルコキシ、(C1−C6)アルキルチオ、又は、ジ(C1−C3)アルキルアミノであり、
−Pは水素;(C1−C6)アルカノイル;(C1−C4)アルキル、ハロゲン若しくはニトロによってフェニルが任意に置換されたベンゾイル;(C1−C6)アルコキシカルボニル;各R3が独立に(C1−C6)アルキル若しくはフェニルを表す−Si(R3)3基;モノ若しくはジ(C1−C6)アルコキシ(C1−C6)アルキル;テトラヒドロフラニル;又は、テトラヒドロピラニルであり、
−nは0、1、2、3、又は、4である
で表される化合物の調製方法であって、
(i)式1
で表される化合物とリパーゼを、ビニル脂肪酸又は酸無水物中で反応させる工程、
(ii)得られた式2又は2’
で表される化合物を対応する式(I)の化合物に変換させる工程
からなる調製方法。Formula (I):
-R is hydrogen or (C 1 -C 6) alkyl,
—R 1 is hydrogen, (C 1 -C 6 ) alkyl or — (CH 2 ) n —OP group;
-R 2 is hydrogen or -OP group,
-R 'is (C 1 -C 6) alkyl or phenyl,
—R ″ is hydrogen, hydroxyl, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) alkylthio, or di (C 1 -C 3 ) alkylamino ,
-P hydrogen; (C 1 -C 6) alkanoyl; (C 1 -C 4) alkyl, benzoyl phenyl by halogen or nitro is optionally substituted; each R 3; (C 1 -C 6 ) alkoxycarbonyl —Si (R 3 ) 3 group independently representing (C 1 -C 6 ) alkyl or phenyl; mono- or di (C 1 -C 6 ) alkoxy (C 1 -C 6 ) alkyl; tetrahydrofuranyl; or tetrahydropyrani And
-N is a method for preparing a compound represented by 0, 1, 2, 3, or 4,
(I) Formula 1
(Ii) the obtained formula 2 or 2 ′
A process comprising the step of converting the compound represented by formula (I) to the corresponding compound of formula (I).
−ヒドロキシ基の保護
−エステル加水分解
−3−又は5−ヒドロキシ基の反転
−脱離基の形成
−所望のビシクロ[3.1.0]ヘキサンを形成する塩基を含んだ閉環反応
−カルボアルコキシ官能基又はカルバモイル官能基から所望の置換基Aへの変換
の1つ又は複数によって行なわれる請求項1〜8のいずれか1項に記載の方法。Step (ii) includes the following steps:
-Protection of the hydroxy group-Ester hydrolysis-Inversion of the 3- or 5-hydroxy group-Formation of a leaving group-Ring closure reaction containing a base to form the desired bicyclo [3.1.0] hexane-Carboalkoxy functionality 9. A process according to any one of claims 1 to 8 carried out by one or more transformations of a group or carbamoyl function into the desired substituent A.
で表される化合物。Formula 2 or 2 ′:
で表される化合物。Formula 1:
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99403065A EP1106618A1 (en) | 1999-12-08 | 1999-12-08 | Precursors of the A-ring of vitamin D, and method and intermediates for the preparation thereof |
| EP99403065.8 | 1999-12-08 | ||
| PCT/EP2000/012225 WO2001042251A1 (en) | 1999-12-08 | 2000-12-04 | Vitamin d precursors, method and intermediates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003535816A JP2003535816A (en) | 2003-12-02 |
| JP4970682B2 true JP4970682B2 (en) | 2012-07-11 |
Family
ID=42331606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001543549A Expired - Lifetime JP4970682B2 (en) | 1999-12-08 | 2000-12-04 | Vitamin D precursors, methods and intermediates |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP4970682B2 (en) |
| KR (1) | KR100732271B1 (en) |
| AR (1) | AR034113A1 (en) |
| IL (1) | IL150089A (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT972762E (en) | 1993-07-09 | 2004-02-27 | Theramex | NEW STRUCTURAL ANALYSIS OF VITAMIN D |
-
2000
- 2000-12-04 KR KR1020027007262A patent/KR100732271B1/en not_active Expired - Lifetime
- 2000-12-04 JP JP2001543549A patent/JP4970682B2/en not_active Expired - Lifetime
- 2000-12-05 AR ARP000106426A patent/AR034113A1/en active IP Right Grant
-
2002
- 2002-06-06 IL IL150089A patent/IL150089A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR034113A1 (en) | 2004-02-04 |
| KR20020061632A (en) | 2002-07-24 |
| IL150089A (en) | 2006-04-10 |
| JP2003535816A (en) | 2003-12-02 |
| KR100732271B1 (en) | 2007-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7915241B2 (en) | Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds | |
| Rosen et al. | Synthetic and biological studies of compactin and related compounds. 3. Synthesis of the hexalin portion of compactin | |
| JP4970682B2 (en) | Vitamin D precursors, methods and intermediates | |
| EP1235832B1 (en) | Vitamin d prescursors, method and intermediates | |
| US7339066B1 (en) | Intermediates for the synthesis of polypropionate antibiotics | |
| EP1240137B1 (en) | Method for making 24(s)-hydroxyvitamin d 2 | |
| EP1169467B1 (en) | Process for the preparation of prostaglandin precursors | |
| EP3705472B1 (en) | Method for producing prostaglandin derivative | |
| JPH11130711A (en) | Synthetic intermediate of 1α, 24,25-trihydroxyvitamin D3s and method for producing the same | |
| JP2005330191A (en) | Method for producing prostaglandin derivative, prostaglandin derivative, intermediate compound therefor and method for producing the same | |
| US20010009770A1 (en) | Process for the preparation of prostaglandin precursors | |
| Aav | Synthesis of 9, 11-secosterols intermediates | |
| JP2005068064A (en) | Process for producing boncrechinic acid and its precursor compound | |
| Peng et al. | Synthesis of (2 E, 4 E)-dienals by double formyl-olefination with an arsonium salt and its application in the syntheses of lipoxygenase metabolites of arachidonic acid | |
| JPH05246983A (en) | Vitamin d3 derivative and its production | |
| JPH0220616B2 (en) | ||
| JPH04305548A (en) | Halogeno allyl alcohol derivative | |
| WO1991009012A1 (en) | Processes for preparing prostaglandins | |
| JPH0210147B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070920 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100827 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100907 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101202 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20101202 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101210 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110106 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110201 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110420 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120217 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120321 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120405 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150413 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4970682 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |